CN111511762A - 抗cd137分子及其用途 - Google Patents
抗cd137分子及其用途 Download PDFInfo
- Publication number
- CN111511762A CN111511762A CN201780095721.7A CN201780095721A CN111511762A CN 111511762 A CN111511762 A CN 111511762A CN 201780095721 A CN201780095721 A CN 201780095721A CN 111511762 A CN111511762 A CN 111511762A
- Authority
- CN
- China
- Prior art keywords
- antibody
- ser
- amino acid
- seq
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009739 binding Methods 0.000 claims abstract description 340
- 230000027455 binding Effects 0.000 claims abstract description 339
- 239000000427 antigen Substances 0.000 claims abstract description 206
- 108091007433 antigens Proteins 0.000 claims abstract description 205
- 102000036639 antigens Human genes 0.000 claims abstract description 205
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims abstract description 195
- 239000012634 fragment Substances 0.000 claims abstract description 193
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 69
- 102000050327 human TNFRSF9 Human genes 0.000 claims abstract description 69
- 201000011510 cancer Diseases 0.000 claims abstract description 33
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 243
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims description 125
- 210000004027 cell Anatomy 0.000 claims description 124
- 241000282414 Homo sapiens Species 0.000 claims description 91
- 238000000034 method Methods 0.000 claims description 86
- 125000000539 amino acid group Chemical group 0.000 claims description 46
- 229910052717 sulfur Inorganic materials 0.000 claims description 44
- 229910052727 yttrium Inorganic materials 0.000 claims description 42
- 239000013598 vector Substances 0.000 claims description 38
- 230000000694 effects Effects 0.000 claims description 32
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 29
- 239000003814 drug Substances 0.000 claims description 27
- 241000282567 Macaca fascicularis Species 0.000 claims description 25
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 25
- 229920001184 polypeptide Polymers 0.000 claims description 23
- 229940124597 therapeutic agent Drugs 0.000 claims description 22
- 229910052720 vanadium Inorganic materials 0.000 claims description 18
- 239000013604 expression vector Substances 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 230000000903 blocking effect Effects 0.000 claims description 14
- 108091033319 polynucleotide Proteins 0.000 claims description 14
- 239000002157 polynucleotide Substances 0.000 claims description 14
- 102000040430 polynucleotide Human genes 0.000 claims description 14
- -1 said antibody Proteins 0.000 claims description 13
- 102000005962 receptors Human genes 0.000 claims description 12
- 108020003175 receptors Proteins 0.000 claims description 12
- 229960005486 vaccine Drugs 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 230000035772 mutation Effects 0.000 claims description 11
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 238000000338 in vitro Methods 0.000 claims description 9
- 230000001965 increasing effect Effects 0.000 claims description 9
- 229910052740 iodine Inorganic materials 0.000 claims description 9
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims description 9
- 230000001419 dependent effect Effects 0.000 claims description 8
- 239000003937 drug carrier Substances 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 238000013518 transcription Methods 0.000 claims description 8
- 230000035897 transcription Effects 0.000 claims description 8
- 210000005260 human cell Anatomy 0.000 claims description 7
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims description 6
- 230000002401 inhibitory effect Effects 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- 238000001959 radiotherapy Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims description 4
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 230000001093 anti-cancer Effects 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 229960004397 cyclophosphamide Drugs 0.000 claims description 3
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 2
- 229960005395 cetuximab Drugs 0.000 claims description 2
- 229960004316 cisplatin Drugs 0.000 claims description 2
- 229960002949 fluorouracil Drugs 0.000 claims description 2
- 229960004641 rituximab Drugs 0.000 claims description 2
- 229960000688 pomalidomide Drugs 0.000 claims 2
- UVSMNLNDYGZFPF-UHFFFAOYSA-N pomalidomide Chemical compound O=C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O UVSMNLNDYGZFPF-UHFFFAOYSA-N 0.000 claims 2
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 claims 1
- UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 claims 1
- 102000006306 Antigen Receptors Human genes 0.000 claims 1
- 108010083359 Antigen Receptors Proteins 0.000 claims 1
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims 1
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims 1
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims 1
- 108700005077 Viral Genes Proteins 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 238000001415 gene therapy Methods 0.000 claims 1
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims 1
- 229960004942 lenalidomide Drugs 0.000 claims 1
- GOTYRUGSSMKFNF-UHFFFAOYSA-N lenalidomide Chemical compound C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 150000003057 platinum Chemical class 0.000 claims 1
- 238000002626 targeted therapy Methods 0.000 claims 1
- 229960003433 thalidomide Drugs 0.000 claims 1
- 229960000575 trastuzumab Drugs 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 abstract description 34
- 108020004707 nucleic acids Proteins 0.000 abstract description 34
- 150000007523 nucleic acids Chemical class 0.000 abstract description 34
- 239000000203 mixture Substances 0.000 abstract description 26
- 210000001744 T-lymphocyte Anatomy 0.000 abstract description 23
- 230000002708 enhancing effect Effects 0.000 abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 230000001225 therapeutic effect Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000021633 leukocyte mediated immunity Effects 0.000 abstract description 2
- 230000003915 cell function Effects 0.000 abstract 1
- 230000008520 organization Effects 0.000 description 90
- 241000699666 Mus <mouse, genus> Species 0.000 description 63
- 108010003137 tyrosyltyrosine Proteins 0.000 description 61
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 54
- 108090000623 proteins and genes Proteins 0.000 description 53
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 44
- 235000001014 amino acid Nutrition 0.000 description 42
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 41
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 40
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 40
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 40
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 40
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 40
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 40
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 40
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 40
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 40
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 40
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 40
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 40
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 40
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 39
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 39
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 39
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 39
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 39
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 39
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 39
- 241000282693 Cercopithecidae Species 0.000 description 37
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 37
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 37
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 36
- 150000001413 amino acids Chemical class 0.000 description 36
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 35
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 35
- 229940024606 amino acid Drugs 0.000 description 35
- 108010044292 tryptophyltyrosine Proteins 0.000 description 35
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 34
- PAQUJCSYVIBPLC-AVGNSLFASA-N Glu-Asp-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PAQUJCSYVIBPLC-AVGNSLFASA-N 0.000 description 34
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 34
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 34
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 34
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 34
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 34
- 241000700159 Rattus Species 0.000 description 34
- QOIKZODVIPOPDD-AVGNSLFASA-N Tyr-Cys-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O QOIKZODVIPOPDD-AVGNSLFASA-N 0.000 description 34
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 34
- 108010015792 glycyllysine Proteins 0.000 description 34
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 32
- YYKZDTVQHTUKDW-RYUDHWBXSA-N Phe-Gly-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N YYKZDTVQHTUKDW-RYUDHWBXSA-N 0.000 description 32
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 32
- 108010017391 lysylvaline Proteins 0.000 description 32
- SZQCDCKIGWQAQN-FXQIFTODSA-N Cys-Arg-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O SZQCDCKIGWQAQN-FXQIFTODSA-N 0.000 description 31
- 241001465754 Metazoa Species 0.000 description 31
- 241000699670 Mus sp. Species 0.000 description 31
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 31
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 29
- OWFGFHQMSBTKLX-UFYCRDLUSA-N Val-Tyr-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N OWFGFHQMSBTKLX-UFYCRDLUSA-N 0.000 description 29
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 29
- 239000003795 chemical substances by application Substances 0.000 description 29
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 28
- HXWALXSAVBLTPK-NUTKFTJISA-N Leu-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N HXWALXSAVBLTPK-NUTKFTJISA-N 0.000 description 28
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 26
- 108010078144 glutaminyl-glycine Proteins 0.000 description 26
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 24
- 108010037850 glycylvaline Proteins 0.000 description 24
- KNMRXHIAVXHCLW-ZLUOBGJFSA-N Asp-Asn-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)C(=O)O KNMRXHIAVXHCLW-ZLUOBGJFSA-N 0.000 description 23
- AMRLSQGGERHDHJ-FXQIFTODSA-N Cys-Ala-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMRLSQGGERHDHJ-FXQIFTODSA-N 0.000 description 23
- YXQCLIVLWCKCRS-RYUDHWBXSA-N Gln-Gly-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N)O YXQCLIVLWCKCRS-RYUDHWBXSA-N 0.000 description 23
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 23
- OGCQGUIWMSBHRZ-CIUDSAMLSA-N Leu-Asn-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OGCQGUIWMSBHRZ-CIUDSAMLSA-N 0.000 description 23
- QUCDKEKDPYISNX-HJGDQZAQSA-N Lys-Asn-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QUCDKEKDPYISNX-HJGDQZAQSA-N 0.000 description 23
- 241000124008 Mammalia Species 0.000 description 23
- SVGAWGVHFIYAEE-JSGCOSHPSA-N Trp-Gly-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 SVGAWGVHFIYAEE-JSGCOSHPSA-N 0.000 description 23
- NKUGCYDFQKFVOJ-JYJNAYRXSA-N Tyr-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NKUGCYDFQKFVOJ-JYJNAYRXSA-N 0.000 description 23
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 23
- 239000000872 buffer Substances 0.000 description 22
- 238000011282 treatment Methods 0.000 description 22
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 21
- GGAPHLIUUTVYMX-QWRGUYRKSA-N Gly-Phe-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)C[NH3+])CC1=CC=CC=C1 GGAPHLIUUTVYMX-QWRGUYRKSA-N 0.000 description 21
- 241000894007 species Species 0.000 description 21
- ASCFJMSGKUIRDU-ZPFDUUQYSA-N Ile-Arg-Gln Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O ASCFJMSGKUIRDU-ZPFDUUQYSA-N 0.000 description 20
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 20
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 20
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 20
- 235000018102 proteins Nutrition 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 18
- 230000000259 anti-tumor effect Effects 0.000 description 18
- 241000282472 Canis lupus familiaris Species 0.000 description 17
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 17
- XWCYBVBLJRWOFR-WDSKDSINSA-N Ser-Gln-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O XWCYBVBLJRWOFR-WDSKDSINSA-N 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 17
- BGWSLEYVITZIQP-DCPHZVHLSA-N Trp-Phe-Ala Chemical compound C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O BGWSLEYVITZIQP-DCPHZVHLSA-N 0.000 description 16
- 108010064235 lysylglycine Proteins 0.000 description 16
- FEZJJKXNPSEYEV-CIUDSAMLSA-N Arg-Gln-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FEZJJKXNPSEYEV-CIUDSAMLSA-N 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 15
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 15
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 15
- DNAZKGFYFRGZIH-QWRGUYRKSA-N Gly-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 DNAZKGFYFRGZIH-QWRGUYRKSA-N 0.000 description 15
- BURPTJBFWIOHEY-UWJYBYFXSA-N Tyr-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BURPTJBFWIOHEY-UWJYBYFXSA-N 0.000 description 15
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 15
- 230000028993 immune response Effects 0.000 description 15
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 14
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 14
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 14
- 210000004881 tumor cell Anatomy 0.000 description 14
- PRLPSDIHSRITSF-UNQGMJICSA-N Arg-Phe-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PRLPSDIHSRITSF-UNQGMJICSA-N 0.000 description 13
- 241000880493 Leptailurus serval Species 0.000 description 13
- 210000004602 germ cell Anatomy 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 238000006467 substitution reaction Methods 0.000 description 13
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 12
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 12
- FIDMVVBUOCMMJG-CIUDSAMLSA-N Ser-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO FIDMVVBUOCMMJG-CIUDSAMLSA-N 0.000 description 12
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 12
- JVYIGCARISMLMV-HOCLYGCPSA-N Val-Gly-Trp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N JVYIGCARISMLMV-HOCLYGCPSA-N 0.000 description 12
- 230000000118 anti-neoplastic effect Effects 0.000 description 12
- 108010013835 arginine glutamate Proteins 0.000 description 12
- 238000003556 assay Methods 0.000 description 12
- 230000037396 body weight Effects 0.000 description 12
- 238000000684 flow cytometry Methods 0.000 description 12
- 239000003446 ligand Substances 0.000 description 12
- 238000010186 staining Methods 0.000 description 12
- 108010061238 threonyl-glycine Proteins 0.000 description 12
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 11
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 11
- OBXVZEAMXFSGPU-FXQIFTODSA-N Ser-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)CN=C(N)N OBXVZEAMXFSGPU-FXQIFTODSA-N 0.000 description 11
- ULVMNZOKDBHKKI-ACZMJKKPSA-N Ser-Gln-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ULVMNZOKDBHKKI-ACZMJKKPSA-N 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- NUQZCPSZHGIYTA-HKUYNNGSSA-N Tyr-Trp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N NUQZCPSZHGIYTA-HKUYNNGSSA-N 0.000 description 11
- 239000000556 agonist Substances 0.000 description 11
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 11
- 108010068265 aspartyltyrosine Proteins 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000013595 glycosylation Effects 0.000 description 11
- 238000006206 glycosylation reaction Methods 0.000 description 11
- PQWTZSNVWSOFFK-FXQIFTODSA-N Arg-Asp-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)CN=C(N)N PQWTZSNVWSOFFK-FXQIFTODSA-N 0.000 description 10
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 10
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 10
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 10
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 10
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 210000000987 immune system Anatomy 0.000 description 10
- JEOCWTUOMKEEMF-RHYQMDGZSA-N Arg-Leu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEOCWTUOMKEEMF-RHYQMDGZSA-N 0.000 description 9
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 9
- KRRMJKMGWWXWDW-STQMWFEESA-N Gly-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KRRMJKMGWWXWDW-STQMWFEESA-N 0.000 description 9
- KOSWSHVQIVTVQF-ZPFDUUQYSA-N Leu-Ile-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KOSWSHVQIVTVQF-ZPFDUUQYSA-N 0.000 description 9
- YOPQYBJJNSIQGZ-JNPHEJMOSA-N Thr-Tyr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 YOPQYBJJNSIQGZ-JNPHEJMOSA-N 0.000 description 9
- CXPJPTFWKXNDKV-NUTKFTJISA-N Trp-Leu-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CXPJPTFWKXNDKV-NUTKFTJISA-N 0.000 description 9
- BABINGWMZBWXIX-BPUTZDHNSA-N Trp-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BABINGWMZBWXIX-BPUTZDHNSA-N 0.000 description 9
- SMLCYZYQFRTLCO-UWJYBYFXSA-N Tyr-Cys-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O SMLCYZYQFRTLCO-UWJYBYFXSA-N 0.000 description 9
- 230000009260 cross reactivity Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 9
- 108010089804 glycyl-threonine Proteins 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 230000001404 mediated effect Effects 0.000 description 9
- 102000014914 Carrier Proteins Human genes 0.000 description 8
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 8
- GWCJMBNBFYBQCV-XPUUQOCRSA-N Gly-Val-Ala Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O GWCJMBNBFYBQCV-XPUUQOCRSA-N 0.000 description 8
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 8
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 8
- 108091008324 binding proteins Proteins 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- RGKKALNPOYURGE-ZKWXMUAHSA-N Asp-Ala-Val Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O RGKKALNPOYURGE-ZKWXMUAHSA-N 0.000 description 7
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 7
- 108010076504 Protein Sorting Signals Proteins 0.000 description 7
- FMDHKPRACUXATF-ACZMJKKPSA-N Ser-Gln-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O FMDHKPRACUXATF-ACZMJKKPSA-N 0.000 description 7
- FKZSXTKZLPPHQU-GQGQLFGLSA-N Ser-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CO)N FKZSXTKZLPPHQU-GQGQLFGLSA-N 0.000 description 7
- GVIGVIOEYBOTCB-XIRDDKMYSA-N Ser-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC(C)C)C(O)=O)=CNC2=C1 GVIGVIOEYBOTCB-XIRDDKMYSA-N 0.000 description 7
- VJOWWOGRNXRQMF-UVBJJODRSA-N Val-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 VJOWWOGRNXRQMF-UVBJJODRSA-N 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 7
- 210000004408 hybridoma Anatomy 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- WZGZDOXCDLLTHE-SYWGBEHUSA-N Ala-Trp-Ile Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 WZGZDOXCDLLTHE-SYWGBEHUSA-N 0.000 description 6
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 6
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 6
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 6
- ITGFVUYOLWBPQW-KKHAAJSZSA-N Asp-Thr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ITGFVUYOLWBPQW-KKHAAJSZSA-N 0.000 description 6
- CXEFNHOVIIDHFU-IHPCNDPISA-N Asp-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC(=O)O)N CXEFNHOVIIDHFU-IHPCNDPISA-N 0.000 description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 6
- 229940116741 CD137 agonist Drugs 0.000 description 6
- BVFQOPGFOQVZTE-ACZMJKKPSA-N Cys-Gln-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O BVFQOPGFOQVZTE-ACZMJKKPSA-N 0.000 description 6
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- LBRCLQMZAHRTLV-ZKWXMUAHSA-N Ile-Gly-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LBRCLQMZAHRTLV-ZKWXMUAHSA-N 0.000 description 6
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 6
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 6
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 6
- LOLUPZNNADDTAA-AVGNSLFASA-N Leu-Gln-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LOLUPZNNADDTAA-AVGNSLFASA-N 0.000 description 6
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 6
- GRIUMVXCJDKVPI-IZPVPAKOSA-N Thr-Thr-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GRIUMVXCJDKVPI-IZPVPAKOSA-N 0.000 description 6
- MWUYSCVVPVITMW-IGNZVWTISA-N Tyr-Tyr-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 MWUYSCVVPVITMW-IGNZVWTISA-N 0.000 description 6
- 101150027964 ada gene Proteins 0.000 description 6
- 235000009582 asparagine Nutrition 0.000 description 6
- 229960001230 asparagine Drugs 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 6
- 108010010147 glycylglutamine Proteins 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 230000004614 tumor growth Effects 0.000 description 6
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 5
- PBSOQGZLPFVXPU-YUMQZZPRSA-N Arg-Glu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PBSOQGZLPFVXPU-YUMQZZPRSA-N 0.000 description 5
- RXBGWGRSWXOBGK-KKUMJFAQSA-N Asp-Lys-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RXBGWGRSWXOBGK-KKUMJFAQSA-N 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 5
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 5
- OYTPNWYZORARHL-XHNCKOQMSA-N Gln-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N OYTPNWYZORARHL-XHNCKOQMSA-N 0.000 description 5
- GHAXJVNBAKGWEJ-AVGNSLFASA-N Gln-Ser-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GHAXJVNBAKGWEJ-AVGNSLFASA-N 0.000 description 5
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 5
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 5
- MUENHEQLLUDKSC-PMVMPFDFSA-N His-Tyr-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CNC=N1 MUENHEQLLUDKSC-PMVMPFDFSA-N 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 5
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 5
- 241001529936 Murinae Species 0.000 description 5
- 230000004988 N-glycosylation Effects 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- OJFFAQFRCVPHNN-JYBASQMISA-N Ser-Thr-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O OJFFAQFRCVPHNN-JYBASQMISA-N 0.000 description 5
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 5
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 5
- MBLJBGZWLHTJBH-SZMVWBNQSA-N Trp-Val-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 MBLJBGZWLHTJBH-SZMVWBNQSA-N 0.000 description 5
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 5
- SFSZDJHNAICYSD-PMVMPFDFSA-N Tyr-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CC4=CC=C(C=C4)O)N SFSZDJHNAICYSD-PMVMPFDFSA-N 0.000 description 5
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 5
- SYFHQHYTNCQCCN-MELADBBJSA-N Tyr-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O SYFHQHYTNCQCCN-MELADBBJSA-N 0.000 description 5
- LUMQYLVYUIRHHU-YJRXYDGGSA-N Tyr-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUMQYLVYUIRHHU-YJRXYDGGSA-N 0.000 description 5
- 108010008355 arginyl-glutamine Proteins 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000002648 combination therapy Methods 0.000 description 5
- 229940127089 cytotoxic agent Drugs 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 210000002865 immune cell Anatomy 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 238000001990 intravenous administration Methods 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000004988 splenocyte Anatomy 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- 206010000117 Abnormal behaviour Diseases 0.000 description 4
- 208000023275 Autoimmune disease Diseases 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 4
- WTUSRDZLLWGYAT-KCTSRDHCSA-N Gly-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN WTUSRDZLLWGYAT-KCTSRDHCSA-N 0.000 description 4
- HQSKKSLNLSTONK-JTQLQIEISA-N Gly-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 HQSKKSLNLSTONK-JTQLQIEISA-N 0.000 description 4
- 101100099884 Homo sapiens CD40 gene Proteins 0.000 description 4
- NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 4
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 4
- UGCIQUYEJIEHKX-GVXVVHGQSA-N Lys-Val-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O UGCIQUYEJIEHKX-GVXVVHGQSA-N 0.000 description 4
- 102000011769 Member 9 Tumor Necrosis Factor Receptor Superfamily Human genes 0.000 description 4
- 108010037274 Member 9 Tumor Necrosis Factor Receptor Superfamily Proteins 0.000 description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 4
- 238000011887 Necropsy Methods 0.000 description 4
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 4
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 4
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 4
- 230000006052 T cell proliferation Effects 0.000 description 4
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 4
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 4
- BJCILVZEZRDIDR-PMVMPFDFSA-N Tyr-Leu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=C(O)C=C1 BJCILVZEZRDIDR-PMVMPFDFSA-N 0.000 description 4
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 4
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 4
- 239000002246 antineoplastic agent Substances 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 208000029742 colonic neoplasm Diseases 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000010494 dissociation reaction Methods 0.000 description 4
- 230000005593 dissociations Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000000099 in vitro assay Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 208000032839 leukemia Diseases 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229960004857 mitomycin Drugs 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 108010038745 tryptophylglycine Proteins 0.000 description 4
- 230000004565 tumor cell growth Effects 0.000 description 4
- 210000005253 yeast cell Anatomy 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 3
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 3
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 3
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 3
- USNJAPJZSGTTPX-XVSYOHENSA-N Asp-Phe-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O USNJAPJZSGTTPX-XVSYOHENSA-N 0.000 description 3
- 102100027207 CD27 antigen Human genes 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 108010092160 Dactinomycin Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XZLLTYBONVKGLO-SDDRHHMPSA-N Gln-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XZLLTYBONVKGLO-SDDRHHMPSA-N 0.000 description 3
- OSCLNNWLKKIQJM-WDSKDSINSA-N Gln-Ser-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O OSCLNNWLKKIQJM-WDSKDSINSA-N 0.000 description 3
- HPBKQFJXDUVNQV-FHWLQOOXSA-N Gln-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O HPBKQFJXDUVNQV-FHWLQOOXSA-N 0.000 description 3
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 3
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 3
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 3
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 3
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- XWUIHCZETFNRPA-IHPCNDPISA-N His-His-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CN=CN1 XWUIHCZETFNRPA-IHPCNDPISA-N 0.000 description 3
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 3
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 3
- QTUSJASXLGLJSR-OSUNSFLBSA-N Ile-Arg-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N QTUSJASXLGLJSR-OSUNSFLBSA-N 0.000 description 3
- NURNJECQNNCRBK-FLBSBUHZSA-N Ile-Thr-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NURNJECQNNCRBK-FLBSBUHZSA-N 0.000 description 3
- OMDWJWGZGMCQND-CFMVVWHZSA-N Ile-Tyr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMDWJWGZGMCQND-CFMVVWHZSA-N 0.000 description 3
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 3
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 3
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 3
- CQGSYZCULZMEDE-SRVKXCTJSA-N Leu-Gln-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O CQGSYZCULZMEDE-SRVKXCTJSA-N 0.000 description 3
- JRJLGNFWYFSJHB-HOCLYGCPSA-N Leu-Gly-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O JRJLGNFWYFSJHB-HOCLYGCPSA-N 0.000 description 3
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 3
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 3
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 3
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KNZQGAUEYZJUSQ-ZLUOBGJFSA-N Ser-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N KNZQGAUEYZJUSQ-ZLUOBGJFSA-N 0.000 description 3
- MUARUIBTKQJKFY-WHFBIAKZSA-N Ser-Gly-Asp Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MUARUIBTKQJKFY-WHFBIAKZSA-N 0.000 description 3
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 3
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 3
- DXPURPNJDFCKKO-RHYQMDGZSA-N Thr-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DXPURPNJDFCKKO-RHYQMDGZSA-N 0.000 description 3
- OETOOJXFNSEYHQ-WFBYXXMGSA-N Trp-Ala-Asp Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 OETOOJXFNSEYHQ-WFBYXXMGSA-N 0.000 description 3
- VEYXZZGMIBKXCN-UBHSHLNASA-N Trp-Asp-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VEYXZZGMIBKXCN-UBHSHLNASA-N 0.000 description 3
- MKDXQPMIQPTTAW-SIXJUCDHSA-N Trp-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N MKDXQPMIQPTTAW-SIXJUCDHSA-N 0.000 description 3
- PKZIWSHDJYIPRH-JBACZVJFSA-N Trp-Tyr-Gln Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKZIWSHDJYIPRH-JBACZVJFSA-N 0.000 description 3
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 3
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 3
- VCXWRWYFJLXITF-AUTRQRHGSA-N Tyr-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VCXWRWYFJLXITF-AUTRQRHGSA-N 0.000 description 3
- ANHVRCNNGJMJNG-BZSNNMDCSA-N Tyr-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)O)N)O ANHVRCNNGJMJNG-BZSNNMDCSA-N 0.000 description 3
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 108010081404 acein-2 Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 238000011374 additional therapy Methods 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 108010087924 alanylproline Proteins 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000022534 cell killing Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000009137 competitive binding Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 3
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 206010016629 fibroma Diseases 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 3
- 230000002489 hematologic effect Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 229960000485 methotrexate Drugs 0.000 description 3
- 201000000050 myeloid neoplasm Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108010031719 prolyl-serine Proteins 0.000 description 3
- 108010070643 prolylglutamic acid Proteins 0.000 description 3
- 235000004400 serine Nutrition 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 206010041823 squamous cell carcinoma Diseases 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 2
- WUHJHHGYVVJMQE-BJDJZHNGSA-N Ala-Leu-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WUHJHHGYVVJMQE-BJDJZHNGSA-N 0.000 description 2
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 2
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 2
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 description 2
- UPAGTDJAORYMEC-VHWLVUOQSA-N Asn-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)N)N UPAGTDJAORYMEC-VHWLVUOQSA-N 0.000 description 2
- NJIKKGUVGUBICV-ZLUOBGJFSA-N Asp-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O NJIKKGUVGUBICV-ZLUOBGJFSA-N 0.000 description 2
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 2
- GYWQGGUCMDCUJE-DLOVCJGASA-N Asp-Phe-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O GYWQGGUCMDCUJE-DLOVCJGASA-N 0.000 description 2
- ZVYYMCXVPZEAPU-CWRNSKLLSA-N Asp-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZVYYMCXVPZEAPU-CWRNSKLLSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 2
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
- 206010058019 Cancer Pain Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 201000009047 Chordoma Diseases 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- BPHKULHWEIUDOB-FXQIFTODSA-N Cys-Gln-Gln Chemical compound SC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O BPHKULHWEIUDOB-FXQIFTODSA-N 0.000 description 2
- CMYVIUWVYHOLRD-ZLUOBGJFSA-N Cys-Ser-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O CMYVIUWVYHOLRD-ZLUOBGJFSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- KZKBJEUWNMQTLV-XDTLVQLUSA-N Gln-Ala-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KZKBJEUWNMQTLV-XDTLVQLUSA-N 0.000 description 2
- MADFVRSKEIEZHZ-DCAQKATOSA-N Gln-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N MADFVRSKEIEZHZ-DCAQKATOSA-N 0.000 description 2
- OACQOWPRWGNKTP-AVGNSLFASA-N Gln-Tyr-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O OACQOWPRWGNKTP-AVGNSLFASA-N 0.000 description 2
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 2
- JPWIMMUNWUKOAD-STQMWFEESA-N Gly-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN JPWIMMUNWUKOAD-STQMWFEESA-N 0.000 description 2
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 2
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 2
- 241001364929 Havel River virus Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 208000017604 Hodgkin disease Diseases 0.000 description 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
- 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 description 2
- 101000679851 Homo sapiens Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 2
- NULSANWBUWLTKN-NAKRPEOUSA-N Ile-Arg-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N NULSANWBUWLTKN-NAKRPEOUSA-N 0.000 description 2
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 2
- JSLIXOUMAOUGBN-JUKXBJQTSA-N Ile-Tyr-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N JSLIXOUMAOUGBN-JUKXBJQTSA-N 0.000 description 2
- 102100029571 Immunoglobulin J chain Human genes 0.000 description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 2
- ZFNLIDNJUWNIJL-WDCWCFNPSA-N Leu-Glu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZFNLIDNJUWNIJL-WDCWCFNPSA-N 0.000 description 2
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 description 2
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- 208000014767 Myeloproliferative disease Diseases 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- KXUZHWXENMYOHC-QEJZJMRPSA-N Phe-Leu-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUZHWXENMYOHC-QEJZJMRPSA-N 0.000 description 2
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 2
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 2
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 2
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 208000006265 Renal cell carcinoma Diseases 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 2
- VQBCMLMPEWPUTB-ACZMJKKPSA-N Ser-Glu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VQBCMLMPEWPUTB-ACZMJKKPSA-N 0.000 description 2
- KQNDIKOYWZTZIX-FXQIFTODSA-N Ser-Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KQNDIKOYWZTZIX-FXQIFTODSA-N 0.000 description 2
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 2
- 108010091769 Shiga Toxin 1 Proteins 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 102100029932 Syntaxin-1A Human genes 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 206010043276 Teratoma Diseases 0.000 description 2
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 2
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 2
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- CXUFDWZBHKUGKK-CABZTGNLSA-N Trp-Ala-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O)=CNC2=C1 CXUFDWZBHKUGKK-CABZTGNLSA-N 0.000 description 2
- PITVQFJBUFDJDD-XEGUGMAKSA-N Trp-Ile Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)=CNC2=C1 PITVQFJBUFDJDD-XEGUGMAKSA-N 0.000 description 2
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 2
- GQEXFCQNAJHJTI-IHPCNDPISA-N Trp-Phe-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GQEXFCQNAJHJTI-IHPCNDPISA-N 0.000 description 2
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 2
- QARCDOCCDOLJSF-HJPIBITLSA-N Tyr-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QARCDOCCDOLJSF-HJPIBITLSA-N 0.000 description 2
- AKKYBQGHUAWPJR-MNSWYVGCSA-N Tyr-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)O AKKYBQGHUAWPJR-MNSWYVGCSA-N 0.000 description 2
- AGDDLOQMXUQPDY-BZSNNMDCSA-N Tyr-Tyr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O AGDDLOQMXUQPDY-BZSNNMDCSA-N 0.000 description 2
- FZADUTOCSFDBRV-RNXOBYDBSA-N Tyr-Tyr-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=C(O)C=C1 FZADUTOCSFDBRV-RNXOBYDBSA-N 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 2
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 2
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 2
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 2
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 2
- SDHZOOIGIUEPDY-JYJNAYRXSA-N Val-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 SDHZOOIGIUEPDY-JYJNAYRXSA-N 0.000 description 2
- QHSSPPHOHJSTML-HOCLYGCPSA-N Val-Trp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N QHSSPPHOHJSTML-HOCLYGCPSA-N 0.000 description 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 2
- 238000012452 Xenomouse strains Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000009830 antibody antigen interaction Effects 0.000 description 2
- 102000025171 antigen binding proteins Human genes 0.000 description 2
- 108091000831 antigen binding proteins Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 108010059459 arginyl-threonyl-phenylalanine Proteins 0.000 description 2
- 108010060035 arginylproline Proteins 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 229960002092 busulfan Drugs 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000012830 cancer therapeutic Substances 0.000 description 2
- 239000002771 cell marker Substances 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 229960000640 dactinomycin Drugs 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 229960000975 daunorubicin Drugs 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- 102000004419 dihydrofolate reductase Human genes 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 2
- 229960005420 etoposide Drugs 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229960003297 gemtuzumab ozogamicin Drugs 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 102000005396 glutamine synthetase Human genes 0.000 description 2
- 108020002326 glutamine synthetase Proteins 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010084760 glycyl-tyrosyl-glycyl-aspartate Proteins 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 231100000226 haematotoxicity Toxicity 0.000 description 2
- 201000011066 hemangioma Diseases 0.000 description 2
- 201000005787 hematologic cancer Diseases 0.000 description 2
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052738 indium Inorganic materials 0.000 description 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 2
- PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000008297 liquid dosage form Substances 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 229960002247 lomustine Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960004296 megestrol acetate Drugs 0.000 description 2
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 2
- 229960001924 melphalan Drugs 0.000 description 2
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 201000005962 mycosis fungoides Diseases 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 238000004091 panning Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 229960003171 plicamycin Drugs 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 239000012146 running buffer Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000007909 solid dosage form Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000012409 standard PCR amplification Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 2
- 229960001278 teniposide Drugs 0.000 description 2
- 229960001196 thiotepa Drugs 0.000 description 2
- 235000008521 threonine Nutrition 0.000 description 2
- WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229960003048 vinblastine Drugs 0.000 description 2
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 2
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 2
- 229960004528 vincristine Drugs 0.000 description 2
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 2
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 2
- LLXVXPPXELIDGQ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(2,5-dioxopyrrol-1-yl)benzoate Chemical compound C=1C=CC(N2C(C=CC2=O)=O)=CC=1C(=O)ON1C(=O)CCC1=O LLXVXPPXELIDGQ-UHFFFAOYSA-N 0.000 description 1
- COEXAQSTZUWMRI-STQMWFEESA-N (2s)-1-[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)NCC(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 COEXAQSTZUWMRI-STQMWFEESA-N 0.000 description 1
- AHOKKYCUWBLDST-QYULHYBRSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=CC=C1 AHOKKYCUWBLDST-QYULHYBRSA-N 0.000 description 1
- HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 1
- QSBWDKUBOZHGOU-UHFFFAOYSA-N 2-acetylsulfanylacetic acid Chemical compound CC(=O)SCC(O)=O QSBWDKUBOZHGOU-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 102000002627 4-1BB Ligand Human genes 0.000 description 1
- 108010082808 4-1BB Ligand Proteins 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 241000321096 Adenoides Species 0.000 description 1
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 1
- IXTPACPAXIOCRG-ACZMJKKPSA-N Ala-Glu-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N IXTPACPAXIOCRG-ACZMJKKPSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- LJFNNUBZSZCZFN-WHFBIAKZSA-N Ala-Gly-Cys Chemical compound N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O LJFNNUBZSZCZFN-WHFBIAKZSA-N 0.000 description 1
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 1
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 1
- NMXKFWOEASXOGB-QSFUFRPTSA-N Ala-Ile-His Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NMXKFWOEASXOGB-QSFUFRPTSA-N 0.000 description 1
- LBYMZCVBOKYZNS-CIUDSAMLSA-N Ala-Leu-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O LBYMZCVBOKYZNS-CIUDSAMLSA-N 0.000 description 1
- BFMIRJBURUXDRG-DLOVCJGASA-N Ala-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 BFMIRJBURUXDRG-DLOVCJGASA-N 0.000 description 1
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 1
- YYAVDNKUWLAFCV-ACZMJKKPSA-N Ala-Ser-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYAVDNKUWLAFCV-ACZMJKKPSA-N 0.000 description 1
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 1
- 239000012114 Alexa Fluor 647 Substances 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 201000003076 Angiosarcoma Diseases 0.000 description 1
- NTAZNGWBXRVEDJ-FXQIFTODSA-N Arg-Asp-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NTAZNGWBXRVEDJ-FXQIFTODSA-N 0.000 description 1
- OZNSCVPYWZRQPY-CIUDSAMLSA-N Arg-Asp-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OZNSCVPYWZRQPY-CIUDSAMLSA-N 0.000 description 1
- FBLMOFHNVQBKRR-IHRRRGAJSA-N Arg-Asp-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FBLMOFHNVQBKRR-IHRRRGAJSA-N 0.000 description 1
- VXXHDZKEQNGXNU-QXEWZRGKSA-N Arg-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N VXXHDZKEQNGXNU-QXEWZRGKSA-N 0.000 description 1
- XLWSGICNBZGYTA-CIUDSAMLSA-N Arg-Glu-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XLWSGICNBZGYTA-CIUDSAMLSA-N 0.000 description 1
- HQIZDMIGUJOSNI-IUCAKERBSA-N Arg-Gly-Arg Chemical compound N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQIZDMIGUJOSNI-IUCAKERBSA-N 0.000 description 1
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 1
- OQCWXQJLCDPRHV-UWVGGRQHSA-N Arg-Gly-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O OQCWXQJLCDPRHV-UWVGGRQHSA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- LXMKTIZAGIBQRX-HRCADAONSA-N Arg-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O LXMKTIZAGIBQRX-HRCADAONSA-N 0.000 description 1
- JOTRDIXZHNQYGP-DCAQKATOSA-N Arg-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N JOTRDIXZHNQYGP-DCAQKATOSA-N 0.000 description 1
- AIFHRTPABBBHKU-RCWTZXSCSA-N Arg-Thr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AIFHRTPABBBHKU-RCWTZXSCSA-N 0.000 description 1
- MOGMYRUNTKYZFB-UNQGMJICSA-N Arg-Thr-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MOGMYRUNTKYZFB-UNQGMJICSA-N 0.000 description 1
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- HAJWYALLJIATCX-FXQIFTODSA-N Asn-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N HAJWYALLJIATCX-FXQIFTODSA-N 0.000 description 1
- SPIPSJXLZVTXJL-ZLUOBGJFSA-N Asn-Cys-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O SPIPSJXLZVTXJL-ZLUOBGJFSA-N 0.000 description 1
- UPALZCBCKAMGIY-PEFMBERDSA-N Asn-Gln-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UPALZCBCKAMGIY-PEFMBERDSA-N 0.000 description 1
- HDHZCEDPLTVHFZ-GUBZILKMSA-N Asn-Leu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O HDHZCEDPLTVHFZ-GUBZILKMSA-N 0.000 description 1
- RAUPFUCUDBQYHE-AVGNSLFASA-N Asn-Phe-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RAUPFUCUDBQYHE-AVGNSLFASA-N 0.000 description 1
- JPPLRQVZMZFOSX-UWJYBYFXSA-N Asn-Tyr-Ala Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 JPPLRQVZMZFOSX-UWJYBYFXSA-N 0.000 description 1
- AAIUGNSRQDGCDC-ZLUOBGJFSA-N Asp-Cys-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N)C(=O)O AAIUGNSRQDGCDC-ZLUOBGJFSA-N 0.000 description 1
- DZQKLNLLWFQONU-LKXGYXEUSA-N Asp-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N)O DZQKLNLLWFQONU-LKXGYXEUSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- PGUYEUCYVNZGGV-QWRGUYRKSA-N Asp-Gly-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PGUYEUCYVNZGGV-QWRGUYRKSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 1
- UZFHNLYQWMGUHU-DCAQKATOSA-N Asp-Lys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZFHNLYQWMGUHU-DCAQKATOSA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- BWJZSLQJNBSUPM-FXQIFTODSA-N Asp-Pro-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O BWJZSLQJNBSUPM-FXQIFTODSA-N 0.000 description 1
- DWOSGXZMLQNDBN-FXQIFTODSA-N Asp-Pro-Cys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CS)C(=O)O DWOSGXZMLQNDBN-FXQIFTODSA-N 0.000 description 1
- GGRSYTUJHAZTFN-IHRRRGAJSA-N Asp-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O GGRSYTUJHAZTFN-IHRRRGAJSA-N 0.000 description 1
- DINOVZWPTMGSRF-QXEWZRGKSA-N Asp-Pro-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O DINOVZWPTMGSRF-QXEWZRGKSA-N 0.000 description 1
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 1
- KACWACLNYLSVCA-VHWLVUOQSA-N Asp-Trp-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KACWACLNYLSVCA-VHWLVUOQSA-N 0.000 description 1
- GHAHOJDCBRXAKC-IHPCNDPISA-N Asp-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N GHAHOJDCBRXAKC-IHPCNDPISA-N 0.000 description 1
- ALMIMUZAWTUNIO-BZSNNMDCSA-N Asp-Tyr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ALMIMUZAWTUNIO-BZSNNMDCSA-N 0.000 description 1
- GYNUXDMCDILYIQ-QRTARXTBSA-N Asp-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N GYNUXDMCDILYIQ-QRTARXTBSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 208000003950 B-cell lymphoma Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006417 Bronchial carcinoma Diseases 0.000 description 1
- 208000003170 Bronchiolo-Alveolar Adenocarcinoma Diseases 0.000 description 1
- 206010058354 Bronchioloalveolar carcinoma Diseases 0.000 description 1
- 101150013553 CD40 gene Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 201000005262 Chondroma Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 208000009798 Craniopharyngioma Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 102100021906 Cyclin-O Human genes 0.000 description 1
- BUIYOWKUSCTBRE-CIUDSAMLSA-N Cys-Arg-Gln Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O BUIYOWKUSCTBRE-CIUDSAMLSA-N 0.000 description 1
- KABHAOSDMIYXTR-GUBZILKMSA-N Cys-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N KABHAOSDMIYXTR-GUBZILKMSA-N 0.000 description 1
- GDNWBSFSHJVXKL-GUBZILKMSA-N Cys-Lys-Gln Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O GDNWBSFSHJVXKL-GUBZILKMSA-N 0.000 description 1
- CIVXDCMSSFGWAL-YUMQZZPRSA-N Cys-Lys-Gly Chemical compound C(CCN)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N CIVXDCMSSFGWAL-YUMQZZPRSA-N 0.000 description 1
- BCWIFCLVCRAIQK-ZLUOBGJFSA-N Cys-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N)O BCWIFCLVCRAIQK-ZLUOBGJFSA-N 0.000 description 1
- ABLQPNMKLMFDQU-BIIVOSGPSA-N Cys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CS)N)C(=O)O ABLQPNMKLMFDQU-BIIVOSGPSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- MBYXEBXZARTUSS-QLWBXOBMSA-N Emetamine Natural products O(C)c1c(OC)cc2c(c(C[C@@H]3[C@H](CC)CN4[C@H](c5c(cc(OC)c(OC)c5)CC4)C3)ncc2)c1 MBYXEBXZARTUSS-QLWBXOBMSA-N 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 201000001342 Fallopian tube cancer Diseases 0.000 description 1
- 208000013452 Fallopian tube neoplasm Diseases 0.000 description 1
- 102000009109 Fc receptors Human genes 0.000 description 1
- 108010087819 Fc receptors Proteins 0.000 description 1
- 108091006020 Fc-tagged proteins Proteins 0.000 description 1
- 108010008177 Fd immunoglobulins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 description 1
- 229940032072 GVAX vaccine Drugs 0.000 description 1
- 208000021309 Germ cell tumor Diseases 0.000 description 1
- 208000007569 Giant Cell Tumors Diseases 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- RGAOLBZBLOJUTP-GRLWGSQLSA-N Gln-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CCC(=O)N)N RGAOLBZBLOJUTP-GRLWGSQLSA-N 0.000 description 1
- TYRMVTKPOWPZBC-SXNHZJKMSA-N Gln-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCC(=O)N)N TYRMVTKPOWPZBC-SXNHZJKMSA-N 0.000 description 1
- QDXMSSWCEVYOLZ-SZMVWBNQSA-N Gln-Leu-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCC(=O)N)N QDXMSSWCEVYOLZ-SZMVWBNQSA-N 0.000 description 1
- XQDGOJPVMSWZSO-SRVKXCTJSA-N Gln-Pro-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N XQDGOJPVMSWZSO-SRVKXCTJSA-N 0.000 description 1
- UBRQJXFDVZNYJP-AVGNSLFASA-N Gln-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UBRQJXFDVZNYJP-AVGNSLFASA-N 0.000 description 1
- KVBPDJIFRQUQFY-ACZMJKKPSA-N Glu-Cys-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O KVBPDJIFRQUQFY-ACZMJKKPSA-N 0.000 description 1
- CLROYXHHUZELFX-FXQIFTODSA-N Glu-Gln-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O CLROYXHHUZELFX-FXQIFTODSA-N 0.000 description 1
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 1
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- OAGVHWYIBZMWLA-YFKPBYRVSA-N Glu-Gly-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)NCC(O)=O OAGVHWYIBZMWLA-YFKPBYRVSA-N 0.000 description 1
- KRRFFAHEAOCBCQ-SIUGBPQLSA-N Glu-Ile-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KRRFFAHEAOCBCQ-SIUGBPQLSA-N 0.000 description 1
- INGJLBQKTRJLFO-UKJIMTQDSA-N Glu-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 1
- UGSVSNXPJJDJKL-SDDRHHMPSA-N Glu-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N UGSVSNXPJJDJKL-SDDRHHMPSA-N 0.000 description 1
- CQAHWYDHKUWYIX-YUMQZZPRSA-N Glu-Pro-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O CQAHWYDHKUWYIX-YUMQZZPRSA-N 0.000 description 1
- HVKAAUOFFTUSAA-XDTLVQLUSA-N Glu-Tyr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O HVKAAUOFFTUSAA-XDTLVQLUSA-N 0.000 description 1
- LSYFGBRDBIQYAQ-FHWLQOOXSA-N Glu-Tyr-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LSYFGBRDBIQYAQ-FHWLQOOXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 1
- LGQZOQRDEUIZJY-YUMQZZPRSA-N Gly-Cys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CS)NC(=O)CN)C(O)=O LGQZOQRDEUIZJY-YUMQZZPRSA-N 0.000 description 1
- DTRUBYPMMVPQPD-YUMQZZPRSA-N Gly-Gln-Arg Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DTRUBYPMMVPQPD-YUMQZZPRSA-N 0.000 description 1
- KTSZUNRRYXPZTK-BQBZGAKWSA-N Gly-Gln-Glu Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KTSZUNRRYXPZTK-BQBZGAKWSA-N 0.000 description 1
- SIYTVHWNKGIGMD-HOTGVXAUSA-N Gly-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)CN SIYTVHWNKGIGMD-HOTGVXAUSA-N 0.000 description 1
- DENRBIYENOKSEX-PEXQALLHSA-N Gly-Ile-His Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 DENRBIYENOKSEX-PEXQALLHSA-N 0.000 description 1
- MKIAPEZXQDILRR-YUMQZZPRSA-N Gly-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN MKIAPEZXQDILRR-YUMQZZPRSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- FKYQEVBRZSFAMJ-QWRGUYRKSA-N Gly-Ser-Tyr Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FKYQEVBRZSFAMJ-QWRGUYRKSA-N 0.000 description 1
- FOKISINOENBSDM-WLTAIBSBSA-N Gly-Thr-Tyr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O FOKISINOENBSDM-WLTAIBSBSA-N 0.000 description 1
- NGBGZCUWFVVJKC-IRXDYDNUSA-N Gly-Tyr-Tyr Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 NGBGZCUWFVVJKC-IRXDYDNUSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010069236 Goserelin Proteins 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 208000002927 Hamartoma Diseases 0.000 description 1
- 208000001258 Hemangiosarcoma Diseases 0.000 description 1
- 206010019629 Hepatic adenoma Diseases 0.000 description 1
- ZNPRMNDAFQKATM-LKTVYLICSA-N His-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZNPRMNDAFQKATM-LKTVYLICSA-N 0.000 description 1
- VLPMGIJPAWENQB-SRVKXCTJSA-N His-Cys-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O VLPMGIJPAWENQB-SRVKXCTJSA-N 0.000 description 1
- ZHHLTWUOWXHVQJ-YUMQZZPRSA-N His-Ser-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZHHLTWUOWXHVQJ-YUMQZZPRSA-N 0.000 description 1
- GIRSNERMXCMDBO-GARJFASQSA-N His-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O GIRSNERMXCMDBO-GARJFASQSA-N 0.000 description 1
- FOCSWPCHUDVNLP-PMVMPFDFSA-N His-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC4=CN=CN4)N FOCSWPCHUDVNLP-PMVMPFDFSA-N 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000897441 Homo sapiens Cyclin-O Proteins 0.000 description 1
- 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 description 1
- 101000666856 Homo sapiens Vasoactive intestinal polypeptide receptor 1 Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- SJIGTGZVQGLMGG-NAKRPEOUSA-N Ile-Cys-Arg Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)O SJIGTGZVQGLMGG-NAKRPEOUSA-N 0.000 description 1
- UCGDDTHMMVWVMV-FSPLSTOPSA-N Ile-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(O)=O UCGDDTHMMVWVMV-FSPLSTOPSA-N 0.000 description 1
- NHJKZMDIMMTVCK-QXEWZRGKSA-N Ile-Gly-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N NHJKZMDIMMTVCK-QXEWZRGKSA-N 0.000 description 1
- KFVUBLZRFSVDGO-BYULHYEWSA-N Ile-Gly-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O KFVUBLZRFSVDGO-BYULHYEWSA-N 0.000 description 1
- LPFBXFILACZHIB-LAEOZQHASA-N Ile-Gly-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)N LPFBXFILACZHIB-LAEOZQHASA-N 0.000 description 1
- DFFTXLCCDFYRKD-MBLNEYKQSA-N Ile-Gly-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N DFFTXLCCDFYRKD-MBLNEYKQSA-N 0.000 description 1
- GTSAALPQZASLPW-KJYZGMDISA-N Ile-His-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N GTSAALPQZASLPW-KJYZGMDISA-N 0.000 description 1
- SVBAHOMTJRFSIC-SXTJYALSSA-N Ile-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SVBAHOMTJRFSIC-SXTJYALSSA-N 0.000 description 1
- JNLSTRPWUXOORL-MMWGEVLESA-N Ile-Ser-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N JNLSTRPWUXOORL-MMWGEVLESA-N 0.000 description 1
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022095 Injection Site reaction Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010061252 Intraocular melanoma Diseases 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
- WQWSMEOYXJTFRU-GUBZILKMSA-N Leu-Glu-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O WQWSMEOYXJTFRU-GUBZILKMSA-N 0.000 description 1
- ZRHDPZAAWLXXIR-SRVKXCTJSA-N Leu-Lys-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O ZRHDPZAAWLXXIR-SRVKXCTJSA-N 0.000 description 1
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 1
- ARNIBBOXIAWUOP-MGHWNKPDSA-N Leu-Tyr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ARNIBBOXIAWUOP-MGHWNKPDSA-N 0.000 description 1
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 206010024612 Lipoma Diseases 0.000 description 1
- 208000002404 Liver Cell Adenoma Diseases 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- GAOJCVKPIGHTGO-UWVGGRQHSA-N Lys-Arg-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O GAOJCVKPIGHTGO-UWVGGRQHSA-N 0.000 description 1
- MQMIRLVJXQNTRJ-SDDRHHMPSA-N Lys-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N)C(=O)O MQMIRLVJXQNTRJ-SDDRHHMPSA-N 0.000 description 1
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 1
- PIXVFCBYEGPZPA-JYJNAYRXSA-N Lys-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N PIXVFCBYEGPZPA-JYJNAYRXSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000012515 MabSelect SuRe Substances 0.000 description 1
- 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- VFKZTMPDYBFSTM-KVTDHHQDSA-N Mitobronitol Chemical compound BrC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CBr VFKZTMPDYBFSTM-KVTDHHQDSA-N 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 241001045988 Neogene Species 0.000 description 1
- 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 1
- 201000004404 Neurofibroma Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000010191 Osteitis Deformans Diseases 0.000 description 1
- 201000009859 Osteochondrosis Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000027868 Paget disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- NOFBJKKOPKJDCO-KKXDTOCCSA-N Phe-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NOFBJKKOPKJDCO-KKXDTOCCSA-N 0.000 description 1
- HCTXJGRYAACKOB-SRVKXCTJSA-N Phe-Asn-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HCTXJGRYAACKOB-SRVKXCTJSA-N 0.000 description 1
- ZBYHVSHBZYHQBW-SRVKXCTJSA-N Phe-Cys-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ZBYHVSHBZYHQBW-SRVKXCTJSA-N 0.000 description 1
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 1
- IEOHQGFKHXUALJ-JYJNAYRXSA-N Phe-Met-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IEOHQGFKHXUALJ-JYJNAYRXSA-N 0.000 description 1
- YMIZSYUAZJSOFL-SRVKXCTJSA-N Phe-Ser-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O YMIZSYUAZJSOFL-SRVKXCTJSA-N 0.000 description 1
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- GNRMAQSIROFNMI-IXOXFDKPSA-N Phe-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GNRMAQSIROFNMI-IXOXFDKPSA-N 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 208000007641 Pinealoma Diseases 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 201000005746 Pituitary adenoma Diseases 0.000 description 1
- 206010061538 Pituitary tumour benign Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- VXCHGLYSIOOZIS-GUBZILKMSA-N Pro-Ala-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 VXCHGLYSIOOZIS-GUBZILKMSA-N 0.000 description 1
- VOHFZDSRPZLXLH-IHRRRGAJSA-N Pro-Asn-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VOHFZDSRPZLXLH-IHRRRGAJSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- XQSREVQDGCPFRJ-STQMWFEESA-N Pro-Gly-Phe Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XQSREVQDGCPFRJ-STQMWFEESA-N 0.000 description 1
- GFHOSBYCLACKEK-GUBZILKMSA-N Pro-Pro-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O GFHOSBYCLACKEK-GUBZILKMSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- JDJMFMVVJHLWDP-UNQGMJICSA-N Pro-Thr-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JDJMFMVVJHLWDP-UNQGMJICSA-N 0.000 description 1
- VBZXFFYOBDLLFE-HSHDSVGOSA-N Pro-Trp-Thr Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H]([C@H](O)C)C(O)=O)C(=O)[C@@H]1CCCN1 VBZXFFYOBDLLFE-HSHDSVGOSA-N 0.000 description 1
- QKWYXRPICJEQAJ-KJEVXHAQSA-N Pro-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2)O QKWYXRPICJEQAJ-KJEVXHAQSA-N 0.000 description 1
- QDDJNKWPTJHROJ-UFYCRDLUSA-N Pro-Tyr-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 QDDJNKWPTJHROJ-UFYCRDLUSA-N 0.000 description 1
- JXVXYRZQIUPYSA-NHCYSSNCSA-N Pro-Val-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JXVXYRZQIUPYSA-NHCYSSNCSA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- 241000283080 Proboscidea <mammal> Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 108010079005 RDV peptide Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 208000005678 Rhabdomyoma Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 description 1
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 1
- UCXDHBORXLVBNC-ZLUOBGJFSA-N Ser-Asn-Cys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(O)=O UCXDHBORXLVBNC-ZLUOBGJFSA-N 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- SWSRFJZZMNLMLY-ZKWXMUAHSA-N Ser-Asp-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O SWSRFJZZMNLMLY-ZKWXMUAHSA-N 0.000 description 1
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 1
- UQFYNFTYDHUIMI-WHFBIAKZSA-N Ser-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CO UQFYNFTYDHUIMI-WHFBIAKZSA-N 0.000 description 1
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 1
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 1
- ZIFYDQAFEMIZII-GUBZILKMSA-N Ser-Leu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZIFYDQAFEMIZII-GUBZILKMSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- AXVNLRQLPLSIPQ-FXQIFTODSA-N Ser-Met-Cys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N AXVNLRQLPLSIPQ-FXQIFTODSA-N 0.000 description 1
- UGTZYIPOBYXWRW-SRVKXCTJSA-N Ser-Phe-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O UGTZYIPOBYXWRW-SRVKXCTJSA-N 0.000 description 1
- RRVFEDGUXSYWOW-BZSNNMDCSA-N Ser-Phe-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RRVFEDGUXSYWOW-BZSNNMDCSA-N 0.000 description 1
- MQUZANJDFOQOBX-SRVKXCTJSA-N Ser-Phe-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O MQUZANJDFOQOBX-SRVKXCTJSA-N 0.000 description 1
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 1
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 1
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 1
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- ZSDXEKUKQAKZFE-XAVMHZPKSA-N Ser-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N)O ZSDXEKUKQAKZFE-XAVMHZPKSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- ATEQEHCGZKBEMU-GQGQLFGLSA-N Ser-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N ATEQEHCGZKBEMU-GQGQLFGLSA-N 0.000 description 1
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 1
- MFQMZDPAZRZAPV-NAKRPEOUSA-N Ser-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N MFQMZDPAZRZAPV-NAKRPEOUSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- 208000009359 Sezary Syndrome Diseases 0.000 description 1
- 208000021388 Sezary disease Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 206010057644 Testis cancer Diseases 0.000 description 1
- NAXBBCLCEOTAIG-RHYQMDGZSA-N Thr-Arg-Lys Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O NAXBBCLCEOTAIG-RHYQMDGZSA-N 0.000 description 1
- JEDIEMIJYSRUBB-FOHZUACHSA-N Thr-Asp-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O JEDIEMIJYSRUBB-FOHZUACHSA-N 0.000 description 1
- KZUJCMPVNXOBAF-LKXGYXEUSA-N Thr-Cys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O KZUJCMPVNXOBAF-LKXGYXEUSA-N 0.000 description 1
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 1
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 1
- SCSVNSNWUTYSFO-WDCWCFNPSA-N Thr-Lys-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O SCSVNSNWUTYSFO-WDCWCFNPSA-N 0.000 description 1
- MGJLBZFUXUGMML-VOAKCMCISA-N Thr-Lys-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MGJLBZFUXUGMML-VOAKCMCISA-N 0.000 description 1
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 1
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 1
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- MFMGPEKYBXFIRF-SUSMZKCASA-N Thr-Thr-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MFMGPEKYBXFIRF-SUSMZKCASA-N 0.000 description 1
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 1
- GJOBRAHDRIDAPT-NGTWOADLSA-N Thr-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H]([C@@H](C)O)N GJOBRAHDRIDAPT-NGTWOADLSA-N 0.000 description 1
- ZEJBJDHSQPOVJV-UAXMHLISSA-N Thr-Trp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZEJBJDHSQPOVJV-UAXMHLISSA-N 0.000 description 1
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 1
- 208000005485 Thrombocytosis Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- IWEQQRMGNVVKQW-OQKDUQJOSA-N Toremifene citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 IWEQQRMGNVVKQW-OQKDUQJOSA-N 0.000 description 1
- LHHDBONOFZDWMW-AAEUAGOBSA-N Trp-Asp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N LHHDBONOFZDWMW-AAEUAGOBSA-N 0.000 description 1
- UIRVSEPRMWDVEW-RNXOBYDBSA-N Trp-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)N UIRVSEPRMWDVEW-RNXOBYDBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
- AKXBNSZMYAOGLS-STQMWFEESA-N Tyr-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AKXBNSZMYAOGLS-STQMWFEESA-N 0.000 description 1
- WJKJJGXZRHDNTN-UWVGGRQHSA-N Tyr-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WJKJJGXZRHDNTN-UWVGGRQHSA-N 0.000 description 1
- MOCXXGZHHSPNEJ-AVGNSLFASA-N Tyr-Cys-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O MOCXXGZHHSPNEJ-AVGNSLFASA-N 0.000 description 1
- UMXSDHPSMROQRB-YJRXYDGGSA-N Tyr-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O UMXSDHPSMROQRB-YJRXYDGGSA-N 0.000 description 1
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 1
- CTDPLKMBVALCGN-JSGCOSHPSA-N Tyr-Gly-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O CTDPLKMBVALCGN-JSGCOSHPSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- ZSXJENBJGRHKIG-UWVGGRQHSA-N Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ZSXJENBJGRHKIG-UWVGGRQHSA-N 0.000 description 1
- QPOUERMDWKKZEG-HJPIBITLSA-N Tyr-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QPOUERMDWKKZEG-HJPIBITLSA-N 0.000 description 1
- VSYROIRKNBCULO-BWAGICSOSA-N Tyr-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O VSYROIRKNBCULO-BWAGICSOSA-N 0.000 description 1
- KLQPIEVIKOQRAW-IZPVPAKOSA-N Tyr-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KLQPIEVIKOQRAW-IZPVPAKOSA-N 0.000 description 1
- LYPKCSYAKLTBHJ-ILWGZMRPSA-N Tyr-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)N)C(=O)O LYPKCSYAKLTBHJ-ILWGZMRPSA-N 0.000 description 1
- RZAGEHHVNYESNR-RNXOBYDBSA-N Tyr-Trp-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RZAGEHHVNYESNR-RNXOBYDBSA-N 0.000 description 1
- WYOBRXPIZVKNMF-IRXDYDNUSA-N Tyr-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 WYOBRXPIZVKNMF-IRXDYDNUSA-N 0.000 description 1
- GBOGMAARMMDZGR-UHFFFAOYSA-N UNPD149280 Natural products N1C(=O)C23OC(=O)C=CC(O)CCCC(C)CC=CC3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 GBOGMAARMMDZGR-UHFFFAOYSA-N 0.000 description 1
- 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 201000005969 Uveal melanoma Diseases 0.000 description 1
- DNOOLPROHJWCSQ-RCWTZXSCSA-N Val-Arg-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DNOOLPROHJWCSQ-RCWTZXSCSA-N 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 1
- FPCIBLUVDNXPJO-XPUUQOCRSA-N Val-Cys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O FPCIBLUVDNXPJO-XPUUQOCRSA-N 0.000 description 1
- KZKMBGXCNLPYKD-YEPSODPASA-N Val-Gly-Thr Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O KZKMBGXCNLPYKD-YEPSODPASA-N 0.000 description 1
- BVWPHWLFGRCECJ-JSGCOSHPSA-N Val-Gly-Tyr Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N BVWPHWLFGRCECJ-JSGCOSHPSA-N 0.000 description 1
- AGXGCFSECFQMKB-NHCYSSNCSA-N Val-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N AGXGCFSECFQMKB-NHCYSSNCSA-N 0.000 description 1
- VNGKMNPAENRGDC-JYJNAYRXSA-N Val-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=CC=C1 VNGKMNPAENRGDC-JYJNAYRXSA-N 0.000 description 1
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 1
- YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 1
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 1
- OFTXTCGQJXTNQS-XGEHTFHBSA-N Val-Thr-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N)O OFTXTCGQJXTNQS-XGEHTFHBSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- STTYIMSDIYISRG-UHFFFAOYSA-N Valyl-Serine Chemical compound CC(C)C(N)C(=O)NC(CO)C(O)=O STTYIMSDIYISRG-UHFFFAOYSA-N 0.000 description 1
- 102100038388 Vasoactive intestinal polypeptide receptor 1 Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047741 Vulval cancer Diseases 0.000 description 1
- 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000017733 acquired polycythemia vera Diseases 0.000 description 1
- 229930183665 actinomycin Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 229960000548 alemtuzumab Drugs 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000006229 amino acid addition Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 206010002224 anaplastic astrocytoma Diseases 0.000 description 1
- 229960002932 anastrozole Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 239000003911 antiadherent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 229940078010 arimidex Drugs 0.000 description 1
- 229940087620 aromasin Drugs 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 229940120638 avastin Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960000397 bevacizumab Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- RSIHSRDYCUFFLA-DYKIIFRCSA-N boldenone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 RSIHSRDYCUFFLA-DYKIIFRCSA-N 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 201000002143 bronchus adenoma Diseases 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000012410 cDNA cloning technique Methods 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 229940112129 campath Drugs 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- UHBYWPGGCSDKFX-UHFFFAOYSA-N carboxyglutamic acid Chemical compound OC(=O)C(N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-UHFFFAOYSA-N 0.000 description 1
- 229960005243 carmustine Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 230000005889 cellular cytotoxicity Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 229960002798 cetrimide Drugs 0.000 description 1
- NDAYQJDHGXTBJL-MWWSRJDJSA-N chembl557217 Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 NDAYQJDHGXTBJL-MWWSRJDJSA-N 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 201000005217 chondroblastoma Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000017760 chronic graft versus host disease Diseases 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- GBOGMAARMMDZGR-JREHFAHYSA-N cytochalasin B Natural products C[C@H]1CCC[C@@H](O)C=CC(=O)O[C@@]23[C@H](C=CC1)[C@H](O)C(=C)[C@@H](C)[C@@H]2[C@H](Cc4ccccc4)NC3=O GBOGMAARMMDZGR-JREHFAHYSA-N 0.000 description 1
- GBOGMAARMMDZGR-TYHYBEHESA-N cytochalasin B Chemical compound C([C@H]1[C@@H]2[C@@H](C([C@@H](O)[C@@H]3/C=C/C[C@H](C)CCC[C@@H](O)/C=C/C(=O)O[C@@]23C(=O)N1)=C)C)C1=CC=CC=C1 GBOGMAARMMDZGR-TYHYBEHESA-N 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- RSIHSRDYCUFFLA-UHFFFAOYSA-N dehydrotestosterone Natural products O=C1C=CC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 RSIHSRDYCUFFLA-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 229960002694 emetine Drugs 0.000 description 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 description 1
- QLHFZUMWECUDIA-UHFFFAOYSA-N emidine Natural products CC(O)C1CCC2(O)C3CC=C4CC(CCC4(C)C3CCC12C)OC5CC(O)C(OC6CC(O)C(OC7CC(O)C(O)C(C)O7)C(C)O6)C(C)O5 QLHFZUMWECUDIA-UHFFFAOYSA-N 0.000 description 1
- 238000013028 emission testing Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 201000002491 encephalomyelitis Diseases 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 229940082789 erbitux Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960000255 exemestane Drugs 0.000 description 1
- 229940043168 fareston Drugs 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 229940087476 femara Drugs 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 201000004098 fibrolamellar carcinoma Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960002258 fulvestrant Drugs 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- STKYPAFSDFAEPH-LURJTMIESA-N glycylvaline Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CN STKYPAFSDFAEPH-LURJTMIESA-N 0.000 description 1
- 229960002913 goserelin Drugs 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 201000009277 hairy cell leukemia Diseases 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 201000002222 hemangioblastoma Diseases 0.000 description 1
- 208000006359 hepatoblastoma Diseases 0.000 description 1
- 201000002735 hepatocellular adenoma Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 238000007489 histopathology method Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 102000050320 human TNFRSF4 Human genes 0.000 description 1
- 102000051144 human TNFSF9 Human genes 0.000 description 1
- 230000008348 humoral response Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 1
- 229960001101 ifosfamide Drugs 0.000 description 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000007916 intrasternal administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 230000002601 intratumoral effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 210000000244 kidney pelvis Anatomy 0.000 description 1
- 208000003849 large cell carcinoma Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000011061 large intestine cancer Diseases 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 229960003881 letrozole Drugs 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000005817 liver abnormality Effects 0.000 description 1
- 238000003468 luciferase reporter gene assay Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- OHSVLFRHMCKCQY-NJFSPNSNSA-N lutetium-177 Chemical compound [177Lu] OHSVLFRHMCKCQY-NJFSPNSNSA-N 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000002794 lymphocyte assay Methods 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 210000004995 male reproductive system Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 208000027202 mammary Paget disease Diseases 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003519 mature b lymphocyte Anatomy 0.000 description 1
- 229960002868 mechlorethamine hydrochloride Drugs 0.000 description 1
- QZIQJVCYUQZDIR-UHFFFAOYSA-N mechlorethamine hydrochloride Chemical compound Cl.ClCCN(C)CCCl QZIQJVCYUQZDIR-UHFFFAOYSA-N 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000003071 memory t lymphocyte Anatomy 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229960005485 mitobronitol Drugs 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 1
- 206010028537 myelofibrosis Diseases 0.000 description 1
- 208000009091 myxoma Diseases 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 101150091879 neo gene Proteins 0.000 description 1
- 208000007538 neurilemmoma Diseases 0.000 description 1
- 108010087904 neutravidin Proteins 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100001092 no hepatotoxicity Toxicity 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 201000002575 ocular melanoma Diseases 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000006548 oncogenic transformation Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 208000003388 osteoid osteoma Diseases 0.000 description 1
- 208000008798 osteoma Diseases 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000024724 pineal body neoplasm Diseases 0.000 description 1
- 201000004123 pineal gland cancer Diseases 0.000 description 1
- 208000021310 pituitary gland adenoma Diseases 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 208000037244 polycythemia vera Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229940124606 potential therapeutic agent Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 229940034080 provenge Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 210000003289 regulatory T cell Anatomy 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039667 schwannoma Diseases 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000008299 semisolid dosage form Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 108010057210 telomerase RNA Proteins 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 229960003087 tioguanine Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 229960005026 toremifene Drugs 0.000 description 1
- XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014723 transformation of host cell by virus Effects 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 1
- 108010077037 tyrosyl-tyrosyl-phenylalanine Proteins 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 206010046885 vaginal cancer Diseases 0.000 description 1
- 208000013139 vaginal neoplasm Diseases 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 108010069784 vitespin Proteins 0.000 description 1
- 201000005102 vulva cancer Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本公开提供了与人CD137结合的抗体或其抗原结合片段、编码所述抗体或其抗原结合片段的核酸、所述抗体或其抗原结合片段的治疗组合物,以及它们用于增强T细胞功能以上调细胞介导的免疫应答以及用于治疗T细胞功能失调病症,诸如肿瘤免疫,以及用于治疗癌症的用途。
Description
对序列表的引用
ASCII文本文件上的以下提交的内容以引用方式整体并入本文:计算机可读形式(CRF)的序列表(文件名:695402000340seqlist.txt,记录日期:2017年8月3日,大小:537KB)。
技术领域
本公开涉及与人CD137结合的抗体或其抗原结合片段、所述抗体或其抗原结合片段的编码核酸、所述抗体或其抗原结合片段的治疗组合物,以及它们的抗肿瘤用途。
背景技术
CD137(也称为CD137受体、4-1BB、TNFRSF9等)是肿瘤坏死因子受体超家族(TNFRS)的跨膜蛋白。目前对CD137的了解表明,其表达通常是活化依赖性的并且存在于免疫细胞的广泛子集中,所述细胞包括活化的NK和NKT细胞、调节T细胞、树突细胞(DC)、被刺激的肥大细胞、分化中的骨髓细胞、单核细胞、嗜中性粒细胞以及嗜酸性粒细胞(Wang,2009,Immunological Reviews 229:192-215)。CD137表达还已证实处于肿瘤血管上(Broll,2001,Amer.J.Clin.Pathol.115(4):543-549;Seaman,2007,Cancer Cell 11:539-554)和发炎或动脉粥样硬化的内皮部位上(Drenkard,2007FASEB J.21:456-463;Olofsson,2008,Circulation 117:1292-1301)。刺激CD137的配体,即CD137配体(CD137L),在活化的抗原呈递细胞(APC)、骨髓祖细胞和造血干细胞上表达。
人CD137是255个氨基酸的蛋白质(GenBank登录号NM_001561;NP_001552;SEQ IDNO.:1)。所述蛋白质包含信号序列(氨基酸残基1-17),接着是细胞外结构域(169个氨基酸)、跨膜区(27个氨基酸),以及细胞内结构域(42个氨基酸)(Cheuk ATC等人2004CancerGene Therapy 11:215-226)。受体以单体和二聚体形式在细胞表面表达并且可能与CD137配体三聚化以进行信号传导。
鼠和人T细胞的许多研究表明,CD137促进增强的细胞增殖、存活和细胞因子产生(Croft,2009,Nat Rev Immunol 9:271-285)。研究已表明,一些CD137激动剂mAb增加共刺激分子表达并且显著增强溶细胞性T淋巴细胞应答,从而在各种模型中导致抗肿瘤功效。CD137激动剂mAb已展示出在预防和治疗环境中的功效。此外,CD137单一疗法和组合疗法肿瘤模型已经建立了持久的抗肿瘤保护性T细胞记忆应答(Lynch,2008,Immunol Rev.22:277-286)。CD137激动剂还已经显示出在多种本领域公认的自身免疫性模型中抑制自身免疫反应(Vinay,2006,J Mol Med 84:726-736)。CD137的这种双重活性提供了在减少可与破坏免疫耐受性的免疫治疗方法相关的自身免疫副作用的同时提供抗肿瘤活性的潜力。
对于结合人CD137,增加CD137介导的应答并从而提供用于治疗各种疾病和病状(包括癌症和自身免疫疾病)的潜在治疗剂的抗体存在长期未满足的需要。此外,对于在不同物种(诸如人和实验动物(小鼠、猴、狗等))之间交叉反应,以使得能够进行动物模型研究并同时提供治疗剂候选物的抗CD137抗体存在需要。
发明内容
本公开的一个目标是提供一种与人CD137结合的分离的结合分子,诸如抗体或其结合片段,或其衍生物。本公开的另一个目标是提供一种包含与CD137结合的结合分子的组合物。本公开的又一个目标是提供用于治疗与CD137信号传导相关或由其介导的疾病和/或病状的方法,其通过使用一种或多种本公开的结合分子实现。本公开的这些和其他目标在本文更完全地描述。
因此,在一个方面,本文提供了一种或多种抗体(例如,分离抗体)或一种或多种其抗原结合片段,所述抗体或其抗原结合片段与人CD137的细胞外结构域结合,并且包括一个或多个(例如,一个或多个、两个或更多个、三个或更多个、四个或更多个、五个或更多个、六个或更多个、七个或更多个、八个或更多个、九个或更多个,或全部10个)以下功能特征:(a)结合SEQ ID NO:1的氨基酸残基34-108内的一个或多个氨基酸残基;(b)不与SEQ ID NO:1的氨基酸残基109-112、125、126、135-138、150和151内的一个或多个氨基酸残基结合;(c)以100nM或更小的KD与人CD137结合;(d)在人CD137上具有激动剂活性;(e)在最高至1000nM的浓度下不与人OX40、CD40、GITR和/或CD27受体结合;(f)与猴、小鼠、大鼠和/或狗CD137交叉反应;(g)不引起ADCC效应;(h)能够抑制肿瘤细胞生长;(i)对癌症具有治疗作用;和/或(j)阻断CD137与CD137L之间的结合。
因此,在一个方面,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体)或其抗原结合片段。在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区包含HVR-H1、HVR-H2和HVR-H3,其中HVR-H1包含根据选自由以下组成的组的式的氨基酸序列:式(I):X1TFX2X3YX4IHWV(SEQ ID NO:2),其中X1为F或Y,X2为S或T,X3为G、N或S,并且X4为A、G或W;式(II):YSIX1SGX2X3WX4WI(SEQ ID NO:3),其中X1为S或T,X2为H或Y,X3为H或Y,并且X4为A、D、G、N、S或T;以及式(III):FSLSTX1GVX2VX3WI(SEQID NO:4),其中X1为G或S,X2为A或G,并且X3为A、G、S或T;其中HVR-H2包含根据选自由以下组成的组的式的氨基酸序列:式(IV):LALIDWX1X2DKX3YSX4SLKSRL(SEQ ID NO:5),其中X1为A、D或Y,X2为D或G,X3为R、S或Y,并且X4为P或T;式(V):IGX1IYHSGX2TYYX3PSLKSRV(SEQID NO:6),其中X1为D或E,X2为N或S,并且X3为N或S;以及式(VI):VSX1ISGX2GX3X4TYYADSVKGRF(SEQ ID NO:7),其中X1为A、G、S、V或Y,X2为A、D、S或Y,X3为D、G或S,并且X4为S或T;并且其中HVR-H3包含根据下式的氨基酸序列:式(VII):ARX1GX2X3X4VX5GDWFX6Y(SEQ ID NO:8),其中X1为E或G,X2为E或S,X3为D或T,X4为A、T或V,X5为A、I、L、T或V,并且X6为A、D或G。
在一些实施方案中,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体)或其抗原结合片段,所述抗体或其抗原结合片段包含重链可变区和轻链可变区,其中重链可变区包含HVR-H1、HVR-H2和HVR-H3,其中HVR-H1包含根据选自由以下组成的组的式的氨基酸序列:式(XII):X1TFSX2YWIHWV(SEQ ID NO:853),其中X1为F或Y,并且X2为N或S;式(XIII):YSIX1SGX2X3WX4WI(SEQ ID NO:854),其中X1为S或T,X2为H或Y,X3为H或Y,并且X4为A、D、G、N或S;以及式(XIV):FSLSTX1GVX2VX3WI(SEQ ID NO:855),其中X1为G或S,X2为A或G,并且X3为A、G或S;其中HVR-H2包含根据选自由以下组成的组的式的氨基酸序列:式(IV):LALIDWX1X2DKX3YSX4SLKSRL(SEQ ID NO:5),其中X1为A、D或Y,X2为D或G,X3为R、S或Y,并且X4为P或T;以及式(XV):VSX1ISGX2GX3X4TYYADSVKGRF(SEQ ID NO:856),其中X1为G、S、V或Y,X2为A、D、S或Y,X3为D、G或S,并且X4为S或T;并且其中HVR-H3包含根据下式的氨基酸序列:式(VII):ARX1GX2X3X4VX5GDWFX6Y(SEQ ID NO:8),其中X1为E或G,X2为E或S,X3为D或T,X4为A、T或V,X5为A、I、L、T或V,并且X6为A、D或G。
在另一方面,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体)或其抗原结合片段。在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中轻链可变区包含HVR-L1、HVR-L2和HVR-L3,其中HVR-L1包含根据下式的氨基酸序列:式(VIII):X1ASQX2X3X4X5X6X7X8(SEQ ID NO:9),其中X1为Q或R,X2为D、G或S,X3为I或V,X4为G、R、S或T,X5为P、R、S或T,X6为A、D、F、S、V或Y,X7为L或V,并且X8为A、G或N;其中HVR-L2包含根据下式的氨基酸序列:式(IX):X1ASX2X3X4X5GX6(SEQ ID NO:10),其中X1为A或D,X2为N、S或T,X3为L或R,X4为A、E或Q,X5为S或T,并且X6为I或V;并且其中HVR-L3包含根据选自由以下组成的组的式的氨基酸序列:式(X):YCQQX1YX2X3X4T(SEQ ID NO:11),其中X1为A、G、S或Y,X2为Q、S或Y,X3为I、L、T或Y,并且X4为I、S、V或W;以及式(XI):YCX1QX2X3X4X5PX6T(SEQ ID NO:12),其中X1为E或Q,X2为P、S或Y,X3为D、L、S、T或Y,X4为D、E、H、S或T,X5为D、L T或W,并且X6为L、P、R或V。
在一些实施方案中,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体)或其抗原结合片段,所述抗体或其抗原结合片段包含重链可变区和轻链可变区,其中轻链可变区包含HVR-L1、HVR-L2和HVR-L3,其中HVR-L1包含根据下式的氨基酸序列:式(XVI):X1ASQX2X3X4X5X6X7X8(SEQ ID NO:857),其中X1为Q或R,X2为D、G或S,X3为I或V,X4为G、R、S或T,X5为P、R、S或T,X6为A、F、S、V或Y,X7为L或V,并且X8为A或G;其中HVR-L2包含根据下式的氨基酸序列:式(XVII):X1ASX2X3X4X5GX6(SEQ ID NO:858),其中X1为A或D,X2为N或S,X3为L或R,X4为A、E或Q,X5为S或T,并且X6为I或V;并且其中HVR-L3包含根据下式的氨基酸序列:式(XVIII):YCQQX1YX2X3WT(SEQ ID NO:859),其中X1为A或G,X2为S或Y,并且X3为I、L或T。
在另一方面,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体)或其抗原结合片段。在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区包含以下各项的HVR-H1、HVR-H2和HVR-H3:VH1、VH2、VH3、VH4、VH5、VH6、VH7、VH8、VH9、VH10、VH11、VH12、VH13、VH14、VH15、VH16、VH17、VH18、VH19、VH20、VH21、VH22、VH23、VH24、VH25、VH26、VH27、VH28、VH29、VH30、VH31、VH32、VH33、VH34、VH35、VH36、VH37、VH38、VH39、VH40、VH41、VH42、VH43、VH44、VH45、VH46、VH47、VH48、VH49、VH50、VH51、VH52、VH53、VH54、VH55、VH56、VH57、VH58、VH59或VH60;并且/或者轻链可变区包含以下各项的HVR-L1、HVR-L2和HVR-L3:VL1、VL2、VH3、VL4、VH5、VL6、VL7、VL8、VL9、VL10、VL11、VL12、VL13、VL14、VL15、VL16、VL17、VL18、VL19、VL20、VL21、VL22、VL23、VL24、VL25、VL26、VL27、VL28、VL29、VL30、VL31、VL32、VL33、VL34、VL35、VL36、VL37、VL38、VL39、VL40、VL41、VL42、VL43、VL44、VL45、VL46、VL47、VL48、VL49、VL50、VL51、VL52、VL53、VL54、VL55、VL56、VL57、VL58、VL59或VL60(如表1c所示)。在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区和轻链可变区包含以下各项的HVR-H1、HVR-H2、HVR-H3、HVR-L1、HVR-L2和HVR-L3:VH1和VL1、VH2和VL2、VH3和VL3、VH4和VL4、VH5和VL5、VH6和VL6、VH7和VL7、VH8和VL8、VH9和VL9、VH10和VL10、VH11和VL11、VH12和VL12、VH13和VL13、VH14和VL14、VH15和VL15、VH16和VL16、VH17和VL17、VH18和VL18、VH19和VL19、VH20和VL20、VH21和VL21、VH22和VL22、VH23和VL23、VH24和VL24、VH25和VL25、VH26和VL26、VH27和VL27、VH28和VL28、VH29和VL29、VH30和VL30、VH31和VL31、VH32和VL32、VH33和VL33、VH34和VL34、VH35和VL35、VH36和VL36、VH37和VL37、VH38和VL38、VH39和VL39、VH40和VL40、VH41和VL41、VH42和VL42、VH43和VL43、VH44和VL44、VH45和VL45、VH46和VL46、VH47和VL47、VH48和VL48、VH49和VL49、VH50和VL50、VH51和VL51、VH52和VL52、VH53和VL53、VH54和VL54、VH55和VL55、VH56和VL56、VH57和VL57、VH58和VL58、VH59和VL59,或VH60和VL60(如表1c所示)。
在另一方面,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体)或其抗原结合片段。在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区包含以下各项的重链可变区:VH1、VH2、VH3、VH4、VH5、VH6、VH7、VH8、VH9、VH10、VH11、VH12、VH13、VH14、VH15、VH16、VH17、VH18、VH19、VH20、VH21、VH22、VH23、VH24、VH25、VH26、VH27、VH28、VH29、VH30、VH31、VH32、VH33、VH34、VH35、VH36、VH37、VH38、VH39、VH40、VH41、VH42、VH43、VH44、VH45、VH46、VH47、VH48、VH49、VH50、VH51、VH52、VH53、VH54、VH55、VH56、VH57、VH58、VH59或VH60;并且/或者轻链可变区包含以下各项的轻链可变区:VL1、VL2、VH3、VL4、VH5、VL6、VL7、VL8、VL9、VL10、VL11、VL12、VL13、VL14、VL15、VL16、VL17、VL18、VL19、VL20、VL21、VL22、VL23、VL24、VL25、VL26、VL27、VL28、VL29、VL30、VL31、VL32、VL33、VL34、VL35、VL36、VL37、VL38、VL39、VL40、VL41、VL42、VL43、VL44、VL45、VL46、VL47、VL48、VL49、VL50、VL51、VL52、VL53、VL54、VL55、VL56、VL57、VL58、VL59或VL60(如表1c所示)。在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区和轻链可变区包括以下各项的重链可变区和轻链可变区:VH1和VL1、VH2和VL2、VH3和VL3、VH4和VL4、VH5和VL5、VH6和VL6、VH7和VL7、VH8和VL8、VH9和VL9、VH10和VL10、VH11和VL11、VH12和VL12、VH13和VL13、VH14和VL14、VH15和VL15、VH16和VL16、VH17和VL17、VH18和VL18、VH19和VL19、VH20和VL20、VH21和VL21、VH22和VL22、VH23和VL23、VH24和VL24、VH25和VL25、VH26和VL26、VH27和VL27、VH28和VL28、VH29和VL29、VH30和VL30、VH31和VL31、VH32和VL32、VH33和VL33、VH34和VL34、VH35和VL35、VH36和VL36、VH37和VL37、VH38和VL38、VH39和VL39、VH40和VL40、VH41和VL41、VH42和VL42、VH43和VL43、VH44和VL44、VH45和VL45、VH46和VL46、VH47和VL47、VH48和VL48、VH49和VL49、VH50和VL50、VH51和VL51、VH52和VL52、VH53和VL53、VH54和VL54、VH55和VL55、VH56和VL56、VH57和VL57、VH58和VL58、VH59和VL59,或VH60和VL60(如表1c所示)。
在另一方面,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体)或其抗原结合片段。在一些实施方案中,抗体或其抗原结合片段与SEQ ID NO:1的氨基酸残基34-108内的一个或多个氨基酸残基结合。在一些实施方案中,抗体或抗原结合片段与SEQ ID NO:1的氨基酸残基34-93内的一个或多个氨基酸残基结合。在一些实施方案中,抗体或抗原结合片段与选自由SEQ ID NO:1的氨基酸残基34-36、53-55和92-93组成的组的一个或多个氨基酸残基结合。在一些实施方案中,抗体或抗原结合片段与SEQ ID NO:1的氨基酸残基34-36中的一个或多个、氨基酸残基53-55中的一个或多个,以及氨基酸残基92-93中的一个或多个结合。在一些实施方案中,抗体或抗原结合片段不与选自由SEQ IDNO:1的氨基酸残基109-112、125、126、135-138、150和151组成的组的氨基酸残基中的一个或多个结合。在一些实施方案中,抗体或抗原结合片段不与SEQ ID NO:1的氨基酸残基109-112、125、126、135-138、150和151结合。在一些实施方案中,抗体或抗原结合片段与来自选自食蟹猴(cynomolgus monkey)、小鼠、大鼠和/或狗的至少一种非人物种的CD137多肽交叉反应。在一些实施方案中,抗体或抗原结合片段与食蟹猴CD137结合。
在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区包含有包含氨基酸序列SEQ ID NO:711的HVR-H1、包含氨基酸序列SEQ ID NO:735的HVR-H2,以及包含氨基酸序列SEQ ID NO:759的HVR-H3;并且/或者其中轻链可变区包含有包含氨基酸序列SEQ ID NO:783的HVR-L1、包含氨基酸序列SEQ ID NO:807的HVR-L2,以及包含氨基酸序列SEQ ID NO:831的HVR-L3。在一些实施方案中,重链可变区包含氨基酸序列SEQ ID NO:41,并且/或者轻链可变区包含氨基酸序列SEQ ID NO:42。在一些实施方案中,抗体包含重链和轻链,并且其中重链包含氨基酸序列SEQ ID NO:617,并且/或者轻链包含氨基酸序列SEQ ID NO:618。
在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区包含有包含氨基酸序列SEQ ID NO:712的HVR-H1、包含氨基酸序列SEQ ID NO:736的HVR-H2,以及包含氨基酸序列SEQ ID NO:760的HVR-H3;并且/或者其中轻链可变区包含有包含氨基酸序列SEQ ID NO:784的HVR-L1、包含氨基酸序列SEQ ID NO:808的HVR-L2,以及包含氨基酸序列SEQ ID NO:832的HVR-L3。在一些实施方案中,重链可变区包含氨基酸序列SEQ ID NO:61,并且/或者轻链可变区包含氨基酸序列SEQ ID NO:62。在一些实施方案中,抗体包含重链和轻链,其中重链包含氨基酸序列SEQ ID NO:619,并且/或者轻链包含氨基酸序列SEQ ID NO:620。
在一些实施方案中,抗体或抗原结合片段包含重链可变区和轻链可变区,其中重链可变区包含有包含氨基酸序列SEQ ID NO:731的HVR-H1、包含氨基酸序列SEQ ID NO:755的HVR-H2,以及包含氨基酸序列SEQ ID NO:779的HVR-H3;并且/或者其中轻链可变区包含有包含氨基酸序列SEQ ID NO:803的HVR-L1、包含氨基酸序列SEQ ID NO:827的HVR-L2,以及包含氨基酸序列SEQ ID NO:851的HVR-L3。在一些实施方案中,重链可变区包含氨基酸序列SEQ ID NO:71,并且/或者轻链可变区包含氨基酸序列SEQ ID NO:72。在一些实施方案中,抗体包含重链和轻链,其中重链包含氨基酸序列SEQ ID NO:657,并且/或者轻链包含氨基酸序列SEQ ID NO:658。
在另一方面,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体),其包含重链可变区和轻链可变区,其中重链可变区包含HVR-H1、HVR-H2和HVR-H3,其中HVR-H1包含根据选自由以下组成的组的式的氨基酸序列:式(I)、式(II)和式(III);HVR-H2包含根据选自由以下组成的组的式的氨基酸序列:式(IV)、式(V)和式(VI);并且HVR-H3包含根据式(VII)的氨基酸序列;并且/或者轻链可变区包含HVR-L1、HVR-L2和HVR-L3,其中HVR-L1包含根据式(VIII)的氨基酸序列;HVR-L2包含根据式(IX)的氨基酸序列;并且HVR-L3包含根据选自由以下组成的组的式的氨基酸序列:式(X)和式(XI)。在一些实施方案中,本文提供了一种与人CD137的细胞外结构域结合的抗体(例如,分离抗体),其包含重链可变区和轻链可变区,其中重链可变区包含HVR-H1、HVR-H2和HVR-H3,其中HVR-H1包含根据选自由以下组成的组的式的氨基酸序列:式(XIII)和式(XVI);HVR-H2包含根据选自由以下组成的组的式的氨基酸序列:式(IV)和式(XV);并且HVR-H3包含根据式(VII)的氨基酸序列;并且/或者轻链可变区包含HVR-L1、HVR-L2和HVR-L3,其中HVR-L1包含根据式(XVI)的氨基酸序列;HVR-L2包含根据式(XVII)的氨基酸序列;并且HVR-L3包含根据式(XVIII)的氨基酸序列。
在一些实施方案中,HVR-H1包含选自由SEQ ID NO:253-312组成的组的氨基酸序列,HVR-H2包含选自由SEQ ID NO:313-372组成的组的氨基酸序列,HVR-H3包含选自由SEQID NO:373-432组成的组的氨基酸序列,HVR-L1包含选自由SEQ ID NO:433-492组成的组的氨基酸序列,HVR-L2包含选自由SEQ ID NO:493-552组成的组的氨基酸序列,并且/或者HVR-L3包含选自由SEQ ID NO:553-612组成的组的氨基酸序列。在一些实施方案中,重链可变区包含选自由SEQ ID NO:13、15、17、19、21、23、25、27、29、31、33、35、37、39、41、43、45、47、49、51、53、55、57、59、61、63、65、67、69、71、73、75、77、79、81、83、85、87、89、91、93、95、97、99、101、103、105、107、109、111、113、115、117、119、121、123、125、127、129和131组成的组的氨基酸序列,并且/或者轻链可变区包含选自由SEQ ID NO:14、16、18、20、22、24、26、28、30、32、34、36、38、40、42、44、46、48、50、52、54、56、58、60、62、64、66、68、70、72、74、76、78、80、82、84、86、88、90、92、94、96、98、100、102、104、106、108、110、112、114、116、118、120、122、124、126、128、130和132组成的组的氨基酸序列。
在一些实施方案中,HVR-H1包含根据选自由式(XII)、式(XIII)和式(XIV)组成的组的式的氨基酸序列;HVR-H2包含根据式(IV)或式(XV)的氨基酸序列;并且HVR-H3包含根据式(VII)的氨基酸序列;并且/或者其中HVR-L1包含根据式(XVI)的氨基酸序列;HVR-L2包含根据式(XVII)的氨基酸序列;并且HVR-L3包含根据式(XVIII)的氨基酸序列。在一些实施方案中,HVR-H1包含选自由SEQ ID NO:709-732组成的组的氨基酸序列,HVR-H2包含选自由SEQ ID NO:733-756组成的组的氨基酸序列,HVR-H3包含选自由SEQ ID NO:757-780组成的组的氨基酸序列,HVR-L1包含选自由SEQ ID NO:781-804组成的组的氨基酸序列,HVR-L2包含选自由SEQ ID NO:805-828组成的组的氨基酸序列,并且HVR-L3包含选自由SEQ ID NO:829-852组成的组的氨基酸序列。在一些实施方案中,重链可变区包含选自由SEQ ID NO:15、17、31、33、35、37、39、41、43、45、47、49、53、61、63、65、67、71、73、75、79、83、85和87组成的组的氨基酸序列,并且/或者轻链可变区包含选自由SEQ ID NO:16、18、32、34、36、38、40、42、44、46、48、50、54、62、64、66、68、72、74、76、80、84、86和88组成的组的氨基酸序列。在一些实施方案中,抗体包含重链和轻链,其中重链包含选自由SEQ ID NO:613、615、617、619、621、623、625、627、629、631、633、635、637、639、641、643、645、647、649、651、653、655、657和659组成的组的氨基酸序列,并且/或者轻链包含选自由SEQ ID NO:614、616、618、620、622、624、626、628、630、632、634、636、638、640、642、644、646、648、650、652、654、656、658和660组成的组的氨基酸序列。
在一些实施方案中,HVR-H1包含氨基酸序列SEQ ID NO:711或731;HVR-H2包含氨基酸序列SEQ ID NO:735或755;HVR-H3包含氨基酸序列SEQ ID NO:759或779;HVR-L1包含氨基酸序列SEQ ID NO:783或803;HVR-L2包含氨基酸序列SEQ ID NO:807或827;并且HVR-L3包含氨基酸序列SEQ ID NO:831或851。在一些实施方案中,重链可变区包含氨基酸序列SEQ ID NO:41或71,并且轻链可变区包含氨基酸序列SEQ ID NO:42或72。在一些实施方案中,抗体包含重链和轻链,其中重链包含氨基酸序列SEQ ID NO:617或657,并且轻链包含氨基酸序列SEQ ID NO:618或658。
在一些实施方案中,HVR-H1包含氨基酸序列SEQ ID NO:712;HVR-H2包含氨基酸序列SEQ ID NO:736;HVR-H3包含氨基酸序列SEQ ID NO:760;HVR-L1包含氨基酸序列SEQ IDNO:784;HVR-L2包含氨基酸序列SEQ ID NO:808;并且HVR-L3包含氨基酸序列SEQ ID NO:832。在一些实施方案中,重链可变区包含氨基酸序列SEQ ID NO:61,并且轻链可变区包含氨基酸序列SEQ ID NO:62。在一些实施方案中,抗体包含重链和轻链,其中重链包含氨基酸序列SEQ ID NO:619,并且轻链包含氨基酸序列SEQ ID NO:620。
在可与任何前述实施方案组合的一些实施方案中,抗体或抗原结合片段以100nM或更小的KD结合人CD137(例如,如通过表面等离子体共振所测量)。在一些实施方案中,抗体或抗原结合片段以50nM或更小的KD结合人CD137(例如,如通过表面等离子体共振所测量)。
在可与任何前述实施方案组合的一些实施方案中,抗体或抗原结合片段与来自选自食蟹猴(例如,GenBank Gene ID 102127961)、小鼠(例如,GenBank Gene ID 21942)、大鼠(例如,GenBank Gene ID 500590)和/或狗(例如,GenBank Gene ID 608274)的至少一种非人物种的CD137多肽交叉反应。在一些实施方案中,抗体或抗原结合片段与食蟹猴CD137结合。
在可与任何前述实施方案组合的一些实施方案中,当与抗体或抗原结合片段接触时,人CD137(例如,当在诸如人细胞的细胞上表达时)的活性降低。
在可与任何前述实施方案组合的一些实施方案中,对于阻断人CD137与人CD137L的体外结合,抗体或抗原结合片段具有约100nM或更小的半最大抑制浓度(IC50)。在一些实施方案中,当抗体或抗原结合片段以约1μM或更大的浓度提供时,抗体或抗原结合片段完全阻断人CD137与人CD137L的体外结合。在可与任何前述实施方案组合的一些实施方案中,当与抗体或抗原结合片段接触时,人CD137(例如,当在诸如人细胞的细胞上表达时)的活性增加。在一些实施方案中,使CD137(例如,在人细胞上表达)与抗体或抗原结合片段接触导致NF-κB依赖性转录增加。
在可与任何前述实施方案组合的一些实施方案中,抗体包含人IgG2 Fc区。在可与任何前述实施方案组合的一些实施方案中,抗体包含人IgG4 Fc区。在一些实施方案中,人IgG4 Fc区包含S241P突变,其中编号是根据Kabat进行的。在一些实施方案中,抗体或抗原结合片段不引起ADCC效应。
在另一方面,本文提供了由包含选自SEQ ID NO:133、135、137、139、141、143、145、147、149、151、153、155、157、159、161、163、165、167、169、171、173、175、177、179、181、183、185、187、189、191、193、195、197、199、201、203、205、207、209、211、213、215、217、219、221、223、225、227、229、231、233、235、237、239、241、243、245、247、249和251的序列的多核苷酸编码的抗体重链可变区,和/或由包含选自SEQ ID NO:134、136、138、140、142、144、146、148、150、152、154、156、158、160、162、164、166、168、170、172、174、176、178、180、182、184、186、188、190、192、194、196、198、200、202、204、206、208、210、212、214、216、218、220、222、224、226、228、230、232、234、236、238、240、242、244、246、248、250和252的序列的多核苷酸编码的抗体轻链可变区。在一些实施方案中,本文提供了由包含选自SEQ ID NO:661、663、665、667、669、671、673、675、677、679、681、683、685、687、689、691、693、695、697、699、701、703、705和707的序列的多核苷酸编码的抗体重链,和/或由包含选自SEQ ID NO:662、664、666、668、670、672、674、676、678、680、682、684、686、688、690、692、694、696、698、700、702、704、706和708的序列的多核苷酸编码的抗体轻链。
在另一方面,本文提供了一种多核苷酸,其编码本文所述的抗体或抗原结合片段中的任一个。在一些实施方案中,本文提供了一种多核苷酸,其包含选自SEQ ID NO:133-252的序列。
在另一方面,本文提供了一种载体,其包含上文所述的多核苷酸中的任一个。在一些实施方案中,载体是表达载体。
在另一方面,本文提供了一种宿主细胞(例如,细菌细胞、酵母细胞、昆虫细胞、哺乳动物细胞(诸如CHO细胞或293T细胞)等),其包含本文所述的多核苷酸或载体中的任一个。在一些实施方案中,本文提供了一种制备抗体或抗原结合片段的方法,其包括在适于产生抗体或抗原结合片段的条件下培养宿主细胞。在一些实施方案中,所述方法还包括回收由宿主细胞产生的抗体或抗原结合片段。
在另一方面,本文提供了一种药物组合物,其包含本文所述的抗体或抗原结合片段(或其任何衍生物)中的任一个以及药学上可接受的载剂。
在另一方面,本文提供了治疗有需要的受试者中的异常细胞生长(例如,癌症)的方法,其包括向受试者施用治疗有效量的本文所述的抗体、抗原结合片段和/或药物组合物中的任一个。在一些实施方案中,本文提供了减少受试者中的肿瘤细胞转移的方法,其包括向所述受试者施用治疗有效量的本文所述的抗体、抗原结合片段和/或药物组合物中的任一个。在一些实施方案中,所述方法还包括向受试者施用治疗有效量的至少一种(例如,至少一种、至少两种、至少三种、至少四种、至少五种、至少10种等)另外治疗剂。在一些实施方案中,至少一种另外治疗剂选自由以下组成的组:病毒基因疗法、免疫检查点抑制剂、靶疗法、放射疗法以及化学疗法。在一些实施方案中,至少一种另外治疗剂选自由以下组成的组:泊马度胺(pomalyst)、来那度胺(revlimid)、雷利度胺(lenalidomide)、泊马度胺(pomalidomide)、沙利度胺(thalidomide)、DNA-烷基化含铂衍生物、顺铂、5-氟尿嘧啶、环磷酰胺、抗CTLA4抗体、抗PD-1抗体、抗PD-L1抗体、抗CD20抗体、抗CD40抗体、抗DR5抗体、抗CD1d抗体、抗TIM3抗体、抗SLAMF7抗体、抗KIR受体抗体、抗OX40抗体、抗HER2抗体、抗ErbB-2抗体、抗EGFR抗体、西妥昔单抗(cetuximab)、利妥昔单抗(rituximab)、曲妥珠单抗(trastuzumab)、派姆单抗(pembrolizumab)、放射疗法、单剂量放射、分割放射(fractionated radiation)、病灶放射(focal radiation)、全器官放射、IL-12、IFNα、GM-CSF、嵌合抗原受体、过继转移的T细胞、抗癌疫苗以及溶瘤病毒。本文还提供了本文所述的药物组合物、抗体和/或抗原结合片段(或其任何衍生物)中的任一个用于治疗有需要的受试者中的异常细胞生长(例如,癌症)和/或减少肿瘤细胞转移的用途。本文还提供了本文所述的抗体或抗原结合片段(或其任何衍生物)中的任一个用于制造用于治疗有需要的受试者中的异常细胞生长(例如,癌症)和/或减少肿瘤细胞转移的药物的用途。
应了解,上文和本文所述的各个实施方案的一种、一些或所有特性可组合以形成本公开的其他实施方案。本公开的这些和其他方面对于本领域技术人员将变得显而易见。本公开的这些和其他实施方案通过随后的具体实施方式进一步描述。
附图说明
图1A示出对于示例性重链可变区(VH)(SEQ ID NO:13)和示例性轻链可变区(VL)(SEQ ID NO:14),相比于Kabat CDR定义的高变区(HVR)定义。
图1B示出与小鼠CD137交叉反应的Fab命中物(hits)的选择。
图2示出示例性抗体对人、猴和小鼠CD137的ELISA结合测定。每个小图针对如小图顶部所指示的不同抗体。
图3A示出示例性抗体对人、猴、小鼠和大鼠CD137的基于FACS的结合测定。每个小图针对如小图顶部所指示的不同抗原。
图3B示出示例性抗体和参考抗体之间物种交叉反应性的比较。
图4B示出AG10131与活化的人、猴、小鼠和大鼠T细胞的结合。
图5示出示例性抗体对CD137,而不是其他TNFR家族成员的结合特异性。
图6A和图6B示出示例性抗体阻断CD137与其同源配体CD137L的结合,这通过ELISA(图6A)和流式细胞术测定(图6B)获得。
图7A示出通过流式细胞术获得的表位作图结果。
图7B示出人(SEQ ID NO:1)、食蟹猴(SEQ ID NO:860)和小鼠(SEQ ID NO:861)CD137的一部分与从表位作图实验中鉴定的目标CD137序列/区域(加注释)的多序列比对。
图8示出在NFκB报告基因测定中示例性抗体的激动剂活性。
图9示出示例性抗体在CD8+T细胞增殖(顶部小图)和INF-γ分泌(底部小图)中的激动剂活性。
图10示出H22小鼠肝癌模型中示例性抗体的抗肿瘤功效,以及CD4+和CD8+T细胞在肿瘤中的浸润。
图11示出示例性抗体在CT26小鼠结肠癌模型中的抗肿瘤功效。
图12示出示例性抗体在EMT6小鼠乳腺癌模型中的抗肿瘤功效。
图13示出用示例性抗体治疗的CT26小鼠在用相同的肿瘤细胞再激发后保持无肿瘤。
图14示出利用来自肿瘤排斥性再激发小鼠的脾细胞实现的肿瘤细胞杀伤。
图15示出AG10131不显示ADCC效应。
图16示出示例性抗体在高浓度下表现出很少聚集。
图17示出示例性抗体在加速应激条件(accelerated stress condition)下的稳定性。
图18示出热稳定性。
图19示出AG10131在最高至每两周100mg/kg(BIW)x 2下在正常小鼠中没有血液学毒性。
图20示出AG10131在最高至每两周100mg/kg(BIW)x 2下在正常小鼠中没有组织学肝异常。
图21示出AG10131在10mg/kg/周x 4下在食蟹猴中没有血液学毒性。
图22示出AG10131在10mg/kg/周x 4下在猴中没有肝毒性。
图23示出AG10131在猴中的药代动力学特征。
图24示出AG10131在大鼠中的药代动力学特征。
图25示出各种抗体在小鼠中的药代动力学特征。
具体实施方式
A.定义
除非本文另外定义,否则与本公开关联使用的科学和技术术语将具有由本领域普通技术人员通常所理解的含义。另外,除非上下文另有要求,否则单数术语应包括复数,并且复数术语应包括单数。一般来说,结合本文所述的抗体工程改造、免疫疗法、细胞和组织培养、分子生物学、免疫学、微生物学、遗传学和蛋白质和核酸化学使用的命名法以及抗体工程改造、免疫疗法、细胞和组织培养、分子生物学、免疫学、微生物学、遗传学和蛋白质和核酸化学的技术是本领域中所熟知且常用的那些。
如本文所用,以下各术语在此部分中均具有与它相关联的含义。
冠词“一个/种(“a”和“an”)”是指一个/种或多个/种(即指至少一个/种)的所述冠词的语法宾语。通过举例的方式,“元件”意指一个元件或多于一个元件。
术语“氨基酸”是指天然存在和合成氨基酸,以及功能类似于天然存在的氨基酸的氨基酸类似物和氨基酸模拟物。天然存在的氨基酸是由遗传密码编码的那些,以及稍后被修饰的那些氨基酸,例如,羟基脯氨酸、γ-羧基谷氨酸盐和O-磷酸丝氨酸。术语“氨基酸类似物”是指具有与天然存在的氨基酸相同的基本化学结构,但是C末端羧基、N末端氨基或侧链官能团已经被化学修饰为另一官能团的化合物。术语“氨基酸模拟物”是指具有与氨基酸的一般化学结构不同的结构,但功能类似于天然存在的氨基酸的化学化合物。
术语“抗体”在本文中以最广泛的意义使用并且具体地涵盖单克隆抗体(包括全长单克隆抗体)、多克隆抗体、多特异性抗体(例如,双特异性抗体)以及抗体片段(例如,单链可变片段或scFv),只要它们表现出期望的生物学活性即可。
术语“抗体”是本领域公认术语并且可指具有由两条相同的重(H)链和两条相同的轻(L)链组成的基本四多肽链结构的抗原结合蛋白(即,免疫球蛋白)。各L链通过一个共价二硫键连接至H链,同时两条H链取决于H链同种型通过一个或多个二硫键彼此连接。每条重链在N末端具有可变区(在本文缩写为VH、),接着是恒定区。重链恒定区包含三个结构域:CH1、CH2和CH3。每条轻链在N末端具有可变区(在本文缩写为VI),接着是在其另一端的恒定区。轻链恒定区包含一个结构域,CL。将VL与VH比对并且将CL与重链的第一恒定结构域(CH1)比对。VH和VL的配对一起形成单一抗原结合位点。IgM抗体由5个基本的异四聚体单元以及被称为J链的另一多肽组成,因此含有10个抗原结合位点;而分泌型IgA抗体可聚合形成包含2-5个基本的4链单元以及J链的多价装配物。
VH和VL区还可以基于结构和序列分析细分成具有高变性的区域,称为高变区(HVR)。HVR散布有更加保守的区域,称为框架区(FW)。为了进行比较,下文列出Yvonne Chen等人(Selection and Analysis of an Optimized Anti-VEGF Antibody:CrystalStructure of an Affinity-matured Fab in Complex with Antigen,J.Mol.Biol.(1999)293,865-881)的Kabat CDR定义(另外参见图1a)。各VH和VL由三个HVR和四个FW组成,以下列顺序从氨基末端到羧基末端排列:FW1、HVR1、FW2、HVR2、FW3、HVR3、FW4。在本公开通篇,重链的三个HVR被称为HVR_H1、HVR_H2和HVR_H3。类似地,轻链的三个HVR被称为HVR_L1、HVR_L2和HVR_L3。
重链和轻链的可变区含有与抗原相互作用的结合结构域。抗体的恒定区可介导免疫球蛋白与宿主组织或因子的结合,包括免疫系统的各种细胞(例如,效应细胞)和经典补体系统的第一组分(Clq)。在轻链和重链内,可变区和恒定区通过具有约12个或更多个氨基酸的“J”区连接,其中重链还包括具有约10个或更多个氨基酸的“D”区。一般参见Fundamental Immunology第7章(Paul,W.编,第2版,Raven Press,N.Y.(1989))。
来自任何脊椎动物物种的L链可基于其恒定结构域的氨基酸序列指定为两种明显不同类型(称为κ和λ)中的一者。取决于其重链的恒定结构域(CH)的氨基酸序列,抗体可指定为不同的种类或同种型。存在五类抗体:IgA、IgD、IgE、IgG和IgM,其分别具有被命名为α(alpha)、δ(delta)、ε(epsilon)、γ(gamma)和μ(mu)的重链。IgG类抗体可以分别通过γ重链Y1-Y4进一步分类为四个亚类IgG1、IgG2、IgG3和IgG4。
术语“抗体衍生物”或抗体的“衍生物”是指能够结合所述抗体所结合的相同抗原(例如,CD137)且包含与另一分子实体连接的所述抗体的氨基酸序列的分子。抗体衍生物中包含的所述抗体的氨基酸序列可以是所述抗体的全长重链、全长轻链、全长重链的任何一个或多个部分、全长轻链的任何一个或多个部分、抗体的任何其他一个或多个片段,或互补抗体。另一分子实体可以是化学或生物分子。另一分子实体的实例包括化学基团、氨基酸、肽、蛋白质(诸如酶、抗体)以及化学化合物。另一分子实体可具有任何实用性,诸如用作检测剂、标记、标志物、药剂或治疗剂。抗体的氨基酸序列可通过化学偶联、基因融合、非共价缔合或其他方式与另一分子实体附接或连接。术语“抗体衍生物”还涵盖嵌合抗体、人源化抗体,以及由CD137抗体的氨基酸序列的修饰,诸如保守氨基酸取代、添加和插入衍生的分子。
术语抗体的“抗原结合片段”或“抗原结合部分”是指抗体的保留与所述抗体所结合的抗原(例如,CD137)相结合的能力的一个或多个部分。抗体的“抗原结合片段”的实例包括(i)Fab片段,其为由VL、VH、CL和CH1结构域组成的一价片段;(ii)F(ab′)2片段,其为包含由在铰链区的二硫键连接的两个Fab片段的二价片段;(iii)由VH和CH1结构域组成的Fd片段;(iv)由抗体的单臂的VL和VH结构域组成的Fv片段;(v)由VH结构域组成的dAb片段(Ward等人,Nature 341:544-546(1989));以及(vi)分离的互补决定区(CDR)。
术语“结合分子”涵盖(1)抗体,(2)抗体的抗原结合片段,以及(3)抗体的衍生物,各自如本文所定义。
术语“结合CD137(binding CD137/binds CD137)”或“与CD137结合(binding toCD137/binds to CD137)”是指如本文所定义的结合分子在体外测定中以100nM或更小的亲和力(KD)与人CD137的结合,所述体外测定诸如实施例4中所述的Biacore测定。
术语“CD137”和“CD137受体”在本申请中可互换使用,并且包括人CD137受体,以及其变体、同种型以及物种同源物。因此,如本文所定义和公开的结合分子也可结合来自除人之外的物种的CD137。在其他情况中,结合分子对于人CD137可以是完全特异性的并且可能不表现出物种或其他类型的交叉反应性。
术语“CD137抗体”是指能够与人CD137受体结合的如本文所定义的抗体。
术语“嵌合抗体”是指包含衍生自不同动物物种的氨基酸序列的抗体,诸如具有衍生自人抗体的可变区和鼠免疫球蛋白恒定区的那些。
术语“竞争结合”是指两种抗体在它们与结合靶标的结合中的相互作用。如果与不存在第二抗体的情况下第一抗体的结合相比,在第二抗体的存在下,第一抗体与其同源表位的结合可检测地减少,那么第一抗体与第二抗体竞争结合。其中在第一抗体的存在下,第二抗体与其表位的结合也可检测地减少的替代情况可以,但不一定是这样的。也就是说,第一抗体可以抑制第二抗体与其表位的结合,而所述第二抗体不抑制第一抗体与其相应表位的结合。然而,在每种抗体可检测地抑制另一抗体与其同源表位的结合的情况下,无论程度是相同、更大还是更小,所述抗体均被称为彼此“交叉竞争”结合它们的一个或多个相应表位。
术语“表位”是指抗原上与抗体(或其抗原结合片段)相结合的部分。可由通过蛋白质的三级折叠来并置的连续氨基酸或不连续氨基酸形成表位。由连续氨基酸形成的表位通常在暴露于变性溶剂时保留,而通过三级折叠形成的表位通常在用变性溶剂处理时丢失。表位可包括处于独特空间构象的不同数量的氨基酸。确定表位的空间构象的方法包括,例如,x射线晶体学、2维核磁共振、与质谱组合的氘氢交换,或定点诱变,或与抗原以及具有其结合抗体及其变体的其复合物结构的计算机建模组合使用的所有方法。参见,例如,Epitope Mapping Protocols,在Methods in Molecular Biology中,第66卷,G.E.Morris编辑,(1996)。一旦确定了抗原的期望表位,就可以例如使用本文所述的技术生成针对所述表位的抗体。抗体的生成和表征也可阐明关于期望表位的信息。由此信息,接着可以竞争性地筛选结合相同表位的抗体。实现这一点的方法是进行交叉竞争研究,以寻找彼此竞争结合的抗体,即竞争结合抗原的抗体。基于其交叉竞争“分拣(binning)”抗体的高通量方法描述于PCT公布号WO 03/48731中。
术语“生殖系”是指抗体基因和基因区段的核苷酸序列,因为其经由生殖细胞从亲代传递至后代。生殖系序列不同于编码成熟B细胞中的抗体的核苷酸序列,所述成熟B细胞在B细胞成熟过程中已通过重组和高变事件发生了改变。
术语“糖基化位点”是指由真核细胞识别为用于附接糖残基的位置的氨基酸残基。在其中附接碳水化合物(诸如低聚糖)的氨基酸通常为天冬酰胺(N-键)、丝氨酸(O-键)和苏氨酸(O-键)残基。附接的特异性位点通常以在本文称为“糖基化位点序列”的氨基酸序列为标志。用于N-连接糖基化的糖基化位点序列为:-Asn-X-Ser-或-Asn-X-Thr-,其中X可以是除脯氨酸之外的任何常规氨基酸。术语“N-连接的”和“O-连接的”是指在糖分子与氨基酸残基之间用作附接位点的化学基团。N-连接的糖通过氨基附接;O-连接的糖通过羟基附接。术语“聚糖占据(glycan occupancy)”是指存在连接至糖基化位点的碳水化合物部分(即,聚糖位点被占据)。在多肽上存在至少两个潜在糖基化位点的情况下,没有一个(0-聚糖位点占据)、一个(1-聚糖位点占据)或两个(2-聚糖位点占据)位点可以被碳水化合物部分占据。
术语“宿主细胞”是指可以被工程改造以产生目标蛋白质、蛋白质片段或肽的细胞系统。宿主细胞包括但不限于培养细胞,例如来源于啮齿动物(大鼠、小鼠、豚鼠或仓鼠)的哺乳动物培养细胞,诸如CHO、BHK、NSO、SP2/0、YB2/0;或人组织或杂交瘤细胞、酵母细胞和昆虫细胞,以及转基因动物或培养组织内包括的细胞。该术语不仅涵盖具体的主题细胞,而且涵盖这种细胞的子代。因为某些修饰可能由于突变或环境影响而在继代中发生,所以所述子代可能不与亲本细胞相同,但仍包括在术语“宿主细胞”的范围内。
术语“人抗体”是指其中轻链和重链的整个氨基酸序列均来自于人免疫球蛋白基因的抗体。如果在小鼠、小鼠细胞或衍生自小鼠细胞的杂交瘤中产生的话,人抗体可包含鼠碳水化合物链。人抗体可通过本领域已知的多种方式制备。
术语“人源化抗体”是指包含来源于人抗体序列的氨基酸残基的嵌合抗体。人源化抗体可包含来自非人动物或合成抗体的一些或所有CDR或HVR,而抗体的框架和恒定区包含来源于人抗体序列的氨基酸残基。
术语“例示性抗体”是指在本公开描述且被命名为表1a和1b所列的那些的抗体中的任一种。这些抗体可属于任何种类(例如,IgA、IgD、IgE、IgG和IgM)。因此,以上鉴定的各抗体涵盖对于VL和VH区具有相同的氨基酸序列的全部五个种类中的抗体。此外,IgG类中的抗体可属于任何亚类(例如,IgG1、IgG2、IgG3和IgG4)。因此,IgG亚类中的以上鉴定的各抗体涵盖对于VL和VH区具有相同的氨基酸序列的全部四个亚类中的抗体。五个种类以及四个IgG亚类中的人抗体的重链恒定区的氨基酸序列是本领域已知的。表1b所示的例示性抗体中IgG4亚类中的每一个的全长重链和轻链的氨基酸序列在本公开中提供。
术语“分离抗体”或“分离的结合分子”是指如本文所定义的抗体或结合分子,其:(1)不与在其天然状态中与其相邻的天然关联组分相关联;(2)不含来自相同物种的其他蛋白质;(3)由来自不同物种的细胞表达;或(4)在自然界中不存在。分离抗体的实例包括已经使用CD137亲和纯化的CD137抗体、已经通过杂交瘤或其他细胞系在体外生成的CD137抗体,以及来源于转基因动物的CD137抗体。
术语“分离核酸”是指与在核酸的天然来源中存在的其他核酸分子分开的基因组、cDNA或合成来源或其组合的核酸分子。例如,关于基因组DNA,术语“分离的”包括与基因组DNA天然相关联的染色体分开的核酸分子。优选地,“分离的”核酸不合天然侧接于所述核酸的序列(即,位于目标核酸的5′端和3′端的序列)。
术语“ka”是指特定抗体-抗原相互作用的缔合速率常数,而术语“kd”是指特定抗体-抗原相互作用的解离速率常数。
术语“KD”是指特定抗体-抗原相互作用的平衡解离常数。它是由kd与ka的比率(即,kd/ka)获得的并且表示为摩尔浓度(M)。KD用作抗体与其结合配偶体的结合亲和力的量度。KD越小,则抗体的结合就越紧密,或抗体与抗原之间的亲和力越高。例如,具有纳摩尔(nM)解离常数的抗体比具有微摩尔(μM)解离常数的抗体更紧密地与结合至特定抗原。抗体的KD值可以使用本领域的良好建立的方法确定。确定抗体KD的一种方法是通过使用表面等离子体共振,通常使用生物传感器系统,诸如系统。使用BIACORETM系统进行的测定程序(BIAcore测定)在本公开的实施例部分中描述。
术语“哺乳动物”是指哺乳动物种类的任何动物物种。哺乳动物的实例包括:人;实验室动物,诸如大鼠、小鼠、猿和豚鼠;家养动物,诸如猫、狗、兔、牛、绵羊、山羊、马和猪;以及圈养野生动物,诸如狮子、老虎、大象等。
关于哺乳动物中的某一疾病病状的术语“预防(prevent或preventing)”是指预防或延迟疾病的发作,或预防其临床或亚临床症状的出现。
如本文所用,两个多肽序列之间的“序列同一性”指示在所述序列之间相同的氨基酸的百分比。多肽的氨基酸序列同一性可以使用已知计算机程序诸如Bestfit、FASTA或BLAST常规地确定(参见,例如Pearson,Methods Enzymol.183:63-98(1990);Pearson,Methods Mol.Biol.132:185-219(2000);Altschul等人,J.Mol.Biol.215:403-410(1990);Altschul等人,Nucelic Acids Res.25:3389-3402(1997))。当使用Bestfit或任何其他序列比对程序确定特定序列是否与参考氨基酸序列具有例如95%同一性时,设定参数,使得在参考氨基酸序列的全长上计算同一性的百分比并且允许参考序列中的氨基酸残基的总数的同源性的间隔最高至5%。确定多肽之间的同一性百分比的这一上述方法适用于本文公开的所有蛋白质、其片段或变体。
在提及如本文所定义的结合分子(例如抗体)与其结合配偶体(例如抗原)的相互作用时,术语“特异性结合(specifically binds)”或“与...特异性结合(specificallybinds to)”是指在给定的一组条件下,结合分子在来自一个动物物种的目标抗原与来自不同动物物种的抗原直向同源物(antigen orthologue)之间作出区分的能力。如在体外测定中所确定的,如果CD137结合分子以其结合大鼠或小鼠的CD137的EC50的50%以下的EC50结合人CD137的话,那么所述CD137结合分子被称为与人CD137特异性结合。抗体的结合特异性可以使用本领域已知的方法确定。此类方法的实例包括使用PHA刺激的原代细胞的FACS、Western blots、ELISA-、RIA-、ECL-、IRMA-测试和肽扫描。
在提及如本文所定义的结合分子(例如抗体)与其结合配偶体(例如抗原)的相互作用时,术语“选择性结合(selectively binds)”或“与...选择性结合(selectivelybinds to)”是指在给定的一组条件下,结合分子在来自一个动物物种的目标抗原(诸如人CD137)与来自相同动物物种的不同抗原(诸如人CD40)之间作出区分的能力。如在体外测定中所确定的,如果CD137结合分子以其结合人CD40或人CD134的EC50的10%以下的EC50结合人CD137的话,那么所述CD137结合分子被称为与人CD137选择性结合。
关于哺乳动物中的某一疾病病状的术语“治疗(treat、treating或treatment)”是指在患有该疾病病状的哺乳动物中导致期望或有益的效应。期望或有益的效应可包括疾病的一种或多种症状(即,肿瘤生长和/或转移,或由免疫细胞的数量和/或活性介导的其他作用等)的频率或严重程度降低,或疾病、病状或病症的进一步发展的停止或抑制。在治疗哺乳动物的癌症的上下文中,期望或有益的效应可包括癌细胞的进一步生长或扩散的抑制、癌细胞的死亡、癌症复发的抑制、癌症相关疼痛的减少,或哺乳动物存活率的提高。所述作用可以是主观或客观的。例如,如果哺乳动物是人,那么人可将精力或活力改善或疼痛减少记录为改善的自觉症状或对疗法的反应。可替代地,临床医生可基于体检、实验室参数、肿瘤标志物或影像学发现注意到肿瘤大小或肿瘤负荷的减小。对于对治疗的反应,临床医生可观察的一些实验室征象包括测试的标准化,诸如白血细胞计数、红血细胞计数、血小板计数、红细胞沉降率以及各种酶水平。另外,临床医生可观察到可检测肿瘤标志物的减少。可替代地,可使用其他测试评估客观改善,诸如声像图、核磁共振测试以及正电子发射测试。
术语“载体”是指能够运输外来核酸分子的核酸分子。外来核酸分子通过重组技术诸如连接或重组连接至载体核酸分子。这允许在宿主细胞或生物体中倍增、选择、进一步操纵或表达外来核酸分子。载体可以是质粒、噬菌体、转座子、粘粒、染色体、病毒或病毒体。一类载体可在引入宿主细胞后整合到宿主细胞的基因组中,并且由此与宿主基因组一起复制(例如,非附加型哺乳动物载体)。另一类载体能够在其被引入的宿主细胞中自主复制(例如,具有细菌复制起点的细菌载体和附加型哺乳动物载体)。能够指导其所操作性地连接的可表达外来核酸的表达的另一特定类型的载体通常称为“表达载体”。表达载体通常具有驱动可表达外来核酸的表达的控制序列。已知为“转录载体”的更简单的载体仅能够转录,但不能翻译:它们可以在靶细胞中复制,但不表达。术语“载体”涵盖所有类型的载体,而不考虑其功能。能够指导其所操作性地连接的可表达核酸的表达的载体通常称为“表达载体”。
除非另外指示,否则本公开的方法和技术通常根据本领域熟知且如本说明书通篇引用和论述的各种一般性和更特定参考文献中所描述的方法来执行。此类参考文献包括,例如,Sambrook和Russell,Molecular Cloning,A Laboratory Approach,Cold SpringHarbor Press,Cold Spring Harbor,N.Y.(2001),Ausubel等人,Current Protocols inMolecular Biology,John Wiley&Sons,NY(2002),以及Harlow和Lane Antibodies:ALaboratory Manual,Cold Spring Harbor Laboratory Press,Cold Spring Harbor,N.Y.(1990)。酶促反应和纯化技术是根据制造商说明书,如本领域中通常所达成或如本文所述来执行。与本文所述的分析化学、合成有机化学以及医学和药物化学结合使用的命名法,以及所述分析化学、合成有机化学以及医学和药物化学的实验室程序和技术是本领域熟知和常用的那些。标准技术用于化学合成、化学分析、药物制备、配制和递送以及患者的治疗。
如本文所用,20种常规氨基酸及其缩写遵循常规用法。参见Immunology-ASynthesis(第2版,E.S.Golub和D.R.Gren编辑,Sinauer Associates,Sunderland,Mass.(1991))。
B.与人CD137结合的结合分子
本公开提供了与人CD137结合的分离的结合分子,包括CD137抗体、CD137抗体的抗原结合片段,以及CD137抗体的衍生物。在一些实施方案中,结合分子是本文所述的任何抗体,包括关于表位结合所描述的抗体和关于HVR、可变区(VL、VH)和IgG(例如,IgG4)轻链和重链的具体氨基酸序列所描述的抗体。在一些实施方案中,本公开涉及结合分子,所述结合分子与人CD137结合,并且具有以下功能特性中的至少一个(例如,至少一个、至少两个、至少三个、至少四个、至少五个、至少六个、至少七个或全部八个):(a)以500nM或更小的KD与人CD137结合;(b)对人CD137具有激动剂活性;(c)在最高至1000nM的浓度下不与人OX40、CD40、GITR和/或CD27受体结合;(d)与猴、小鼠、大鼠或狗CD137交叉反应;(e)不引起ADCC效应;(f)能够抑制肿瘤细胞生长;(g)对癌症具有治疗作用;以及(h)阻断CD137与CD137L之间的结合。在一些实施方案中,本文公开的抗体还可以阻断,例如完全阻断,CD137与其配体CD137L之间的结合。本文还提供了与如本文所述的抗体或抗原结合片段中的一种或多种交叉竞争结合人CD137的一种或多种抗CD137抗体或抗原结合片段。
在一些实施方案中,抗体或其抗原结合片段与SEQ ID NO:1的氨基酸残基34-108内的一个或多个氨基酸残基结合。在一些实施方案中,抗体或抗原结合片段与SEQ ID NO:1的氨基酸残基34-93内的一个或多个氨基酸残基结合。在一些实施方案中,抗体或抗原结合片段与选自由SEQ ID NO:1的氨基酸残基34-36、53-55和92-93组成的组的一个或多个氨基酸残基结合。在一些实施方案中,抗体或抗原结合片段与SEQ ID NO:1的氨基酸残基34-36中的一个或多个、氨基酸残基53-55中的一个或多个,以及氨基酸残基92-93中的一个或多个结合。在一些实施方案中,抗体或抗原结合片段不与选自由SEQ ID NO:1的氨基酸残基109-112、125、126、135-138、150和151组成的组的氨基酸残基中的一个或多个结合。在一些实施方案中,抗体或抗原结合片段不与SEQ ID NO:1的氨基酸残基109-112、125、126、135-138、150和151结合。测量抗体或抗原结合片段结合靶抗原的能力的方法可使用本领域已知的任何方法进行,包括例如,通过表面等离子体共振、ELISA、等温滴定量热法、过滤结合测定、EMSA等。在一些实施方案中,抗体或抗原结合片段结合靶抗原的能力通过表面等离子体共振测量(参见例如,以下实施例1)。
在一些实施方案中,抗体或抗原结合片段以约500nM或更小(例如,约500nM或更小、约400nM或更小、约300nM或更小、约200nM或更小、约150nM或更小、约100nM或更小、约90nM或更小、约80nM或更小、约75nM或更小、约70nM或更小、约60nM或更小、约50nM或更小、约40nM或更小、约30nM或更小、约25nM或更小、约20nM或更小、约10nM或更小、约1nM或更小、约0.1nM或更小等)的KD与人CD137结合。在一些实施方案中,抗体或抗原结合片段以约100nM或更小的KD与人CD137结合。在一些实施方案中,抗体或抗原结合片段以约50nM或更小的KD与人CD137结合。测量抗体或抗原结合片段的KD的方法可使用本领域已知的任何方法进行,包括例如,通过表面等离子体共振、ELISA、等温滴定量热法、过滤结合测定、EMSA等。在一些实施方案中,KD通过表面等离子体共振测量(参见例如,以下实施例1)。
抗CD137抗体必须交联,以变得具有激动性。例如,交联通过Fcγ受体在体内实现,而通常多克隆抗Fc抗体在体外用于基于细胞的实验中。在一些实施方案中,本文所述的抗体或抗原结合片段对人CD137具有激动剂活性。在一些实施方案中,当表达人CD137的细胞(例如,人细胞)接触抗体或抗原结合片段时,抗体或抗原结合片段诱导人CD137的一种或多种(例如,一种或多种、两种或更多种、三种或更多种等)活性。各种CD137活性是本领域已知的并且可包括但不限于NF-κB依赖性转录的诱导、T细胞增殖的诱导、T细胞存活的延长、活化T细胞的共刺激、细胞因子分泌(诸如IL-2)的诱导,以及单核细胞活化的诱导。在一些实施方案中,一种或多种CD137活性不是CD137与其配体的结合。测量CD137活性(例如,NF-κB依赖性转录和/或T细胞增殖的诱导等)的方法是本领域已知的,包括,例如,经由以下实施例8和9中所述的方法。在一些实施方案中,抗体或抗原结合片段增加表达人CD137的细胞(例如,人细胞)中的NF-κB依赖性转录。在一些实施方案中,相对于不与抗体或抗原结合片段接触的对应细胞(例如,不与抗体接触,或与同种型对照抗体接触的对应细胞),在与抗体或抗原结合片段接触的表达CD137的细胞(例如,人细胞)中,NF-κB依赖性转录增加约10%或更多、约20%或更多、约30%或更多、约40%或更多、约50%或更多、约60%或更多、约70%或更多、约80%或更多、约90%或更多,或约99%或更多。在一些实施方案中,相对于不与抗体或抗原结合片段接触的对应细胞(例如,不与抗体接触,或与同种型对照抗体接触的对应细胞),在与抗体或抗原结合片段接触的表达CD137的细胞(例如,人细胞)中,NF-κB依赖性转录增加约2倍、3倍、4倍、5倍、6倍、7倍、8倍、9倍、10倍、100倍、1000倍或更多。
在一些实施方案中,抗体或抗原结合片段与猴(例如,食蟹猴)、小鼠、大鼠和/或狗CD137交叉反应。在一些实施方案中,抗体或抗原结合片段与猴CD137交叉反应。在一些实施方案中,抗体或抗原结合片段与小鼠CD137交叉反应。在一些实施方案中,抗体或抗原结合片段与大鼠CD137交叉反应。在一些实施方案中,抗体或抗原结合片段与狗CD137交叉反应。在一些实施方案中,抗体或抗原结合片段与猴和小鼠CD137;猴和大鼠CD137;猴和狗CD137;小鼠和大鼠CD137;小鼠和狗CD137;大鼠和狗CD137;猴、小鼠和大鼠CD137;猴、小鼠和狗CD137;猴、大鼠和狗CD137;小鼠、大鼠和狗CD137;或猴、小鼠、大鼠和狗CD137交叉反应。在一些实施方案中,抗体或抗原结合片段在约100nM下(例如,在约1nM下、在约10nM下、在约25nM下、在约50nM下、在约75nM下、在约100nM下)交叉反应。测量抗体交叉反应性的方法是本领域已知的,包括但不限于表面等离子体共振、ELISA、等温滴定量热法、过滤结合测定、EMSA等。在一些实施方案中,交叉反应性通过ELISA测量(参见例如,以下实施例2)。
在一些实施方案中,抗体不引起ADCC效应。测量ADCC效应的方法(例如,体内方法)是本领域已知的,包括但不限于经由以下实施例11中所述的方法。在一些实施方案中,相对于对照,抗体不引起超过约10%的ADCC效应(不引起超过约10%、超过约5%、超过约1%、超过约0.1%、超过约0.01%的ADCC效应)。
在一些实施方案中,抗体或抗原结合片段能够抑制肿瘤细胞生长/增殖。在一些实施方案中,相对于不与抗体或抗原结合片段接触的对应肿瘤细胞,当与抗体或抗原结合片段接触时,肿瘤细胞生长/增殖被抑制至少约5%(例如,至少约5%、至少约10%、至少约20%、至少约30%、至少约40%、至少约50%、至少约60%、至少约70%、至少约80%、至少约90%,或至少约99%)。在一些实施方案中,在将抗体或抗原结合片段施用给受试者时,抗体或抗原结合片段能够减小受试者的肿瘤体积。在一些实施方案中,相对于受试者的初始肿瘤体积(例如,在施用抗体或抗原结合片段之前),抗体或抗原结合片段能够将受试者的肿瘤体积减少至少约5%(例如,至少约5%、至少约10%、至少约20%、至少约30%、至少约40%、至少约50%、至少约60%、至少约70%、至少约80%、至少约90%,或至少约99%)。监测肿瘤细胞生长/增殖、肿瘤体积和/或肿瘤抑制的方法是本领域已知的,包括,例如,经由以下实施例10中所述的方法。
在一些实施方案中,抗体或抗原结合片段对癌症具有治疗作用。在一些实施方案中,抗体或抗原结合片段减少癌症的一种或多种体征或症状。在一些实施方案中,当施用抗体或抗原结合片段时,罹患癌症的受试者进入部分或完全缓解。
在另一方面,本公开提供了与本公开的例示性抗体中的任一种,诸如AG10058、AG10059和/或AG10131竞争或交叉竞争结合人CD137的分离抗体。在一个特定实施方案中,本公开提供了与本公开的例示性抗体中的任一种竞争或交叉竞争结合人CD137上的相同表位的分离抗体。抗体与另一抗体竞争或交叉竞争结合的能力可以使用本领域已知的标准结合测定确定,诸如BIAcore分析、ELISA测定或流式细胞术。例如,可以允许本公开的例示性抗体在饱和条件下与人CD137结合,然后测量测试抗体结合CD137的能力。如果测试抗体能够与例示性抗体同时结合至CD137,那么测试抗体结合至与例示性抗体不同的表位。然而,如果测试抗体不能同时结合至CD137,那么测试抗体结合至例示性抗体所结合表位的相同表位、重叠表位,或与其紧密相邻的表位。此实验可以使用各种方法执行,诸如ELISA、RIA、FACS或表面等离子体共振。
在一些实施方案中,抗体或抗原结合片段阻断CD137与其配体(例如,人CD137与人CD137L)之间的结合。在一些实施方案中,抗体或抗原结合片段在体外阻断CD137与其配体之间的结合。在一些实施方案中,对于阻断CD137与其配体的结合,抗体或抗原结合片段具有约500nM或更小(例如,约500nM或更小、约400nM或更小、约300nM或更小、约200nM或更小、约100nM或更小、约50nM或更小、约25nM或更小、约10nM或更小、约1nM或更小等)的半最大抑制浓度(IC50)。在一些实施方案中,对于阻断CD137与其配体的结合,抗体或抗原结合片段具有约100nM或更小的半最大抑制浓度(IC50)。在一些实施方案中,当以约100nM或更大(例如,约100nM或更大、约500nM或更大、约1μM或更大、约10μM或更大等)的浓度提供时,抗体或抗原结合片段完全阻断人CD137与其配体的结合。如本文所用,术语“完全阻断(completeblocking或completely blocks)”是指抗体或抗原结合片段将第一蛋白质与第二蛋白质之间的结合减少至少约80%(例如,至少约80%、至少约85%、至少约90%、至少约95%、至少约99%等)的能力。测量抗体或抗原结合片段阻断第一蛋白质(例如,CD137)与第二蛋白质(例如,CD137L)的结合的能力的方法是本领域已知的,包括但不限于经由BIAcore分析、ELISA测定和流式细胞术(参见例如,以下实施例6)。
B-1.CD137抗体
在一些方面,本公开提供了一种分离抗体,其在SEQ ID NO.:1的氨基酸残基34-108或34-93内的表位上结合至人CD137。在一些实施方案中,抗体以50nM或更小的KD结合人CD137,如通过表面等离子体共振所测量的。在某些实施方案中,抗体可以与选自由食蟹猴、小鼠、大鼠和狗组成的列表的至少一种非人物种交叉反应。
在一个方面,本公开提供了一种分离抗体,其包含重链可变区和轻链可变区,a)其中重链可变区包含HVR-H1、HVR-H2和HVR-H3,其中HVR-H1包含根据选自由以下组成的组的式的氨基酸序列:式(I):X1TFX2X3YX4IHWV(SEQ ID NO:2),其中X1为F或Y,X2为S或T,X3为G、N或S,并且X4为A、G或W;式(II):YSIX1SGX2X3WX4WI(SEQ ID NO:3),其中X1为S或T,X2为H或Y,X3为H或Y,并且X4为A、D、G、N、S或T;以及式(III):FSLSTX1GVX2VX3WI(SEQ ID NO:4),其中X1为G或S,X2为A或G,并且X3为A、G、S或T;其中HVR-H2包含根据选自由以下组成的组的式的氨基酸序列:式(IV):LALIDWX1X2DKX3YSX4SLKSRL(SEQ ID NO:5),其中X1为A、D或Y,X2为D或G,X3为R、S或Y,并且X4为P或T;式(V):IGX1IYHSGX2TYYX3PSLKSRV(SEQ ID NO:6),其中X1为D或E,X2为N或S,并且X3为N或S;以及式(VI):VSX1ISGX2GX3X4TYYADSVKGRF(SEQ IDNO:7),其中X1为A、G、S、V或Y,X2为A、D、S或Y,X3为D、G或S,并且X4为S或T;并且其中HVR-H3包含根据下式的氨基酸序列:式(VII):ARX1GX2X3X4VX5GDWFX6Y(SEQ ID NO:8),其中X1为E或G,X2为E或S,X3为D或T,X4为A、T或V,X5为A、I、L、T或V,并且X6为A、D或G;并且/或者b)其中轻链可变区包含HVR-L1、HVR-L2和HVR-L3,其中HVR-L1包含根据下式的氨基酸序列:式(VIII):X1ASQX2X3X4X5X6X7X8(SEQ ID NO:9),其中X1为Q或R,X2为D、G或S,X3为I或V,X4为G、R、S或T,X5为P、R、S或T,X6为A、D、F、S、V或Y,X7为L或V,并且X8为A、G或N;其中HVR-L2包含根据下式的氨基酸序列:式(IX):X1ASX2X3X4X5GX6(SEQ ID NO:10),其中X1为A或D,X2为N、S或T,X3为L或R,X4为A、E或Q,X5为S或T,并且X6为I或V;并且其中HVR-L3包含根据选自由以下组成的组的式的氨基酸序列:式(X):YCQQX1YX2X3X4T(SEQ ID NO:11),其中X1为A、G、S或Y,X2为Q、S或Y,X3为I、L、T或Y,并且X4为I、S、V或W;以及式(XI):YCX1QX2X3X4X5PX6T(SEQID NO:12),其中X1为E或Q,X2为P、S或Y,X3为D、L、S、T或Y,X4为D、E、H、S或T,X5为D、L T或W,并且X6为L、P、R或V。
在一些实施方案中,所述抗体可以包含具有选自由SEQ ID NO:253-312组成的组的氨基酸序列的HVR_H1、具有选自由SEQ ID NO:313-372组成的组的氨基酸序列的HVR_H2、具有选自由SEQ ID NO:373-432组成的组的氨基酸序列的HVR_H3、具有选自由SEQ ID NO:433-492组成的组的氨基酸序列的HVR_L1、具有选自由SEQ ID NO:493-552组成的组的氨基酸序列的HVR_L2,和/或具有选自由SEQ ID NO:553-612组成的组的氨基酸序列的HVR_L3。
在某些实施方案中,抗体可以包含具有选自由SEQ ID NO:13-132组成的组的氨基酸序列的VL和/或VH,其可以优选地分别由选自由SEQ ID NO:133-252组成的组的DNA序列编码。
在一些实施方案中,所述抗体可以包含具有选自由SEQ ID NO:709-732组成的组的氨基酸序列的HVR_H1、具有选自由SEQ ID NO:733-756组成的组的氨基酸序列的HVR_H2、具有选自由SEQ ID NO:757-780组成的组的氨基酸序列的HVR_H3、具有选自由SEQ ID NO:781-804组成的组的氨基酸序列的HVR_L1、具有选自由SEQ ID NO:805-828组成的组的氨基酸序列的HVR_L2,和/或具有选自由SEQ ID NO:829-852组成的组的氨基酸序列的HVR_L3。
在某些实施方案中,抗体可以包含具有选自由SEQ ID NO:613-660组成的组的氨基酸序列的轻链和/或重链(例如,IgG诸如IgG4的那些),其可以优选地分别由选自由SEQID NO:661-708组成的组的DNA序列编码。
本文所述的CD137抗体可以属于任何种类,诸如IgG、IgM、IgE、IgA或IgD。优选的是,CD137抗体属于IgG类,诸如IgG1、IgG2、IgG3或IgG4亚类。可以使用本领域已知的方法将CD137抗体从一个种类或亚类转换为另一种类或亚类。用于产生属于期望种类或亚类的抗体的示例性方法包括以下步骤:分离编码CD137抗体的重链的核酸和编码CD137抗体的轻链的核酸;分离编码VH区的序列;将VH序列与编码期望种类或亚类的重链恒定区的序列连接;在细胞中表达轻链基因和重链构建体;以及收集CD137抗体。
此外,本公开提供的抗体可以是单克隆或多克隆,但优选为单克隆。
本公开提供的具体分离抗体的实例包括表1a和1b中列出的那些。这些抗体的重链可变区、IgG2和IgG4亚类的全长重链、轻链可变区以及全长轻链的核苷酸和氨基酸序列也在下文提供。
本公开的抗体可以通过本领域已知的技术产生,包括常规单克隆抗体方法,例如,标准体细胞杂交技术(参见例如,Kohler和Milstein,Nature 256:495(1975)、B淋巴细胞的病毒或致癌转化,或重组抗体技术,如下文详细描述。
杂交瘤产生是非常完善的程序。用于制备杂交瘤的常见动物系统是鼠系统。用于分离供融合用的免疫的脾细胞的免疫方案和技术是本领域已知的。融合配偶体(例如,鼠骨髓瘤细胞)和融合程序也是已知的。可用于制备本公开提供的人CD137抗体的一种众所周知的方法涉及XenoMouseTM动物系统的使用。XenoMouseTM小鼠是工程改造的小鼠品系,其包含大片段的人免疫球蛋白重链和轻链基因座并且在小鼠抗体产生中有缺陷。参见,例如,Green等人,Nature Genetics 7:13-21(1994)和WO2003/040170。将动物用CD137抗原免疫。CD137抗原是分离和/或纯化的CD137,优选地CD137。它可以是CD137的片段,诸如CD137的细胞外结构域,尤其是包含SEQ ID NO:1的氨基酸残基34-108或34-93的CD137细胞外结构域片段。动物的免疫可以通过本领域已知的任何方法进行。参见,例如,Harlow和Lane,Antibodies:A Laboratory Manual,New York:Cold Spring Harbor Press,1990。用于对非人动物诸如小鼠、大鼠、绵羊、山羊、猪、牛和马免疫的方法在本领域中是众所周知的。参见,例如,Harlow和Lane,同上以及美国专利号5,994,619。CD137抗原可与佐剂一起施用以刺激免疫应答。示例性佐剂包括完全或不完全弗氏佐剂、RIBI(胞壁酰二肽)或ISCOM(免疫刺激复合物)。在用CD137抗原对动物免疫之后,由分离自免疫动物的细胞制备产生抗体的永生化细胞系。在免疫之后,将动物处死并且将淋巴结和/或脾B细胞永生化。将细胞永生化的方法包括但不限于用致癌基因转染所述细胞,用致癌病毒感染所述细胞,在针对永生化细胞选择的条件下培养所述细胞,使所述细胞经受致癌或突变化合物,将所述细胞与永生化细胞(例如,骨髓瘤细胞)融合,以及使肿瘤抑制基因失活。参见,例如,Harlow和Lane,同上。如果使用具有骨髓瘤细胞的融合体,骨髓瘤细胞优选地不分泌免疫球蛋白多肽(非分泌细胞系)。永生化细胞使用CD137、其部分或表达CD137的细胞筛选。选择产生CD137抗体的细胞,例如杂交瘤,克隆并针对期望特征进一步筛选,所述特征包括稳健的生长、高抗体产量和期望的抗体特征,如下文进一步讨论。杂交瘤可以在体内在同系动物中,在缺乏免疫系统的动物(例如,裸小鼠)中,或在体外在细胞培养物中扩展。选择、克隆和扩展杂交瘤的方法是本领域普通技术人员所熟知的。
本公开的抗体还可以使用噬菌体展示或酵母展示方法制备。在本领域建立了用于分离人抗体的此类展示方法,诸如Achim Knappik等人,“Fully Synthetic HumanCombinatorial Antibody Libraries(HuCAL)Based on Modular Consensus Frameworksand CDRs Randomized with Trinucleotides.”J.Mol.Biol.(2000)296,57-86;以及Michael J.Feldhaus等人,“Flow-cytometric isolation of human antibodies from anon-immune Saccharomyces cerevisiae surface display library”Nat Biotechnol(2003)21:163-170。
B-2.抗原结合片段
在一些其他方面,本公开提供了本公开提供的任何CD137抗体的抗原结合片段。
抗原结合片段可包含抗体的任何序列。在一些实施方案中,抗原结合片段包含以下的氨基酸序列:(1)CD137抗体的轻链;(2)CD137抗体的重链;(3)来自CD137抗体的轻链的可变区;(4)来自CD137抗体的重链的可变区;(5)CD137抗体的一个或多个HVR(两个、三个、四个、五个或六个HRV);或(6)来自CD137抗体的轻链的三个HVR和来自所述CD137抗体的重链的三个HVR。
在一些特定实施方案中,本公开提供了选自表1a和1b中列出的那些的抗体的抗原结合片段。
在一些其他特定实施方案中,CD137抗体的抗原结合片段包括:(i)Fab片段,其为由VL、VH、CL和CH1结构域组成的一价片段;(ii)F(ab′)2片段,其为包含由在铰链区的二硫键连接的两个Fab片段的二价片段;(iii)由VH和CH1结构域组成的Fd片段;(iv)由抗体的单臂的VL和VH结构域组成的Fv片段;(v)由VH结构域组成的dAb片段(Ward等人,(1989)Nature341:544-546);(vi)分离的CDR,以及(vii)单链抗体(scFv),其为包含与抗体的VH区连接的抗体的VL区的多肽。Bird等人,(1988)Science 242:423-426和Huston等人,(1988)Proc.Natl.Acad.Sci.USA 85:5879-5883。
在一些特定实施方案中,抗原结合片段是选自表1a中列出的那些的Fab片段。
B-3.抗体衍生物
在一些另外的方面,本公开提供了本公开提供的任何CD137抗体的衍生物。
在一个方面,抗体衍生物衍生自本公开的例示性抗体(“亲本抗体”)的氨基酸序列的修饰,同时保留亲本抗体氨基酸序列的总体分子结构。亲本抗体链的任何区域的氨基酸序列可被修饰,诸如框架区、HVR区或恒定区。修饰的类型包括亲本抗体的一个或多个氨基酸的取代、插入、缺失或其组合。
在一些实施方案中,抗体衍生物包含VL或VH区,其与如SEQ ID NO:13-132中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_H1氨基酸序列区域,其与如SEQ ID NO:253-312中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_H2氨基酸序列区域,其与如SEQ ID NO:313-372中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_H3氨基酸序列区域,其与如SEQ ID NO:373-432中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含表1a所示的所有Fab命中物的HVR_L1氨基酸序列,其可见于SEQ ID NO:433-492。在一些实施方案中,抗体衍生物包含表1a所示的所有Fab命中物的HVR_L2氨基酸序列,其可见于SEQ ID NO:493-552。
在一些实施方案中,抗体衍生物包含表1a所示的所有Fab命中物的HVR_L3氨基酸序列,其可见于SEQ ID NO:553-612。在一些特定实施方案中,所述衍生物包含对如SEQ IDNO:13-132和253-612中的任一个中所示的氨基酸序列的1、2、3、4、5、6、7、8、9、10、11、12、13、14或15个保守或非保守取代,和/或1、2、3、4、5、6、7、8、9、10、11、12、13、14或15个添加和/或缺失。
在一些实施方案中,抗体衍生物包含与如SEQ ID NO:613-660中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性的轻链或重链。
在一些实施方案中,抗体衍生物包含HVR_H1氨基酸序列区域,其与如SEQ ID NO:709-732中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_H2氨基酸序列区域,其与如SEQ ID NO:733-756中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_H3氨基酸序列区域,其与如SEQID NO:757-780中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_L1氨基酸序列区域,其与如SEQ ID NO:781-804中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_L2氨基酸序列区域,其与如SEQ ID NO:805-828中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,抗体衍生物包含HVR_L3氨基酸序列区域,其与如SEQ ID NO:829-852中的任一个中所示的氨基酸序列具有至少65%、至少75%、至少85%、至少90%、至少95%、至少96%、至少97%、至少98%或至少99%同一性。在一些实施方案中,所述衍生物包含对如SEQ ID NO:613-660和709-852中的任一个中所示的氨基酸序列的1、2、3、4、5、6、7、8、9、10、11、12、13、14或15个保守或非保守取代,和/或1、2、3、4、5、6、7、8、9、10、11、12、13、14或15个添加和/或缺失。
氨基酸取代涵盖保守取代和非保守取代。术语“保守氨基酸取代”是指一个氨基酸替换为另一个氨基酸,其中两个氨基酸在某些物理-化学特性上具有相似性,诸如所涉及残基的极性、电荷、溶解度、疏水性、亲水性、和/或两亲性质。例如,取代通常可以在以下组中的每一个内进行:(a)非极性(疏水性)氨基酸,诸如丙氨酸、亮氨酸、异亮氨酸、缬氨酸、脯氨酸、苯丙氨酸、色氨酸以及甲硫氨酸;(b)极性中性氨基酸,诸如甘氨酸、丝氨酸、苏氨酸、半胱氨酸、酪氨酸、天冬酰胺以及谷氨酰胺;(c)带正电的(碱性)氨基酸,诸如精氨酸、赖氨酸以及组氨酸;以及(d)带负电的(酸性)氨基酸,诸如天冬氨酸和谷氨酸。
修饰可在抗体的氨基酸序列的任何位置进行,包括HVR、框架区或恒定区。在--个实施方案中,本公开提供了一种抗体衍生物,其包含本公开的例示性抗体的VH和VL HVR序列,还包含与例示性抗体的那些不同的框架序列。此类框架序列可以从包括生殖系抗体基因序列的公共DNA数据库或公布的参考文献获得。例如,人重链和轻链可变区基因的生殖系DNA序列可以在Genbank数据库或“VBase”人生殖系序列数据库中找到(Kabat,E.A.等人,Sequences of Proteins of Immunological Interest,第5版,美国卫生与公共服务部(U.S.Department of Health and Human Services),NIH出版号91-3242(1991);Tomlinson,I.M.等人,J.Mol.Biol.227:776-798(1992);以及Cox,J.P.L.等人,Eur.J.Immunol.24:827-836(1994))。可用于构建抗体衍生物的框架序列包括在结构上类似于本公开的例示性抗体所用的框架序列,例如,类似于本公开的例示性抗体所用的VH3-23框架序列和/或VLλ3或λ1-13框架序列的那些。例如,可以将例示性抗体的HVR_H1、HVR_H2和HVR_H3序列,以及HVR_L1、HVR_L2和HVR_L3序列移植到具有与框架序列所来源的生殖系免疫球蛋白基因中所发现的相同序列的框架区上,或可以将HVR序列移植到与生殖系序列相比包含一个或多个突变的框架区上。
在一个特定实施方案中,抗体衍生物是包含本公开的例示性抗体的氨基酸序列的嵌合抗体。在一个实例中,来自一种或多种例示性人抗体的一个或多个HVR与来自非人动物(诸如小鼠或大鼠)的抗体的HVR组合。在另一个实例中,嵌合抗体的所有HVR来源于一种或多种例示性抗体。在一些特定实施方案中,嵌合抗体包含来自例示性抗体的重链可变区或轻链可变区的一个、两个或三个HVR。可以使用本领域已知的常规方法生成嵌合抗体。
另一类修饰是使VH和/或VL链的HRV区内的氨基酸残基突变。可以执行定点诱变或PCR介导的诱变以引入一个或多个突变,并且可以在本领域已知的体外或体内测定中评估对抗体结合或其他感兴趣的功能特性的影响。通常,引入保守取代。突变可以是氨基酸添加和/或缺失。此外,通常改变HVR区内的不超过一个、两个、三个、四个或五个残基。在一些实施方案中,抗体衍生物在重链HVR和/或轻链HVR中包含1、2、3或4个氨基酸取代。在另一个实施方案中,氨基酸取代是将抗体中的一个或多个半胱氨酸变为另一残基,诸如但不限于丙氨酸或丝氨酸。半胱氨酸可以是经典或非经典半胱氨酸。在一个实施方案中,相对于例示性抗体的氨基酸序列,抗体衍生物在重链HVR区中具有1、2、3或4个保守氨基酸取代。
还可对VH和/或VL区内的框架残基进行修饰。通常,制备此类框架变体以降低抗体的免疫原性。一种方法是将一个或多个框架残基“回复突变”为对应的生殖系序列。已经进行了体细胞突变的抗体可包含不同于抗体所来源的生殖系序列的框架残基。可以通过将抗体框架序列与抗体所来源的生殖系序列相比较来鉴定此类残基。为了将框架区序列恢复至其生殖系构造,可以通过例如定点诱变或PCR介导的诱变将体细胞突变“回复突变”为生殖系序列。
此外,还可在例示性抗体的Fc区内进行修饰,通常以改变抗体的一种或多种功能特性,诸如血清半衰期、补体固定、Fc受体结合,和/或抗原依赖性细胞毒性。在一个实例中,CH1的铰链区经过修饰,使得铰链区中的半胱氨酸残基数量改变,例如增加或减少。此方法在美国专利号5,677,425中进一步描述。改变CH1的铰链区中的半胱氨酸残基数量,例如,以有利于轻链和重链的装配,或增加或降低抗体的稳定性。在另一情况下,使抗体的Fc铰链区突变,以减少抗体的生物学半衰期。
此外,可根据本领域已知的常规实验对本公开的抗体进行修饰,以改变其潜在的糖基化位点或模式。在另一方面,本公开提供了本公开的CD137抗体的衍生物,其在轻链或重链的可变区中包含至少一个突变,所述突变改变可变区中的糖基化模式。对于抗原的结合,这种抗体衍生物可具有增大的亲和力和/或改变的特异性。突变可在V区中增添新的糖基化位点,改变一个或多个V区糖基化位点的位置,或除去先前存在的V区糖基化位点。在一个实施方案中,本公开提供了CD137抗体的衍生物,其在重链可变区中的天冬酰胺处具有潜在的N-连接糖基化位点,其中一个重链可变区中的潜在的N-连接糖基化位点被除去。在另一个实施方案中,本公开提供了CD137抗体的衍生物,其在重链可变区中的天冬酰胺处具有潜在的N-连接糖基化位点,其中两个重链可变区中的潜在的N-连接糖基化位点均被除去。改变抗体的糖基化模式的方法是本领域已知的,诸如美国专利号6,933,368中描述的那些,所述专利的公开内容以引用方式并入本文。
在另一方面,本公开提供了一种抗体衍生物,其包含与另一分子实体连接的如本文所述的CD137抗体,或其抗原结合片段。另一分子实体的实例包括药剂、肽或蛋白质、检测剂或标记,以及抗体。
在一些实施方案中,抗体衍生物包含与药剂连接的本公开的抗体。药剂的实例包括细胞毒性剂或其他癌症治疗剂,以及放射性同位素。细胞毒性剂的具体实例包括紫杉醇、细胞松弛素B、短杆菌肽D、溴化乙锭、依米丁(emetine)、丝裂霉素、依托泊苷(etoposide)、替尼泊苷(tenoposide)、长春新碱、长春花碱、秋水仙碱、多柔比星、柔红霉素、二羟基炭疽菌素二酮、米托蒽醌、光神霉素、放线菌素D、1-去氢睾酮、糖皮质激素、普鲁卡因、丁卡因、利多卡因、普萘洛尔和嘌呤霉素以及其类似物或同源物。治疗剂还包括,例如,抗代谢物(例如,甲氨蝶呤、6-巯基嘌呤、6-硫鸟嘌呤、阿糖胞苷、5-氟尿嘧啶氮烯咪胺)、烷化剂(例如,二氯甲基二乙胺、塞替派苯丁酸氮芥(thioepa chlorambucil)、美法仑(melphalan)、卡莫司汀(carmustine)(BSNU)和洛莫司汀(lomustine)(CCNU)、环磷酰胺、白消安(busulfan)、二溴甘露醇、链脲霉素、丝裂霉素C和顺式二氯二胺铂(II)(DDP)顺铂)、蒽环霉素(例如,柔红霉素(以前称为道诺霉素)和多柔比星)、抗生素(例如,更生霉素(以前称为放线菌素)、博来霉素、光神霉素和安曲霉素(AMC))和抗有丝分裂剂(例如,长春新碱和长春花碱)。可以与抗体缀合以用于诊断或治疗性用途的放射性同位素的实例包括但不限于碘131、铟111、钇90和镥177。用于将抗体与药剂连接的方法是本领域已知的,诸如使用各种接头技术。接头类型的实例包括含有腙、硫醚、酯、二硫化物和肽的接头。对于用于将治疗剂与抗体连接的接头和方法的进一步讨论,另外参见Saito等人,Adv.Drug Deliv.Rev.55:199-215(2003);Trail等人,Cancer Immunol.Immunother.52:328-337(2003);Payne,Cancer Cell 3:207-212(2003);Allen,Nat.Rev.Cancer 2:750-763(2002);Pastan,I.和Kreitman,Curr.Opin.Investig.Drugs 3:1089-1091(2002);Senter,P.D.和Springer,C.J.(2001)Adv.Drug Deliv.Rev.53:247-264。
在一个特定实施方案中,抗体衍生物是CD137抗体多聚体,其为CD137抗体的多聚体形式,诸如单体抗体的抗体二聚体、三聚体或高阶多聚体(higher-order multimer)。抗体多聚体内的各个单体可以是相同或不同的。此外,多聚体内的各个单体可具有相同或不同的结合特异性。抗体的多聚化可通过抗体的天然聚集实现。例如,一定百分比的纯化抗体制剂(例如,纯化的IgG4分子)自发形成包含抗体同型二聚体和其他高阶抗体多聚体的蛋白质聚集物。可替代地,抗体同型二聚体可通过本领域已知的化学连接技术形成,诸如通过使用交联剂。合适的交联剂包括为异源双功能、具有由适当的间隔基分开的两个不同的反应性基团(诸如间马来酰亚胺基苯甲酰基-N-羟基琥珀酰亚胺酯、4-(马来酰亚胺基甲基)环己烷-1-羧酸琥珀酰亚胺基酯和S-乙酰基硫代-乙酸N-琥珀酰亚胺基酯)或为同源双功能(诸如双琥珀酰亚胺辛二酸酯)的那些。此类接头可从例如Pierce Chemical Company,Rockford,IL商购获得。还可以通过本领域已知的重组DNA技术使抗体多聚化。
本公开提供的其他抗体衍生物的实例包括单链抗体、双抗体、结构域抗体、纳米抗体和迷你抗体(unibodies)。“单链抗体”(scFv)由包含与VH结构域连接的VL结构域的单个多肽链组成,其中VL结构域和VH结构域配对形成一价分子。单链抗体可以根据本领域已知的方法制备(参见,例如,Bird等人,(1988)Science 242:423-426和Huston等人,(1988)Proc.Natl.Acad.Sci.USA 85:5879-5883)。“双抗体”由两条链组成,每条链包含通过短肽接头连接的同一多肽链上与轻链可变区连接的重链可变区,其中同一条链上的两个区域不彼此配对,但是与另一条链上的互补结构域配对形成双特异性分子。制备双抗体的方法是本领域已知的(参见,例如,HolligerP.等人,(1993)Proc.Natl.Acad.Sci.USA 90:6444-6448和Poljak R.J.等人,(1994)Structure 2:1121-1123)。结构域抗体(dAb)是抗体的小功能结合单元,其对应于抗体的重链或轻链的可变区。结构域抗体在细菌、酵母和哺乳动物细胞系统中良好表达。结构域抗体及其产生方法的另外细节是本领域已知的(参见,例如,美国专利号6,291,158;6,582,915;6,593,081;6,172,197;6,696,245;欧洲专利0368684&0616640;WO05/035572、WO04/101790、WO04/081026、WO04/058821、WO04/003019和WO03/002609)。纳米抗体衍生自抗体的重链。纳米抗体通常包含单个可变结构域和两个恒定结构域(CH2和CH3)并且保持原始抗体的抗原结合能力。可以通过本领域已知的方法制备纳米抗体(参见例如,美国专利号6,765,087、美国专利号6,838,254、WO 06/079372)。迷你抗体由IgG4抗体的一条轻链和一条重链组成。可通过除去IgG4抗体的铰链区制备迷你抗体。迷你抗体及其制备方法的另外细节可见于WO2007/059782。
C.产生CD137抗体的核酸、载体、宿主细胞和重组方法
本公开的另一方面提供一种分离的核酸分子,其包含编码本公开提供的结合分子的氨基酸序列的核苷酸序列。由所述核苷酸序列编码的氨基酸序列可以是抗体的任何部分,诸如HVR,包含一个、两个或三个HVR的序列,重链的可变区,轻链的可变区,或可以是全长重链或全长轻链。本公开的核酸可以是,例如,DNA或RNA,并且可包含或可不包含内含子序列。通常,核酸是cDNA分子。
在一些实施方案中,本公开提供了一种分离的核酸分子,其包含编码氨基酸序列的核苷酸序列或由其组成,所述氨基酸序列选自由以下组成的组:(1)例示性抗体的HVR_H3或HVR_L3的氨基酸序列;(2)例示性抗体的重链的可变区或轻链的可变区;或(3)例示性抗体的全长重链或全长轻链。
在其他实施方案中,核酸分子包含核苷酸序列或由其组成,所述核苷酸序列编码如SEQ ID NO:13-132、253-612、613-660和709-852中的任一个中所示的氨基酸序列。
在其他实施方案中,核酸分子包含选自由SEQ ID NO:133-252和661-708组成的组的核苷酸序列或由其组成。
本公开的核酸可以使用任何合适的分子生物学技术获得。对于杂交瘤表达的抗体,编码通过杂交瘤制备的抗体的轻链和重链的cDNA可以通过PCR扩增或cDNA克隆技术获得。对于从免疫球蛋白基因文库获得的抗体(例如,使用噬菌体展示技术),可以从文库中回收编码所述抗体的核酸。
可以通过将编码VH的DNA操作性地连接至编码重链恒定区(CH1、CH2和CH3)的另一DNA分子而将编码VH区的分离DNA转换成全长重链基因。人重链恒定区基因的序列是本领域已知的(参见例如,Kabat等人(1991)Sequences of Proteins of ImmunologicalInterest,第5版,美国卫生与公共服务部,NIH出版号91-3242)并且涵盖这些区域的DNA片段可以通过标准PCR扩增获得。重链恒定区可以是IgG1、IgG2、IgG3、IgG4、IgA、IgE、IgM或IgD恒定区,但最优选的是不具有ADCC效应的IgG4或IgG2恒定区。IgG4恒定区序列可以是已知存在于不同个体中的各种等位基因或同种异型中的任一个。这些同种异型代表IgG4恒定区中天然存在的氨基酸取代。对于Fab片段重链基因,可以将编码VH的DNA操作性地连接至仅编码重链CH1恒定区的另一DNA分子。
可以通过将编码VL的DNA操作性地连接至编码轻链恒定区CL的另一DNA分子而将编码VL区的分离DNA转换成全长轻链基因(以及Fab轻链基因)。人轻链恒定区基因的序列是本领域已知的(参见例如,Kabat等人(1991)Sequences of Proteins of ImmunologicalInterest,第5版,美国卫生与公共服务部,NIH出版号91-3242)并且涵盖这些区域的DNA片段可以通过标准PCR扩增获得。轻链恒定区可以是κ或λ恒定区。
为了产生scFv基因,将编码VH和VL的DNA片段操作性地连接至编码柔性接头,例如编码氨基酸序列(Gly4-Ser)3的另一片段,使得VH和VL序列可以表达为具有通过柔性接头连接的VL和VH区的连续的单链蛋白质(参见例如,Bird等人,Science 242:423-426(1988);Huston等人,Proc.Natl.Acad.Sci.USA 85:5879-5883(1988);以及McCafferty等人,Nature 348:552-554(1990))。
本公开还提供了一种载体,其包含本公开提供的核酸分子。所述核酸分子可编码轻链或重链的一部分(诸如CDR或HVR)、全长轻链或重链、包含重链或轻链的一部分或全长的多肽,或抗体衍生物或抗原结合片段的氨基酸序列。在一些实施方案中,载体是可用于表达结合分子诸如抗体或其抗原结合片段的表达载体。在一些实施方案中,本文提供了载体,其中第一载体包含编码如本文所述的重链可变区的多核苷酸序列,并且第二载体包含编码如本文所述的轻链可变区的多核苷酸序列。在一些实施方案中,单个载体包含编码如本文所述的重链可变区和如本文所述的轻链可变区的多核苷酸。
为了表达本公开的结合分子,将编码部分或全长轻链和重链的DNA插入表达载体中,使得DNA分子操作性地连接至转录和翻译控制序列。在此上下文中,术语“操作性地连接”是指抗体基因连接到载体中,使得载体内的转录和翻译控制序列发挥其调控DNA分子的转录和翻译的预期功能。所选择的表达载体和表达控制序列应可与所使用的表达宿主细胞相容。抗体轻链基因和抗体重链基因可插入独立载体中,或者更通常两个基因插入同一表达载体中。抗体基因通过任何合适的方法插入表达载体中(例如,连接抗体基因片段和载体上的互补限制性位点,或基于同源重组的DNA连接)。本文所述抗体的轻链和重链可变区可以用于产生任何抗体同种型和亚类的全长抗体基因,这通过将它们插入已经编码期望的同种型和亚类的重链恒定区和轻链恒定区的表达载体中,使得VH区段操作性地连接至载体内的一个或多个CH区段并且VL区段操作性地连接至载体内的CL区段来实现。另外或可替代地,重组表达载体可以编码有助于宿主细胞分泌抗体链的信号肽。可将抗体链基因克隆到载体中,使得信号肽与抗体链基因的氨基末端同框连接。信号肽可以是免疫球蛋白信号肽或异源信号肽(即来自非免疫球蛋白的信号肽)。
除抗体链基因外,本公开的表达载体通常还携带控制抗体链基因在宿主细胞中的表达的调控序列。术语“调控序列”旨在包括启动子、增强子和控制抗体链基因的转录或翻译的其他表达控制元件(例如,聚腺苷酸化信号)。此类调控序列描述于,例如,Goeddel(Gene Expression Technology.Methods in Enzymology 185,Academic Press,SanDiego,Calif.(1990))中。本领域技术人员将认识到,表达载体的设计,包括调控序列的选择,可取决于诸如待转化的宿主细胞的选择、期望蛋白质的表达水平等因素。用于哺乳动物宿主细胞表达的调控序列的实例包括指导哺乳动物细胞中的高水平蛋白质表达的病毒元件,诸如来源于巨细胞病毒(CMV)、猿猴病毒40(SV40)、腺病毒(例如,腺病毒主要晚期启动子(AdMLP))和多瘤病毒的启动子和/或增强子。可替代地,可使用非病毒调控序列,诸如遍在蛋白启动子或β-球蛋白启动子。此外,调控元件包含来自不同来源的序列,诸如SR启动子系统,其包含来自SV40早期启动子和人T细胞白血病1型病毒的长末端重复序列的序列(Takebe,Y.等人(1988)Mol.Cell.Biol.8:466-472)。
除抗体链基因和调控序列外,表达载体还可携带另外的序列,诸如调控载体在宿主细胞中的复制的序列(例如,复制起点)和选择性标志物基因。选择性标志物基因有助于载体已经引入其中的宿主细胞的选择(参见例如,美国专利号4,399,216、4,634,665和5,179,017,所有均由Axel等人申请)。举例来说,通常选择性标志物基因将对于药物诸如G418、潮霉素或甲氨喋呤的抗性赋予其中已经引入载体的宿主细胞。选择性标志物基因包括二氢叶酸还原酶(DHFR)基因(用于使用甲氨蝶呤选择/扩增的dhfr-宿主细胞中)和neo基因(用于G418选择)。
为表达轻链和重链,通过任何合适的技术将编码重链和轻链的一种或多种表达载体转染到宿主细胞中。各种形式的术语“转染”旨在涵盖通常用于将外源DNA引入原核或真核宿主细胞中的广泛多种技术,例如电穿孔、磷酸钙沉淀、DEAE-葡聚糖转染等。尽管可以在原核或真核宿主细胞中表达本公开的抗体,但是最通常在真核细胞且通常在哺乳动物宿主细胞中表达抗体。
本公开还提供了一种宿主细胞,其包含本公开提供的核酸分子。宿主细胞实际上可以是表达载体适用的任何细胞。所述细胞可以是,例如,高级真核宿主细胞,诸如哺乳动物细胞;低级真核宿主细胞,诸如酵母细胞;并且可以是原核细胞,诸如细菌细胞。将重组核酸构建体引入宿主细胞中可以通过磷酸钙转染、DEAE、葡聚糖介导的转染、电穿孔或噬菌体感染实现。
适用于转化的真核宿主包括大肠杆菌(E.coli)、枯草芽孢杆菌(Bacillussubtilis)、鼠伤寒沙门氏菌(Salmonella typhimurium)以及假单胞菌属(Pseudomonas)、链霉菌属(Streptomyces)和葡萄球菌属(Staphylococcus)内的各菌种。
用于表达本公开的结合分子的哺乳动物宿主细胞包括,例如,中国仓鼠卵巢(CHO)细胞(包括dhfr-CHO细胞,描述于Urlaub和Chasin,Proc.Natl.Acad.Sci.USA 77:4216-4220(1980)中,其与DHFR选择性标志物一起使用,例如,如Kaufman和Sharp,J.Mol.Biol.159:601-621(1982)中所述)、NS0骨髓瘤细胞、COS细胞和Sp2细胞。具体地讲,对于与NS0骨髓瘤或CHO细胞一起使用,另一表达系统是WO 87/04462、WO 89/01036和EP338,841中公开的GS(谷氨酰胺合成酶)基因表达系统。当将编码抗体基因的表达载体引入到哺乳动物宿主细胞中时,通过将宿主细胞培养一段足以允许抗体在宿主细胞中表达或使抗体分泌到宿主细胞所生长的培养基中的时间来产生抗体。抗体可以使用任何合适的蛋白质纯化方法从培养基中回收。
D.组合物
在其他方面,本公开提供了一种组合物,其包含本公开提供的结合分子。在一个方面,所述组合物是包含结合分子和药学上可接受的载剂的药物组合物。所述组合物可以通过本领域已知的常规方法制备。
在一些实施方案中,本公开提供了一种组合物,其包含本公开提供的抗体或其抗原结合片段,以及药学上可接受的载剂,其中所述抗体包含有包含本文公开的HVR氨基酸序列的可变结构域,并且其中所述组合物包含与所述组合物中存在的抗体或其抗原结合部分的总量相比不超过约11%、10%、8%、5%、3%或2%的在所述氨基酸序列的天冬酰胺处糖基化的所述抗体或抗原结合部分。在另一个实施方案中,所述组合物包含与所述组合物中存在的抗体或其抗原结合部分的总量相比至少约2%的在所述氨基酸序列的天冬酰胺处糖基化的所述抗体或抗原结合部分。
术语“药学上可接受的载剂”是指适于在用于递送结合分子的制剂中使用的任何非活性物质。载剂可以是抗粘剂、粘结剂、包衣、崩解剂、填料或稀释剂、防腐剂(诸如抗氧化剂、抗细菌剂或抗真菌剂)、甜味剂、吸收延迟剂、湿润剂、乳化剂、缓冲剂等。合适的药学上可接受的载剂的实例包括水、乙醇、多元醇(诸如甘油、丙二醇、聚乙二醇等)右旋糖、植物油(诸如橄榄油)、盐水、缓冲液、缓冲盐水,以及等渗剂,诸如糖、聚醇、山梨醇和氯化钠。
组合物可处于任何合适的形式,诸如液体、半固体和固体剂型。液体剂型的实例包括溶液(例如,可注射和可输注溶液)、微乳液、脂质体、分散体或混悬液。固体剂型的实例包括片剂、丸剂、胶囊、微胶囊和粉剂。适用于递送结合分子的组合物的特定形式是无菌液体,诸如溶液、悬浮液或分散液,以用于注射或输注。无菌溶液可以通过将所需量的抗体掺入适当的载剂中,然后进行灭菌微过滤来制备。一般来说,通过将抗体掺入无菌媒介物中来制备分散液,所述无菌媒介物包含基本分散介质和其他载剂。对于用于制备无菌液体的无菌粉末来说,制备方法包括真空干燥和冷冻干燥(冻干),以产生活性成分加上来自其先前经过无菌过滤的溶液的任何另外的期望成分的粉末。组合物的各种剂型可以通过本领域已知的常规技术制备。
组合物中包含的结合分子的相对量将取决于多种因素而变化,诸如所用的具体结合分子和载剂、剂型以及期望的释放和药效动力学特征。单一剂型中结合分子的量将通常为产生治疗效果的量,但也可以是较少的量。一般来说,此量将在相对于剂型的总重量约0.01%至约99%、约0.1%至约70%,或约1%至约30%的范围内。
除结合分子外,一种或多种另外的治疗剂可包含在组合物中。另外治疗剂的实例在下文描述。待包含在组合物中的另外治疗剂的合适量可以由本领域技术人员容易地选择,并且将取决于多种因素而变化,诸如所用的特定药剂和载剂、剂型,以及期望的释放和药效动力学特征。包括在单一剂型中的另外治疗剂的量将通常为产生治疗效果的药剂的量,但也可以是较少的量。
E.结合分子和药物组合物的用途
本公开提供的结合分子和药物组合物可用于治疗、诊断或其他目的,诸如调节免疫应答、治疗癌症、增强其他癌症疗法的功效、增强疫苗功效,或治疗自身免疫疾病。因此,在其他方面,本公开提供了使用结合分子或药物组合物的方法。在一个方面,本公开提供了一种治疗哺乳动物的病症的方法,其包括向需要治疗的哺乳动物施用治疗有效量的本公开提供的结合分子。结合分子可以是CD137激动剂或拮抗剂。在一些实施方案中,结合分子是CD137激动剂。在一些实施方案中,哺乳动物是人。
在一些实施方案中,病症是癌症。CD137涉及其中的多种癌症,无论是恶性还是良性且无论是原发性还是继发性癌症,都可使用本公开提供的方法进行治疗或预防。此类癌症的实例包括肺癌诸如支气管癌(例如,鳞状细胞癌、小细胞癌、大细胞癌和腺癌)、肺泡细胞癌、支气管腺瘤、软骨瘤性错构瘤(非癌性)以及肉瘤(癌性);心脏癌症,诸如粘液瘤、纤维瘤和横纹肌瘤;骨癌,诸如骨软骨瘤、软骨瘤(condromas)、成软骨细胞瘤、软骨粘液样纤维瘤、骨样骨瘤、巨细胞肿瘤、软骨肉瘤、多发性骨髓瘤、骨肉瘤、纤维肉瘤、恶性纤维组织细胞瘤、尤文氏瘤(尤文氏肉瘤)和网状细胞肉瘤;脑癌,诸如神经胶质瘤(例如,多形性成胶质细胞瘤)、间变型星形细胞瘤、星形细胞瘤、少突神经胶质瘤、成神经管细胞瘤、脊索瘤、神经鞘瘤、室管膜瘤、脑膜瘤、垂体腺瘤、松果体瘤、骨瘤、成血管细胞瘤、颅咽管瘤、脊索瘤、生殖细胞瘤、畸胎瘤、皮样囊肿和血管瘤;消化系统中的癌症,诸如平滑肌瘤、表皮样癌、腺癌、平滑肌肉瘤、胃腺癌、肠道脂肪瘤、肠道神经纤维瘤、肠道纤维瘤、大肠中的息肉以及结肠直肠癌;肝癌,诸如肝细胞腺瘤、血管瘤、肝细胞癌、纤维板层癌、胆管癌、肝胚细胞瘤和血管肉瘤;肾癌,诸如肾腺癌、肾细胞癌、肾上腺样瘤和肾盂的移行细胞癌;膀胱癌;血癌,诸如急性淋巴细胞性(成淋巴细胞性)白血病、急性髓性(髓细胞性、骨髓性、成髓细胞性、髓单核细胞性)白血病、慢性淋巴细胞性白血病(例如,塞扎里综合征(Sezary syndrome)和毛细胞白血病)、慢性髓细胞性(髓样、骨髓性、粒细胞性)白血病、霍奇金氏淋巴瘤、非霍奇金氏淋巴瘤、B细胞淋巴瘤、蕈样肉芽肿病和骨髓增生病(包括诸如真性红细胞增多、骨髓纤维化、血小板增多症和慢性粒细胞性白血病的骨髓增生病);皮肤癌,诸如基底细胞癌、鳞状细胞癌、黑素瘤、卡波西肉瘤和佩吉特病;头颈癌;眼相关癌症,诸如视网膜母细胞瘤和眼内黑素癌;男性生殖系统癌症,诸如良性前列腺肥大、前列腺癌和睾丸癌(例如,精原细胞瘤、畸胎瘤、胚胎癌和绒毛膜癌);乳腺癌;女性生殖系统癌症,诸如子宫癌(子宫内膜癌)、宫颈癌(宫颈癌)、卵巢癌症(卵巢癌)、外阴癌、阴道癌、输卵管癌和水泡状胎块;甲状腺癌(包括乳突癌、滤泡癌、退行发育性癌或髓样癌);嗜铬细胞瘤(肾上腺);甲状旁腺的非癌性生长;胰腺癌;以及血癌,诸如白血病、骨髓瘤、非霍奇金氏淋巴瘤和霍奇金氏淋巴瘤。
在一些其他实施方案中,病症是自身免疫疾病。可用结合分子治疗的自身免疫疾病的实例包括自身免疫性脑脊髓炎、红斑狼疮和类风湿性关节炎。结合分子还可用于治疗炎症(诸如过敏性哮喘)和慢性移植物抗宿主病,
在另一方面,本公开提供了一种在哺乳动物中增强免疫应答的方法,其包括向哺乳动物施用治疗有效量的本公开提供的结合分子。在一些实施方案中,结合分子是CD137抗体或其抗原结合片段并且哺乳动物是人。在另一个实施方案中,结合分子是CD137激动剂抗体或其抗原结合片段。术语“增强免疫应答”或其语法变型是指刺激、激起、增加、提高或加强哺乳动物的免疫系统的任何应答。免疫应答可以是细胞应答(即,细胞介导的,诸如细胞毒性T淋巴细胞介导的)或体液应答(即,抗体介导的应答),并且可以是初次免疫应答或二次免疫应答。免疫应答增强的实例包括CD4+辅助T细胞活性的增加和溶细胞性T细胞的产生。免疫应答的增强可以使用本领域技术人员已知的多种体外或体内测量进行评估,包括但不限于细胞毒性T淋巴细胞测定、细胞因子的释放(例如IL-2产生)、肿瘤的消退、荷瘤动物的存活、抗体产生、免疫细胞增殖、细胞表面标志物的表达,以及细胞毒性。通常,当与未治疗哺乳动物或未使用所要求保护的方法治疗的哺乳动物的免疫应答相比时,本公开的方法增强哺乳动物的免疫应答。在一个实施方案中,结合分子用于增强人对微生物病原体(诸如病毒)的免疫应答。在另一个实施方案中,结合分子用于增强人对疫苗的免疫应答。结合分子可以是CD137激动剂或拮抗剂。在一些实施方案中,结合分子是CD137激动剂。在一个实施方案中,所述方法增强细胞免疫应答,尤其是细胞毒性T细胞应答。在另一个实施方案中,细胞免疫应答是T辅助细胞应答。在另一个实施方案中,免疫应答是细胞因子产生,尤其是IL-2产生。结合分子可用于增强人对微生物病原体(诸如病毒)或对疫苗的免疫应答。结合分子可以是CD137激动剂或拮抗剂。在一些实施方案中,结合分子是CD137激动剂。
在实践治疗方法时,结合分子可作为单一疗法单独施用,或与一种或多种另外的治疗剂或疗法组合施用。因此,在另一方面,本公开提供了一种组合疗法,其包括与一种或多种另外的疗法或治疗剂组合的结合分子,以用于分开、顺序或同时施用。术语“另外的疗法”是指不采用本公开提供的结合分子作为治疗剂的疗法。术语“另外的治疗剂”是指除本公开提供的结合分子之外的任何治疗剂。在一个特定方面,本公开提供了一种用于在哺乳动物中治疗癌症的组合疗法,其包括向哺乳动物施用治疗有效量的与一种或多种另外的治疗剂组合的本公开提供的结合分子。在另一个实施方案中,哺乳动物是人。
广泛多种癌症治疗剂可与本公开提供的结合分子组合使用。本领域普通技术人员将认识到可与本公开的方法和结合分子组合使用的其他癌症疗法的存在和发展,并且将不局限于本文所述疗法的那些形式。可在用于治疗癌症的组合疗法中使用的另外的治疗剂的类别的实例包括(1)化学治疗剂,(2)免疫治疗剂,以及(3)激素治疗剂。
术语“化学治疗剂”是指可以导致癌细胞死亡或干扰癌细胞的生长、分裂、修复和/或功能的化学或生物学物质。化学治疗剂的实例包括在WO 2006/129163和US 20060153808中公开的那些,所述专利的公开内容以引用方式并入本文。特定的化学治疗剂的实例包括:(1)烷化剂,诸如瘤可宁(chlorambucil)(LEUKERAN)、环磷酰胺(mcyclophosphamide)(CYTOXAN)、异环磷酰胺(IFEX)、盐酸氮芥(MUSTARGEN)、塞替派(THIOPLEX)、链脲霉素(ZANOSAR)、卡莫司汀(BICNU、GLIADELWAFER)、洛莫司汀(CEENU)和达卡巴嗪(DTIC-DOME);(2)生物碱或植物长春花生物碱,包括细胞毒性抗生素,诸如多柔比星(ADRIAMYCIN)、表柔比星(ELLENCE、PHARMORUBICIN)、柔红霉素(CERUBIDINE、DAUNOXOME)、奈莫柔比星、伊达比星(IDAMYCIN PFS、ZAVEDOS)、米托蒽醌(DHAD,NOVANTRONE)、更生霉素(放线菌素D、COSMEGEN)、普卡霉素(MITHRACIN)、丝裂霉素(MUTAMYCIN)和博来霉素(BLENOXANE)、酒石酸长春瑞滨(NAVELBINE))、长春碱(VELBAN)、长春新碱(ONCOVIN)和长春地辛(ELDISINE);(3)抗代谢药,诸如卡培他滨(XELODA)、阿糖胞苷(CYTOSAR-U)、氟达拉滨(FLUDARA)、吉西他滨(GEMZAR)、羟基脲(HYDRA)、甲氨蝶呤(FOLEX、MEXATE、TREXALL)、奈拉滨(ARRANON)、三甲曲沙(NEUTREXIN)和培美曲塞(ALIMTA);(4)嘧啶拮抗剂,诸如5-氟尿嘧啶(5-FU)、卡培他滨(XELODA)、雷替曲塞(TOMUDEX)、替加氟-尿嘧啶(UFTORAL)和吉西他滨(GEMZAR);(5)紫杉烷,诸如多西他赛(TAXOTERE)、紫杉醇(TAXOL);(6)铂类药物,诸如顺铂(PLATINOL)和卡铂(PARAPLATIN)以及奥沙利铂(ELOXATIN);(7)拓扑异构酶抑制剂,诸如伊立替康(CAMPTOSAR)、拓扑替康(HYCAMTIN)、依托泊苷(ETOPOPHOS、VEPESSID、TOPOSAR)和替尼泊苷(VUMON);(8)表鬼臼毒素(鬼臼毒素衍生物),诸如依托泊苷(ETOPOPHOS、VEPESSID、TOPOSAR);(9)叶酸衍生物,诸如亚叶酸(WELLCOVORIN);(10)亚硝基脲,诸如卡莫司汀(BiCNU)、洛莫司汀(CeeNU);(11)受体酪氨酸激酶,包括表皮生长因子受体(EGFR)、血管内皮生长因子(VEGF)、胰岛素受体、胰岛素样生长因子受体(IGFR)、肝细胞生长因子受体(HGFR)和血小板源性生长因子受体(PDGFR)的抑制剂,诸如吉非替尼(IRESSA)、厄洛替尼(TARCEVA)、硼替佐米(VELCADE)、甲磺酸伊马替尼(GLEEVEC)、吉非替尼(genefitinib)、拉帕替尼、索拉非尼、沙利度胺、舒尼替尼(SUTENT)、阿西替尼、利妥昔单抗(RITUXAN、MABTHERA)、曲妥珠单抗(HERCEPTIN)、西妥昔单抗(ERBITUX)、贝伐珠单抗(AVASTIN)和来尼珠单抗(ranibizumab,LUCENTIS)、lym-1(ONCOLYM)、WO2002/053596中公开的胰岛素样生长因子-1受体(IGF-1R)的抗体);(12)血管生成抑制剂,诸如贝伐珠单抗(AVASTIN)、苏拉明(GERMANIN)、血管抑素、SU5416、沙利度胺和基质金属蛋白酶抑制剂(诸如巴马司他(batimastat)和马立马司他(marimastat)),和WO2002055106中公开的那些;以及(13)蛋白酶体抑制剂,诸如硼替佐米(VELCADE)。
术语“免疫治疗剂”是指可增强哺乳动物的免疫应答的化学或生物学物质。免疫治疗剂的实例包括:卡介苗(BCG);细胞因子,诸如干扰素;疫苗,诸如MyVax个性化免疫疗法、Onyvax-P、Oncophage、GRNVAC1、Favld、Provenge、GVAX、Lovaxin C、BiovaxID、GMXX和NeuVax;以及抗体,诸如阿仑单抗(CAMPATH)、贝伐单抗(AVASTIN)、西妥昔单抗(ERBITUX)、吉妥珠单抗奥唑米星(gemtuzunab ozogamicin)(MYLOTARG)、替伊莫单抗(ibritumomabtiuxetan)(ZEVALIN)、帕尼单抗(VECTIBIX)、利妥昔单抗(RITUXAN、MABTHERA)、曲妥珠单抗(HERCEPTIN)、托西莫单抗(BEXXAR)、伊匹木单抗(YERVOY)、曲美利木单抗(tremelimumab)、CAT-3888、针对OX40受体的激动剂抗体(诸如WO2009/079335中公开的那些)、针对CD40受体的激动剂抗体(诸如WO2003/040170中公开的那些,以及TLR-9激动剂(诸如WO2003/015711、WO2004/016805和WO2009/022215中公开的那些)。
术语“激素治疗剂”是指抑制或消除激素的产生,或抑制或抵消激素对癌细胞的生长和/或存活的作用的化学或生物学物质。适用于本文中的方法的此类药剂的实例包括US20070117809中公开的那些。特定的激素治疗剂的实例包括他莫昔芬(NOLVADEX)、托瑞米芬(Fareston)、氟维司群(FASLODEX)、阿那曲唑(ARIMIDEX)、依西美坦(AROMASIN)、来曲唑(FEMARA)、醋酸甲地孕酮(MEGACE)、戈舍瑞林(ZOLADEX)和亮丙立德(LUPRON)。本公开的结合分子还可与非药物激素疗法组合使用,所述非药物激素疗法诸如(1)除去全部或部分的参与激素产生的器官或腺体诸如卵巢、睾丸、肾上腺和垂体的手术方法,以及(2)放射治疗,其中使患者的器官或腺体经受量足以抑制或消除靶向激素的产生的放射。
用于治疗癌症的组合疗法还涵盖结合分子与除去肿瘤的手术的组合。可在手术之前、期间或之后向哺乳动物施用结合分子。
用于治疗癌症的组合疗法还涵盖结合分子与放射疗法诸如电离(电磁)放射疗法(例如,X射线或γ射线)和粒子束放射疗法(例如,高线性能放射(high linear energyradiation))的组合。放射源对于哺乳动物可以是外部的或内部的。可在放射疗法之前、期间或之后向哺乳动物施用结合分子。
可以通过任何合适的施用的肠途径或肠胃外途径施用本公开提供的结合分子和组合物。术语施用的“肠途径”是指经由胃肠道的任何部分的施用。肠途径的实例包括口腔、粘膜、颊面和直肠途径,或胃内途径。施用的“肠胃外途径”是指除了肠途径以外的施用途径。施用的肠胃外途径的实例包括静脉内、肌内、真皮内、腹膜内、瘤内、膀胱内、动脉内、鞘内、囊内、眶内、心脏内、经气管、关节内、被膜下、蛛网膜下、脊柱内、硬膜外和胸骨内、皮下或局部施用。可使用任何合适的方法施用本公开的抗体和组合物,诸如通过口服摄取、鼻胃管、胃造口管(gastrostomy tube)、注射、输注、可植入输注泵,以及渗透泵。合适的施用途径和方法可取决于多种因素而变化,诸如所用的具体抗体、期望的吸收速率、所用的具体制剂或剂型、所治疗病症的类型或严重程度、具体的作用部位,以及患者的状况,并且可以由本领域技术人员容易地选择。
术语结合分子的“治疗有效量”是指对于预期治疗目的有效的量。例如,在增强免疫应答的上下文中,“治疗有效量”是在刺激、激起、增加、提高或加强哺乳动物免疫系统的任何应答中有效的任何量。在治疗疾病的上下文中,“治疗有效量”是足以在所治疗的哺乳动物中引起任何期望或有益的效应的任何量。具体地,在癌症的治疗中,期望或有益的效应的实例包括癌细胞的进一步生长或扩散的抑制、癌细胞的死亡、癌症复发的抑制、癌症相关疼痛的减少,或哺乳动物存活率的提高。CD137抗体的治疗有效量的范围通常为约0.001至约500mg/kg,且更通常地为约0.01至约100mg/kg的哺乳动物体重。例如,所述量可以是约0.3mg/kg、1mg/kg、3mg/kg、5mg/kg、10mg/kg、50mg/kg或100mg/kg的哺乳动物体重。在一些实施方案中,CD 137抗体的治疗有效量在约0.01-30mg/kg的哺乳动物体重的范围内。在一些其他实施方案中,CD137抗体的治疗有效量在约0.05-15mg/kg的哺乳动物体重的范围内。待施用的精确剂量水平可由本领域技术人员容易地确定,并且将取决于多种因素,诸如待治疗病症的类型和严重程度、所使用的特定结合分子、施用途径、施用时间、治疗的持续时间、所使用的特定的另外的疗法、所治疗的患者的年龄、性别、体重、状况、一般健康和先前的医疗史,以及医学领域中熟知的类似因素。
通常在多个情况下施用结合分子或组合物。单一剂量之间的间隔可以是,例如,每周1次、每月1次、每3个月1次或每年1次。示例性治疗方案使施用为每周1次、每2周1次、每3周1次、每4周1次、每月1次、每3个月1次或每3至6个月1次。CD137抗体的典型剂量方案包括静脉内施用1mg/kg体重或3mg/kg体重,使用下列给药方案中的一个:(i)每4周1次,进行6次剂量,然后每3个月1次;(ii)每3周1次;(iii)3mg/kg体重1次,然后1mg/kg体重,每3周1次。
通过参考以下实施例将更完全地理解本公开。然而,实施例不应解释为限制本公开的范围。应了解,本文所述的实施例和实施方案仅用于例示性目的,并且将建议本领域的技术人员根据其进行各种修改或变化,并且它们将包括在本申请的精神和权限以及所附权利要求书的范围内。本公开通篇引用的所有附图以及所有参考文献、专利和公布的专利申请的内容明确地以引用方式整体并入本文。
实施例
实施例1
特异性结合人CD137的初级Fab的生成
使用专有质粒文库(参见在代理人案卷号69540-2000140下与此同时提交的标题为“Dynamic Human Antibody Light Chain Libraries”的PCT国际申请,其以引用方式整体并入本文;另外参见在代理人案卷号69540-2000240下与此同时提交的标题为“DynamicHuman Heavy Chain Antibody Libraries”的PCT国际申请,其以引用方式整体并入本文)淘选(pan against)人CD137抗原。进行共计三轮或四轮淘选。在最后一轮淘选之后,进行单菌落上清液ELISA,以鉴定特异性识别人CD137的初级命中物。初级命中物定义为其ELISA信号为背景的至少两倍的那些。对它们进行测序,将独特克隆表达并通过ForteBio和Biacore针对亲和力测量进行纯化。将列表精细调整为Fab中具有ELISA阳性命中物和独特序列两者的124个。根据KD应答信号R>0.1,R2>0.9和亲和力KD<100nM的标准,将列表进一步精细调整为60个命中物(表1a)。接着将其中的24个转换成IgG(表1b),以用于详细的生物物理和功能表征。
将与独特命中物相对应的Fab在大肠杆菌中表达并纯化。通过ForteBio OctetRED96系统测量它们对人CD137的亲和力。简而言之,使用AHC传感器(Anti-Human IgG FcCapture Dip and Read Biosensors)捕获CD137-hisFc融合蛋白(Sino Biological目录号10041-H03H),并且浸插到含有用动力学缓冲液(kinetic buffer)(10mM HEPES、150mMNaCl、3mM EDTA、0.005%体积/体积表面活性剂P20,pH 7.4、)稀释至5-10μg/ml的纯化Fab的孔中。获取的ForteBio数据用Data Acquisition软件7.1处理,并且将动力学数据拟合于1∶1朗格缪尔(Langmuir)结合模型。亲和力和动力学参数(已减除背景)在表1a中列出。它们对应的IgG对人CD137的亲和力通过Biacore测量并且在表1b中示出。
表1a:所选Fab对人CD137的亲和力和对应的氨基酸序列(在SEQ ID NO.中)
编码氨基酸序列SEQ ID NO:13-132的对应DNA序列分别可见于SEQ ID NO:133-252。表1a所示的所有Fab命中物的HVR_H1氨基酸序列分别可见于SEQ ID NO:253-312。表1a所示的所有Fab命中物的HVR_H2氨基酸序列分别可见于SEQ ID NO:313-372。表1a所示的所有Fab命中物的HVR_H3氨基酸序列分别可见于SEQ ID NO:373-432。表1a所示的所有Fab命中物的HVR_L1氨基酸序列分别可见于SEQ ID NO:433-492。表1a所示的所有Fab命中物的HVR_L2氨基酸序列分别可见于SEQ ID NO:493-552。表1a所示的所有Fab命中物的HVR_L3氨基酸序列分别可见于SEQ ID NO:553-612(另外参见表1c)。
表1b:Fab和对应IgG对人CD137的亲和力
编码氨基酸序列SEQ ID NO:613-660的对应DNA序列分别可见于SEQ ID NO:661-708。表1b所示的所有IgG序列的HVR_H1氨基酸序列分别可见于SEQ ID NO:709-732。表1b所示的所有IgG序列的HVR_H2氨基酸序列分别可见于SEQ ID NO:733-756。表1b所示的所有IgG序列的HVR_H3氨基酸序列分别可见于SEQ ID NO:757-780。表1b所示的所有IgG序列的HVR_L1氨基酸序列分别可见于SEQ ID NO:781-804。表1b所示的所有IgG序列的HVR_L2氨基酸序列分别可见于SEQ ID NO:805-828。表1b所示的所有IgG序列的HVR_L3氨基酸序列分别可见于SEQ ID NO:829-852。
表1c:Fab的CDR序列
实施例2
与小鼠CD137交叉反应的Fab命中物的选择
Fab命中物的物种交叉反应性使用ELISA确定。简而言之,将200μL的5μg/mL抗人IgG(Fab特异性)(Sigma#I5260)涂布在Maxisorp微板(Thermo Scientific 446469)上,在4℃下过夜。封闭之后,添加100μL Fab 5310(5μg/mL)、5351(2.8μg/mL)和5365(5μg/mL)并孵育1hr。洗涤三次之后,添加与人FC片段融合的人或小鼠CD137抗原的系列稀释液并孵育1hr。洗涤之后,将HRP标记的山羊抗人FC用PBS 1∶2000稀释,并添加到每个孔中,孵育1hr。将板洗涤三次并且与TMB底物一起在室温下孵育20min。在反应停止后,测量450nm下的吸光度。结果呈现于图1b中,下部小图示出Fab 5310和5365结合人和小鼠CD137两者,而Fab5351结合人CD137,但不结合小鼠CD137。
实施例3
IgG转换和表达:AG10058、AG10059和AG10131
将Fab 5310、5351和5365的重链和轻链单独克隆到具有S241P突变的IgG4同种型中的哺乳动物表达载体pCDNA3.3(Thermo Fisher Scientific)中。另外分别将两个参考抗体的重链和轻链克隆到IgG4和IgG2同种型中的pCDNA3.3中。
参考抗体AC1097中使用的重链可变区包含序列EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS(SEQ ID NO:862),并且参考抗体AC1097中的轻链可变区包含序列SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL(SEQ ID NO:863)。参考抗体AC1121中使用的重链可变区包含序列QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQSPEKGLEWIGEINHGGYVTYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGNYDWYFDLWGRGTLVTVSS(SEQ ID NO:864),并且参考抗体AC1121中的轻链可变区包含序列EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIK(SEQ ID NO:865)。本文使用的IgG在表2中示出。
表2:IgG的列表
IgG | Fab | 同种型 | 描述 |
AC1097 | 参考1 | IgG2 | 参考Ab |
AC1121 | 参考2 | IgG4(S241P) | 参考Ab |
AG10058 | 5310 | IgG4(S241P) | Adagene mAb |
AG10059 | 5351 | IgG4(S241P) | Adagene mAb |
AG10131 | 5365 | IgG4(S241P) | Adagene mAb |
AG10154 | IgG4(S241P) | 同种型对照 |
按照制造商的说明书,将质粒对瞬时转染到HEK293F细胞中。收获上清液,通过离心和过滤使其澄清,并且利用标准蛋白A亲和色谱(MabSelect SuRe,GE Healthcare)纯化IgG。将蛋白质洗脱并中和,并且缓冲液交换到PB缓冲液(20mM磷酸钠、150mM NaCl,pH 7.0)中。通过紫外分光光度法(UV-spectrophotometry)确定蛋白质浓度,并且通过SDS-PAGE或SEC-HPLC,在变性、还原和非还原条件下分析IgG纯度。
实施例4
对人、猴和小鼠CD137的结合亲和力
通过BIAcore、ELISA和流式细胞术测量IgG对人、猴和小鼠CD137的结合亲和力。结果汇总在表3中。
表3:抗体对人、猴和小鼠CD137的结合亲和力
NC:不交叉反应
4a.通过SPR测量结合亲和力和动力学
使用BiacoreTM T200仪器(Biacore AB,Uppsala,Sweden),根据制造商的指南,通过表面等离子体共振(SPR)分析检查抗体对人、猴和小鼠CD137蛋白的结合亲和力和动力学。根据胺偶联试剂盒(GE Biacore#BR-1000-50)的说明书,通过将来自人抗体捕获试剂盒(Human Antibody Capture Kit)(GE BR-1008-39)的抗人IgG(Fc)抗体的氨基偶联到传感器芯片的羧基化表面上而将其固定在CM5芯片上。使用固定的抗人IgG(Fc)抗体捕获AG10058、AG10059、AG10131、AC1121和AC1097。最后,将六种浓度(3.13、6.25、12.5、25、50、100)(nM)(在运行缓冲液中稀释)的人CD137-His6(Sino Biological#10041-H08H)以30μI/min的流速注射300秒,并且解离时间为300秒。所用的运行缓冲液为1×HBS-EP(10mMHEPES、150mM NaCl、3mM EDTA、0.005%体积/体积表面活性剂P20,pH 7.4,25℃)。使用不具有固定蛋白质的空白流动池在各情况下进行对应的对照,以用于“背景”减除。使用BiacoreT200评估软件(Biacore AB,Uppsala,Sweden),根据制造商的指南将缔合和解离曲线拟合于1∶1朗格缪尔结合模型。如表3所示,所有抗体均与人CD137结合。AG10058和AG10059显示出比两种参考抗体更高的亲和力。除了AC1121参考mAb之外,所有抗体均结合猴CD137。只有AG10058和AG10131结合小鼠和大鼠CD137。AG10058具有比AG10131(64.5nM)更高的亲和力(15.2nM)。
4b.使用ELISA测定测量对可溶性CD137的结合亲和力
制备与人FC片段融合的人、猴或小鼠CD137的系列稀释液并用于涂布ELISA板,在37℃下1hr。封闭之后,添加100μLIgG(5μg/mL)并在37℃下孵育1hr。将板洗涤三次,然后与HRP缀合的蛋白质L(1∶2000稀释液)一起在37℃下孵育1hr。再次将板洗涤三次并且与TMB底物一起在室温下孵育20min。在反应停止后,测量450nm下的吸光度。通过Graphpad Prism 6利用非线性拟合分析数据。如图2所示,所有抗体均以类似的sub nM亲和力结合人CD137(FC融合蛋白)。除了AC1121参考mAb之外,所有抗体均以类似的sub nM亲和力结合猴CD137。与来自Biacore的结果一致,只有AG10058和AG10131结合小鼠CD137。AG10058具有比AG10131(23.9nM)更高的亲和力(0.3nM)。
4c.通过流式细胞术测量对在细胞表面过表达的CD137的结合亲和力
还评估了抗体对在HEK293F细胞的表面上瞬时表达的人、猴和小鼠CD137的亲和力。简而言之,用来自双顺反子IRES载体的表达全长人、猴或小鼠CD137的质粒转染HEK293F细胞,使用EGFP鉴定转染细胞。48hr后,收获转染细胞并且接着用冷的FACS缓冲液(补充有1%BSA的PBS)洗涤一次。然后将细胞与各种IgG(各自为100nM)一起在冰上孵育1hr,用预先冷却的FACS缓冲液洗涤两次,并且与Alexa647缀合的小鼠抗人FC抗体一起在冰上孵育30min。将细胞洗涤一次,然后通过流式细胞术(CytoFlex)进行分析。如图3a所示,所有抗体均以低nM亲和力与在细胞表面上表达的人CD137结合。AG10058、AG10059和AG10131略优于两种参考抗体。除了AC1121参考mAb之外,所有抗体均以低nM亲和力结合猴CD137,AG10058、AG10059和AG10131略优于AC1097参考抗体。与来自Biacore和ELISA的结果一致,只有AG10058和AG10131结合小鼠和大鼠CD137。AG10058对小鼠CD137的亲和力高于AG10131。另外,AG10058和AG10131(各自为100nM)还结合在HEK293F细胞表面上过表达的大鼠和犬CD137(图3b)。
4d.IgG与活化的人、猴、小鼠和大鼠T细胞的结合。
使用人、猴、小鼠和大鼠的PMA和离子霉素刺激的PBMC或T细胞进一步确认示例性抗体的物种交叉反应性。通过Ficoll-密度梯度离心分离人和食蟹猴PBMC。简而言之,将来自健康供体或食蟹猴的新鲜全血用等体积的PBS稀释并且仔细地加载到Histopaque 1077(14ml,在50ml离心管中)的顶部。利用无闸减速(brake off),在室温下以1,200×g离心30分钟。离心之后,用移液管将上层仔细抽吸至0.5cm的含有单核细胞的不透明界面之内。弃去上层。用移液管将不透明界面(约3-5ml)仔细转移到干净的50ml锥形离心管中。用20ml的PBS洗涤细胞,通过在400×g下离心5分钟收集细胞,并且将细胞重悬于20ml的PBS中。用血球计对细胞计数,并且通过在400×g下离心5分钟再次收集细胞。通过以下方式分离小鼠或大鼠脾细胞:使脾穿过附接至50-mL锥形管的45μm细胞筛网以得到单细胞悬浮液,并且用PBS将细胞洗涤穿过筛网。以1600rpm离心5min并弃去上清液。将细胞沉淀物重悬于2ml红血细胞裂解溶液中,持续2min。过量添加10倍体积的PBS并且以1600rpm离心5min来收集细胞。弃去上清液并且将脾细胞重悬于RPMI 1640/10%FBS中。分别利用对人、猴、小鼠和大鼠具有特异性的商业试剂盒(Stemcell Technologies)中的磁珠,通过阴性选择从PBMC(人/猴)或脾细胞(小鼠/大鼠)中富集泛T细胞(Pan-T cell)。人/猴PBMC,或小鼠/大鼠脾细胞的活化通过将细胞与50ng/ml PMA+1μM离子霉素一起在37℃、5%CO2下孵育过夜来进行。
将活化细胞(~2x105个细胞/管)在预先冷却的染色缓冲液(补充有2%FBS的PBS)中洗涤并且与100nM测试抗体一起在冰上孵育1hr。然后将细胞用1mL染色缓冲液洗涤两次并且重悬于包含Alexa647缀合的小鼠抗人FC抗体和物种特异性T细胞标志物抗体的100μL染色缓冲液中。T细胞标志物抗体使用如下:CD3、CD4或CD8。在黑暗中孵育30分钟后,用染色缓冲液洗涤细胞两次。最后,将细胞重悬于300μL染色缓冲液中并通过BeckmanCytoFlex进行分析。使用Flowjo 10软件进行数据分析。如图4a所示,所有测试抗体均结合活化的人和猴T细胞,但不结合原初人T细胞。进一步评估AG10131对活化的小鼠和大鼠T细胞的结合亲和力(图4b)。AG10131结合活化的小鼠和大鼠T细胞。
概括地说,AG10058和AG10131抗体对人和猴CD137显示出更高的亲和力。它们表现出广泛的物种交叉反应性,对于AG10131而言包括人、食蟹猴、小鼠、大鼠和狗,但是对于AG10058而言包括人、食蟹猴、小鼠和狗,从而允许快速评估在小鼠同系模型中的体内功效。
实施例5
抗体对CD137的结合选择性
抗体对CD137的选择性使用其对TNFR超家族成员的结合亲和力的流式细胞术分析进行评估。将包括CD 137、OX40、CD40、GITR和CD27的TNFRSF受体在HEK293F细胞的表面上瞬时过表达。将转染细胞在预先冷却的染色缓冲液(补充有2%FBS的PBS)中洗涤并且与100nM测试抗体一起在冰上孵育1hr。用染色缓冲液洗涤细胞两次,添加Alexa647缀合的小鼠抗人FC抗体并在冰上孵育30min。将样品用染色缓冲液洗涤一次,然后通过流式细胞术进行分析。如图5所示,AG10058、AG10059和AG10131与CD137特异性结合,但是不特异性结合任何其他所测试的家族成员或用空载体转染的亲本细胞。
实施例6
使用ELISA和流式细胞术测试配体竞争
通过ELISA和流式细胞术测定,针对抗体阻断CD137与其同源配体CD137L结合的能力对所述抗体进行测试。如图6a和6b所示,所有测试抗体均阻断CD137和CD137L的结合。
6a.通过ELISA测试配体竞争结合
将重组人CD137(与人Fc和His标签融合)在PBS中稀释至1μg/mL并涂布在Maxisorp板上,在4℃下过夜。将板用补充有3%脱脂奶的PBS在37℃下封闭1hr。洗涤之后,向每个孔中添加50uL生物素化的CD137L(4μg/mL)和各种浓度的测试抗体(在500μg/mL至2μg/mL范围内的八份1∶2系列稀释液)的总体积100uL混合物并在37℃下孵育1hr。将板洗涤三次并且向每个孔中添加100μLHRP缀合的中性亲和素(neutravidin)(1∶1000)并在37℃下孵育1hr。如先前所述将板洗涤,添加50μLTMB底物溶液并在室温下孵育20分钟,然后通过50μLH2SO4停止反应。如图6a所示,所有测试抗体AG10058、AG10059和AG10131均阻断CD137与CD137L的结合。AG10131表现出最强或完全阻断能力,在大约uM范围,接着是>uM的显著阻断的AG10058;以及处于uM范围的有效阻断的AG10059。这些数据表明,在所测试的条件下且利用所用的试剂,广泛物种交叉反应性抗体AG10131和AG10058是CD137与其配体CD137L之间的相互作用的高度有效抑制剂,而AG10059仅显示出对CD137与其配体CD137L之间的相互作用的中等有效阻断。应注意,与人和猴CD137交叉反应的参考抗体AC1097,而仅与人CD137反应的AC1121几乎根本不显示出阻断。
6b.通过流式细胞术测试配体竟争结合
将编码全长人CD137的质粒在HEK293F细胞中瞬时表达。将细胞用染色缓冲液(补充有1%BSA的PBS)洗涤并重悬于含有100nM测试抗体的染色缓冲液中。在冰上孵育30min后,向每个孔中添加33nM生物素化的CD137L并且再在冰上孵育1hr。将细胞用染色缓冲液洗涤两次,添加50μL含有Alexa fluor 647缀合的链霉亲和素的染色缓冲液并在冰上孵育30min。将细胞洗涤一次并通过CytoFlex流式细胞术进行分析。如图6b所示,所有三种测试抗体均可以浓度依赖性方式阻断CD137与CD137L之间的结合。AG10131显示出最强阻断能力,接着是具有显著阻断的AG10058,以及具有不太有效阻断的AG10059。这些数据表明,广泛物种交叉反应性抗体AG10131和AG10058高度有效地阻断CD137与其配体CD137L之间的相互作用,而AG10059显示出对CD137与其配体CD137L之间的相互作用的部分阻断。相比之下,与人和猴CD137交叉反应的AC1097参考抗体仅显示出部分阻断,而仅与人CD137反应的AC1121参考抗体不显示出阻断。
实施例7
表位作图
为了在氨基酸残基水平上确定测试抗体的结合区域,在人CD137的细胞外结构域上进行一系列突变(表5)。使用这些CD137突变质粒转染HEK293F细胞。抗体与人CD137突变体的结合通过流式细胞术分析进行评估,如先前在实施例5中描述且在图7A中示出。结果汇总于表5中,连同这些抗体与处于感兴趣的差异(differentiation)的人、猴、小鼠和大鼠CD137的交叉反应性,指示了来自衍生自Adagene文库的命中物的精细表位。AG10131与全部4个物种结合,而AG10058结合全部3种CD137,但不结合大鼠CD137。AG10058、AG10059和AG10131丧失对GFT34AAA、FSS53AAA和FH92AA突变的结合能力,表明其结合表位在这些区域内,例如SEQ ID NO.:1的氨基酸残基34-93或34-108(另外参见图7B)。AG10058和AG10131可结合相同或高度相似的表位,而AG10059可结合与AG10058和AG10131不同的表位。
突变构建体意在将AG10058、AG10059和AG10131所结合的表位与参考抗体AC1121和AC1097区分开。清楚的是,所有三种抗体AG10058、AG10059和AG10131靶向与AC1121和AC1097非常不同的表位。AG10058、AG10059和AG10131在由突变体Hu_FH92AA和Hu_FSS53AAA以及可能的Hu_GTF34AAA限定的区域中不同于AC1121,而AG10058、AG10059和AG10131在由大多数所用突变体限定的区域中不同于AC1097,Hu_FH92AA以及它们与猴的物种交叉反应性除外,但是在其他物种交叉反应性诸如小鼠、大鼠和狗CD137中不同。在一些实施方案中,AG10058、AG10059和AG10131或本文公开的其他抗体不结合位于SEQ ID NO.:1的氨基酸残基115-156内的表位。图7A和表5中还示出,人CD137配体与野生型人CD137相对突变型人CD137的结合与测试抗体的结合模式良好匹配,这与这些抗体阻断CD137配体与其受体的结合的观察是一致的。
表5:表位作图
实施例8
NFκB荧光素酶报告基因测定中抗体的激动剂活性
使用NFκB报告基因测定评估抗体的激动剂活性。将293T细胞用表达人、猴或小鼠CD137的质粒以及NFκB光素酶报告基因质粒转染。4h后,以0.4x 106/mL的密度将50μL细胞涂板到96孔板的每个测定孔中。添加含有测试抗体和3∶1比率的交联抗体(Fab’山羊抗人IgG FC)的总体积50μL抗体混合物并孵育18h。除去培养基后,添加50μL Passive裂解缓冲液(Promega E1980)并且在37℃下孵育30min。将20μL裂解物转移到白板中并添加荧光素酶底物。测量萤火虫和肾素(Renina)的发光信号并且它们的比率用于通过GraphPad Prism6.0软件进行数据分析。如图8所示,相比于同种型对照抗体,当人和猴CD137表达时,所有测试抗体均激活NFκB报告基因表达。当小鼠CD137表达时,AG10058和AG10131,但不是AG10059,激活NFκB报告基因表达。这与AG10058和AG10131结合小鼠CD137,而AG10059则不如此的之前观察一致。
实施例9
T细胞活化测定中抗体的激动剂活性
在T细胞活化测定中进一步确认抗体的激动剂活性。用单独的或连同50μL在1×PBS中的测试抗体(60μg/mL、20μg/mL、6μg/mL、2μg/mL和0μg/mL)一起的50μL抗CD3抗体(2μg/ml)涂布96孔细胞培养板,在4℃下过夜。使用根据制造商的说明书的方案分离CD8+T细胞。以1×107个细胞/mL的密度在补充有10%FBS的RPMI 1640培养基中制备细胞。将200μL细胞涂板到每个测定孔中并在37℃、5%CO2培养箱中孵育4天。每天在显微镜下检查细胞的增殖。孵育96hr后,将100μL上清液转移到新的96孔板中以进行IFN-γ检测。T细胞增殖使用Cell Titer Glow试剂盒(Promega)测定。如图9所示,相比于同种型对照抗体,所有测试抗体均以剂量依赖性方式诱导CD8+T细胞增殖和IFN-γ分泌。
实施例10
在小鼠同系模型中的抗肿瘤活性
与小鼠CD137的物种交叉反应性允许快速体内功能评估。AG10058和AG10131已经在多个小鼠同系模型中进行了测试。对BALB/c小鼠(n=8/组)皮下移植2×106个H22肝癌细胞(Xiao等人,Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunityagainst murine H22 hepatocarcinoma in vivo.Clin Cancer Res.2007;13(6):1823-30.)、5×105个CT26结肠癌细胞,或5×105个EMT6乳腺癌细胞。当肿瘤建立(>50mm3)时,开始每周两次通过腹膜内注射用同种型对照抗体、AG10058或AG10131进行治疗,持续最多至3周。每周两次监测肿瘤生长并报告为随时间推移的平均肿瘤体积±s.e.m.。如图10-13所示,相比于同种型对照抗体,AG10058和AG10131在这些不同的同系小鼠肿瘤模型中表现出有效的体内抗肿瘤活性。
10a.CD137激动剂抗体在H22小鼠肝癌模型中表现出抗肿瘤功效
首先,以50mg/kg的剂量持续3周每周两次施用AG10058或AG10131。两种分子均显示出几乎100%TGI(肿瘤生长抑制)(图10,小图a)。CD4和CD8标志物的免疫组织化学染色显示,AG10131显著增加CD4+和CD8+T细胞在H22肿瘤微环境中的浸润(Xiao等人,Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22hepatocarcinoma in vivo.Clin Cancer Res.2007;13(6):1823-30.)(图10,小图b)。降低至3mg/kg的进一步剂量滴定仍然显示出~100%TGI,表明两种分子均具有有效的抗肿瘤活性(图10,小图c和d)。降低至1和0.1mg/kg的AG10131的进一步剂量滴定在0.1mg/kg和1mg/kg下显示出大于50%TGI(图10,小图e)。
10b.CD137激动剂抗体在CT26小鼠j结肠癌模型中表现出抗肿瘤功效
如图10所示,AG10058和AG10131在CT26小鼠结肠癌模型中在50mg/kg的剂量下显示出几乎100%TGI(肿瘤生长抑制)(图11,小图a)(Martinez-Forero等人,T cellcostimulation with anti-CD137monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes.J Immunol.2013;190(12):6694-706)。AG10131的进一步剂量滴定(图11,小图b)在5mg/kg和1mg/kg的剂量下显示出几乎100%TGI。在0.1mg/kg剂量下,实现大约40%TGI,表明了剂量依赖性抗肿瘤活性。
10c.EMT6乳腺癌模型
在EMT6小鼠乳腺癌同系模型中进一步评估抗肿瘤活性(Shi和Siemann,Augmentedantitumor effects of radiation therapy by 4-1BB antibody(BMS-469492)treatment.Anticancer Res.2006;26:3445-53)(图12)。AG10058和AG10131均表现出几乎~100%肿瘤生长抑制。
10d.对CD137激动剂抗体治疗具有完全应答的小鼠在用新肿瘤细胞再激发后保持无肿瘤
在CT26肿瘤模型中用AG10058或AG10131治疗3周后,具有完全肿瘤消退的小鼠保持一个多月不进行治疗。然后在第62天对保持完全应答的小鼠在相对侧腹部用5×105个CT26肿瘤细胞进行皮下再激发,并监测肿瘤生长。同时利用接种了相同数量的CT26肿瘤细胞的原初小鼠建立再激发对照组。如图13所示,用AG10131治疗(在1和5mg/kg下,参见图13,分别为顶部小图和底部小图)在CT26肿瘤模型中表现出有效的抗肿瘤活性,AG10131(1mg/kg组)中的5/8、AG10131(5mg/kg组)中的6/8在再次用CT26肿瘤细胞再激发之前在60天中显示出完全应答。此外,这些小鼠在用相同的肿瘤细胞再激发之后保持无肿瘤,表明在这些小鼠中发展了特定的抗肿瘤记忆。
为了证明这一假设,从这些肿瘤排斥性再激发小鼠和对照小鼠中收集脾细胞并且将其与丝裂霉素C阻滞的(arrested)CT26肿瘤细胞一起在体外共培养7天以扩增肿瘤特异性记忆T细胞。然后回收这些脾细胞并且与荧光标记的活CT26肿瘤细胞以不同的E/T比率混合4h,并且通过活/死染色和FACS分析检测肿瘤细胞杀伤。如图14所示,利用来自之前用AG10058和AG10131治疗的肿瘤排斥性再激发小鼠的脾细胞观察到显著增加的肿瘤细胞杀伤。
实施例11
AG10131-IgG4不引起ADCC效应
利用EasySep人CD8+T细胞富集试剂盒(StemCell Technologies)从来自健康供体的外周血中分离人CD8+T细胞,接着用PMA(50ng/ml)+离子霉素(1uM)体外刺激18小时。然后用钙黄绿素-AM标记这些活化的CD8+T细胞并用作靶细胞。利用人NK分离试剂盒(StemCellTechnologies)分离来自不同健康供体的NK细胞,并用作效应细胞。对于抗体依赖性细胞毒性(ADCC)测定,在不存在和存在系列稀释抗体的情况下,将效应细胞(NK)和靶细胞(活化的CD8+T细胞)以5∶1比率在96孔板中混合,在培养条件下持续4小时。然后收集来自每个孔的上清液,并且通过读板器SpectraMax i3x(Ex 488nm,Em 520nm)检测荧光信号。使用同种型hIgG4 mAb作为阴性对照,而人源化的OKT3(来自Novoprotein的抗CD3 hIgG1)用作阳性对照。接着使用下式计算%裂解:%裂解=[(实验释放)-Ave(靶标+NK)]/[Ave(靶标Max)-Ave(仅靶标)]×100%(图15)。
实施例12
抗体的开发性特征
对于开发性评估,将纯化的AG10058、AG10059、AG10131和AC1097交换到PB缓冲液(20mM PB、150mM NaCl,pH 7.0)中。所有实验,包括过滤、离心、加速应激测试,均在PB缓冲液中进行。对于所有SEC-HPLC分析,使用TSKgel柱(Tosoh Bioscience G3000SWxl)。
12a.溶解度
所有三种抗体可以在没有明显沉淀的情况下在PB缓冲液中浓缩至高于100mg/ml(表6)。然后将抗体在PB缓冲液中调节至20mg/ml。然后通过SEC-HPLC对样品(各自10μg)进行测定,以检测高分子量(HMW)聚集物。如色谱图(图16)中所示,对于所有测试抗体,在高浓度(20mg/ml)下均未观察到HMW聚集物的增加。
表6:抗体的溶解度
12b.在加速应激条件下的抗体溶解度
还在加速应激条件下检查抗体溶解度,结果汇总于表7中。所有抗体在六个冷冻(-80℃)和融化(室温)循环之后仍保持稳定(图17)。在50℃下七天后,HMW聚集物或LMW片段的变化很小(图17)。在更长期时间过程的实验中(40℃持续最多至28天),所有抗体保持稳定,并且HMW聚集物或LMW片段没有显著增加(图17)。
表7:HMW在加速条件下的变化
此外,通过差示扫描量热法(DSC)测得的热稳定性显示,AG10131和AG10058在高达至少约59℃时是稳定的。转变中点Tm(几乎所有蛋白质结构域发生去折叠转变时的特征温度)在图18和以下表8中示出。
表8:通过DSC测得的热稳定性
Tm开始点(℃) | Tm1(℃) | Tm2(℃) | |
AG10058 | 61.5 | 67.3 | 76.9 |
AG10131 | 59.3 | 67.6 | 81.5 |
此外,AG10131和AG10058在离心之后的最高可实现浓度分别超过180mg/mL和220mg/mL。
实施例13
在相关物种中的安全性特征:小鼠和食蟹猴
13a.AG10131在正常C57BL/6小鼠中的重复给药毒性研究。
AG10131的重复给药毒性在正常C57BL/6小鼠中进行。在第1天、第4天、第8天和第11天腹膜内(i.p.)(10mL/kg)施用媒介物、AG10131(100mg/kg)。每组中包括五只雌性小鼠(7-8周龄)。每天监测小鼠的异常行为和症状,并且每天测量食物摄取和体重。在第14天,对动物实施安乐死以进行尸检和其他分析。从每只动物中收集血液,其中每组2份血液样品用于血液学分析(RBC、血小板、WBC、WBC分类)并且该组中的另外3份血液样品用于血液生物化学分析(AL、AST、ALB、GLB、A/G、TBIL、ALP、GGT和LDH)。收集来自每只小鼠的以下器官并保存在FFPE中:心脏、肺、胸腺、肝、脾和肾。制备肝组织的FFPE块、切片并H&E染色以用于组织病理学分析。
在整个研究的生命阶段(in-life period)期间,未观察到异常行为或计划外的动物死亡。与媒介物治疗相比,AG10131不影响食物摄取和体重。在使用AG10131的治疗组的小鼠中,尸检也未显示出任何明显的病变。血液学分析未显示出任何显著变化,在用AG10131治疗的小鼠中测试的血液生物化学参数同样如此(图19)。在所有这些小鼠的肝的组织病理学切片中均未发现明显异常(图20)。总体而言,AG10131在此研究中耐受良好并且在小鼠中未观察到显著毒性。
13b.AG10131在食蟹猴中的重复给药研究
在正常的食蟹猴中进行AG10131的重复给药研究。在第0天、第7天、第14天和第22天,静脉内(i.v.)(1mL/kg)施用人IgG4同种型对照(10mg/kg)、AG10131(0.5和10mg/kg)。每组中包括一只雄性和一只雌性食蟹猴(3~5岁)。每天监测动物的异常行为和临床体征,并且每天测量食物摄取。在给药前第(-15)天、第(-5)天和给药后第6天、第13天、第18天和第26天测量体重。在给药前第(-12)天、第(-5)天和给药后第7天、第14天、第19天和第27天(仅10mg/kg组)测量血液学和血液化学参数,在给药前第(-12)天、第(-5)天和给药后第6天、第13天、第18天进行尿液分析。在第27天对10mg/kg组中的动物实施安乐死,以进行尸检和其他分析。切除主要器官并称重。制备FFPE肝组织块、切片并H&E染色以进行组织病理学分析。
在整个研究的生命阶段(in-life period)期间,在所有组中均未观察到异常行为或计划外的动物死亡。与媒介物治疗相比,10mg/kg的AG10131治疗不影响食物摄取和体重。未注意到临床体征,也包括注射部位反应。在用10mg/kg的AG10131治疗的食蟹猴中检查的所有器官中,尸检未显示出任何明显病变和重量异常。在所有治疗组中,血液学、血液化学和尿液参数也在正常范围内(图21)。在以10mg/kg重复给药AG10131后,肝的组织病理学分析未显示出任何明显异常,包括淋巴细胞浸润(图22)。总体而言,AG10131在最高至10mg/kg周剂量下在食蟹猴中耐受良好并且未检测到明显毒性。
实施例14
AG10131在食蟹猴中的药代动力学
14a.AG10131在食蟹猴中的药代动力学
在原初食蟹猴中进行AG10131的药代动力学研究。将三种剂量水平的AG10131(10mg/kg、30mg/kg和100mg/kg)静脉内推注施用给三组猴。每组合有3只雄性和3只雌性。在给药前、给药后0.083、0.25、0.5、1、2、6、12、24、36、48、72、96、120、144、168、240、336、408、504、672和840小时收集血清样品。通过ELISA确定AG10131的血清浓度。
在16只动物中的12只中,AG10131在第14天(336hr)快速清除,即来自低剂量和中等剂量组的所有动物,以及来自高剂量组的6只动物中的2只。在第21天,又多2只来自高剂量组的动物显示出快速清除。这14只动物中的血清浓度低或低于量化的极限。这与在这些动物中产生抗药抗体的观察是一致的。将来自高剂量组的具有可能不受影响的药代动力学的两只动物的数据拟合,以预测药代动力学参数(图23)。AG10131的半衰期在7.3至8.8天的范围内。
14b.AG10131在大鼠中的药代动力学
在原初SD大鼠中进行AG10131的药代动力学研究。将三种剂量水平的AG10131(10mg/kg、30mg/kg和100mg/kg)静脉内推注施用给三组动物。每组合有15只雄性和15只雌性。在各时间点从3只动物中收集血清样品:给药前、给药后0.083、0.25、0.5、1、2、6、12、24、36、48、72、96、120、144、168、240、336、408、504、672和840小时。通过ELISA确定AG10131的血清浓度并且通过Phoenix Professional V6.3分析数据。
结果:来自低剂量、中等剂量和高剂量的PK参数相似(图24)。AG10131的清除速率为约0.004ml/kg/min。AG10131的半衰期在11.5至14.6天的范围内。
14c.AG10131在小鼠中的药代动力学
在约8周龄的BALB/c小鼠中进行AG10131的药代动力学研究。通过尾静脉以1mg/kg向每个给药组的3只雌性BALB/c小鼠静脉内注射包括AG10131的测试抗体。在给药后1h、8、48、168和336小时收集血液样品(每份样品~100u1)。从没有施用抗体的3只原初雌性小鼠中收集空白对照血液。包括AG10131的每种测试抗体的血清浓度通过ELISA确定,其中抗人IgG(Fc特异性)抗体用于捕获并且HRP标记的抗人IgG(Fab特异性)抗体用于检测。
所有测试抗体,包括同种型对照(AG10154)、两种基准抗体(AC1020和AC1021)以及三种Adagene抗体(AG10131、AG10058和AG10059)在小鼠中表现出相当的药代动力学(图25)。
序列表
<110> 天演药业(Adagene Inc.)
<120> 抗CD137分子及其用途
<130> 695402000340
<140> 尚未分配
<141> 与此同时
<160> 865
<170> PatentIn 3.5版
<210> 1
<211> 255
<212> PRT
<213> 智人(Homo sapiens)
<400> 1
Met Gly Asn Ser Cys Tyr Asn Ile Val Ala Thr Leu Leu Leu Val Leu
1 5 10 15
Asn Phe Glu Arg Thr Arg Ser Leu Gln Asp Pro Cys Ser Asn Cys Pro
20 25 30
Ala Gly Thr Phe Cys Asp Asn Asn Arg Asn Gln Ile Cys Ser Pro Cys
35 40 45
Pro Pro Asn Ser Phe Ser Ser Ala Gly Gly Gln Arg Thr Cys Asp Ile
50 55 60
Cys Arg Gln Cys Lys Gly Val Phe Arg Thr Arg Lys Glu Cys Ser Ser
65 70 75 80
Thr Ser Asn Ala Glu Cys Asp Cys Thr Pro Gly Phe His Cys Leu Gly
85 90 95
Ala Gly Cys Ser Met Cys Glu Gln Asp Cys Lys Gln Gly Gln Glu Leu
100 105 110
Thr Lys Lys Gly Cys Lys Asp Cys Cys Phe Gly Thr Phe Asn Asp Gln
115 120 125
Lys Arg Gly Ile Cys Arg Pro Trp Thr Asn Cys Ser Leu Asp Gly Lys
130 135 140
Ser Val Leu Val Asn Gly Thr Lys Glu Arg Asp Val Val Cys Gly Pro
145 150 155 160
Ser Pro Ala Asp Leu Ser Pro Gly Ala Ser Ser Val Thr Pro Pro Ala
165 170 175
Pro Ala Arg Glu Pro Gly His Ser Pro Gln Ile Ile Ser Phe Phe Leu
180 185 190
Ala Leu Thr Ser Thr Ala Leu Leu Phe Leu Leu Phe Phe Leu Thr Leu
195 200 205
Arg Phe Ser Val Val Lys Arg Gly Arg Lys Lys Leu Leu Tyr Ile Phe
210 215 220
Lys Gln Pro Phe Met Arg Pro Val Gln Thr Thr Gln Glu Glu Asp Gly
225 230 235 240
Cys Ser Cys Arg Phe Pro Glu Glu Glu Glu Gly Gly Cys Glu Leu
245 250 255
<210> 2
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (1)..(1)
<223> X1:F或Y
<220>
<221> X2
<222> (4)..(4)
<223> X2:S或T
<220>
<221> X3
<222> (5)..(5)
<223> X3:G或N或S
<220>
<221> X4
<222> (7)..(7)
<223> X4:A或G或W
<400> 2
Xaa Thr Phe Xaa Xaa Tyr Xaa Ile His Trp Val
1 5 10
<210> 3
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (4)..(4)
<223> X1:S或T
<220>
<221> X2
<222> (7)..(7)
<223> X2:H或Y
<220>
<221> X3
<222> (8)..(8)
<223> X3:H或Y
<220>
<221> X4
<222> (10)..(10)
<223> X4:A或D或G或N或S或T
<400> 3
Tyr Ser Ile Xaa Ser Gly Xaa Xaa Trp Xaa Trp Ile
1 5 10
<210> 4
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (6)..(6)
<223> X1:G或S
<220>
<221> X2
<222> (9)..(9)
<223> X2:A或G
<220>
<221> X3
<222> (11)..(11)
<223> X3:A或G或S或T
<400> 4
Phe Ser Leu Ser Thr Xaa Gly Val Xaa Val Xaa Trp Ile
1 5 10
<210> 5
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (7)..(7)
<223> X1:A或D或Y
<220>
<221> X2
<222> (8)..(8)
<223> X2:D或G
<220>
<221> X3
<222> (11)..(11)
<223> X3:R或S或Y
<220>
<221> X4
<222> (14)..(14)
<223> X4:P或T
<400> 5
Leu Ala Leu Ile Asp Trp Xaa Xaa Asp Lys Xaa Tyr Ser Xaa Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 6
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (3)..(3)
<223> X1:D或E
<220>
<221> X2
<222> (9)..(9)
<223> X2:N或S
<220>
<221> X3
<222> (13)..(13)
<223> X3:N或S
<400> 6
Ile Gly Xaa Ile Tyr His Ser Gly Xaa Thr Tyr Tyr Xaa Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 7
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (3)..(3)
<223> X1:A或G或S或V或Y
<220>
<221> X2
<222> (7)..(7)
<223> X2:A或D或S或Y
<220>
<221> X3
<222> (9)..(9)
<223> X3:D或G或S
<220>
<221> X4
<222> (10)..(10)
<223> X4:S或T
<400> 7
Val Ser Xaa Ile Ser Gly Xaa Gly Xaa Xaa Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 8
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (3)..(3)
<223> X1:E或G
<220>
<221> X2
<222> (5)..(5)
<223> X2:E或S
<220>
<221> X3
<222> (6)..(6)
<223> X3:D或T
<220>
<221> X4
<222> (7)..(7)
<223> X4:A或T或V
<220>
<221> X5
<222> (9)..(9)
<223> X5:A或I或L或T或V
<220>
<221> X6
<222> (14)..(14)
<223> X6:A或D或G
<400> 8
Ala Arg Xaa Gly Xaa Xaa Xaa Val Xaa Gly Asp Trp Phe Xaa Tyr
1 5 10 15
<210> 9
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (1)..(1)
<223> X1:Q或R
<220>
<221> X2
<222> (5)..(5)
<223> X2:D或G或S
<220>
<221> X3
<222> (6)..(6)
<223> X3:I或V
<220>
<221> X4
<222> (7)..(7)
<223> X4:G或R或S或T
<220>
<221> X5
<222> (8)..(8)
<223> X5:P或R或S或T
<220>
<221> X6
<222> (9)..(9)
<223> X6:A或D或F或S或V或Y
<220>
<221> X7
<222> (10)..(10)
<223> X7:L或V
<220>
<221> X8
<222> (11)..(11)
<223> X8:A或G或N
<400> 9
Xaa Ala Ser Gln Xaa Xaa Xaa Xaa Xaa Xaa Xaa
1 5 10
<210> 10
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (1)..(1)
<223> X1:A或D
<220>
<221> X2
<222> (4)..(4)
<223> X2:N或S或T
<220>
<221> X3
<222> (5)..(5)
<223> X3:L或R
<220>
<221> X4
<222> (6)..(6)
<223> X4:A或E或Q
<220>
<221> X5
<222> (7)..(7)
<223> X5:S或T
<220>
<221> X6
<222> (9)..(9)
<223> X6:I或V
<400> 10
Xaa Ala Ser Xaa Xaa Xaa Xaa Gly Xaa
1 5
<210> 11
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (5)..(5)
<223> X1:A或G或S或Y
<220>
<221> X2
<222> (7)..(7)
<223> X2:Q或S或Y
<220>
<221> X3
<222> (8)..(8)
<223> X3:I或L或T或Y
<220>
<221> X4
<222> (9)..(9)
<223> X4:I或S或V或W
<400> 11
Tyr Cys Gln Gln Xaa Tyr Xaa Xaa Xaa Thr
1 5 10
<210> 12
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<220>
<221> X1
<222> (3)..(3)
<223> X1:E或Q
<220>
<221> X2
<222> (5)..(5)
<223> X2:P或S或Y
<220>
<221> X3
<222> (6)..(6)
<223> X3:D或L或S或T或Y
<220>
<221> X4
<222> (7)..(7)
<223> X4:D或E或H或S或T
<220>
<221> X5
<222> (8)..(8)
<223> X5:D或L或T或W
<220>
<221> X6
<222> (10)..(10)
<223> X6:L或P或R或V
<400> 12
Tyr Cys Xaa Gln Xaa Xaa Xaa Xaa Pro Xaa Thr
1 5 10
<210> 13
<211> 117
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 13
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Ser Tyr
20 25 30
Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Gly Ile Ser Gly Ala Gly Asp Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Arg Asp Tyr Asp Phe Asp Tyr Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser
115
<210> 14
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 14
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Ser His
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 15
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 15
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly Ile Ile Asn Pro Asn Phe Gly Asp Thr Asn Tyr Ala Gln
50 55 60
Lys Phe Gln Gly Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Asp Glu Tyr Tyr Gly Gly Ser Tyr Tyr Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 16
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 16
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Arg Thr Ala
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Asp Trp Pro Pro
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 17
<211> 121
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 17
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Ser Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Asp Asp Leu Tyr Ser Trp Tyr Phe Asp Val Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 18
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 18
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Ser
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 19
<211> 120
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 19
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
Tyr His Trp Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ala Ile Ser Gly Ala Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Asp Gly Tyr Gly Gly Ser Tyr Phe Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 20
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 20
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Thr Phe
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 21
<211> 120
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 21
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Thr Gly Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Gly Arg Ile Arg Ser Lys Thr Asp Gly Tyr Thr Thr Glu Tyr Ala Ala
50 55 60
Pro Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Leu Gly Gly His Trp Tyr Phe Asp Val Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 22
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 22
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Arg Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Glu Gln Pro Leu Glu Leu Pro Arg
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 23
<211> 122
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 23
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
His His Trp Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Gly Ile Ser Gly Tyr Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Asp Pro Tyr Ser Ser Gly Ser Gly Tyr Phe Asp Tyr Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 24
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 24
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Ala
20 25 30
Leu Gly Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Tyr Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 25
<211> 117
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 25
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
Tyr Tyr Trp Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Gly Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Thr Tyr Ser Phe Asp Val Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser
115
<210> 26
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 26
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Asp
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Tyr Ile Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 27
<211> 117
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 27
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Ala Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Tyr Arg Gly Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser
115
<210> 28
<211> 109
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 28
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Glu Ser Val Thr Ser Thr
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu
35 40 45
Ile Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln
65 70 75 80
Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Asp Trp Pro
85 90 95
Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 29
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 29
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
Tyr His Trp Asn Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Asp Pro Asn Tyr Tyr Ser Ser Gly Ser Tyr Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 30
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 30
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Phe
20 25 30
Leu Gly Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 31
<211> 121
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 31
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
Tyr Tyr Trp Asp Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Tyr Tyr Gly Tyr Gly Tyr Ala Leu Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 32
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 32
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 33
<211> 119
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 33
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
His Tyr Trp Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Leu Ala Leu Ile Asp Trp Tyr Gly Asp Lys Tyr Tyr Ser Thr Ser Leu
50 55 60
Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Asp Tyr Tyr Gly Ser His Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 34
<211> 112
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 34
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Glu Ser Val Asp Phe Asp
20 25 30
Gly Phe Ser Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro
35 40 45
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser
50 55 60
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser
65 70 75 80
Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp
85 90 95
Thr Leu Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105 110
<210> 35
<211> 122
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 35
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Phe Ser Asn Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Gly Ser Thr Thr Val Ala Gly Asp Trp Phe Ala Tyr Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 36
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 36
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Phe
20 25 30
Leu Gly Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Leu Val Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 37
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 37
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Gly
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 38
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 38
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Thr Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 39
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 39
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 40
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 40
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Ser Thr Phe
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 41
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 41
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 42
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 42
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Pro Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 43
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 43
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 44
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 44
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Ser Pro Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 45
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 45
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
Tyr His Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 46
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 46
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Gly Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 47
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 47
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Ala Val Ala Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 48
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 48
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Arg Thr Phe
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 49
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 49
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Val Val Thr Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 50
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 50
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Val
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 51
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 51
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
His His Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ala Ile Ser Gly Asp Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Ala Val Thr Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 52
<211> 106
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 52
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Arg Val Gly Tyr Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
35 40 45
Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
50 55 60
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu
65 70 75 80
Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Thr Trp Thr Phe
85 90 95
Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 53
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 53
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Glu Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 54
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 54
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Arg Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 55
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 55
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Gly Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Ala Val Ala Gly Asp Trp Phe Asp
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 56
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 56
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Arg Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 57
<211> 119
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 57
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Gly Ile Ser Gly Asp Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Thr Arg Glu Asp Tyr Gly Pro His Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 58
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 58
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Thr Thr Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Tyr Ser Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 59
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 59
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
His Tyr Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ala Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 60
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 60
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Ser
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 61
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 61
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
His Tyr Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 62
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 62
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Phe
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 63
<211> 120
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 63
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Val Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Arg Gly Leu Val Leu Asp Ala Phe Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 64
<211> 110
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 64
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Gly Arg
20 25 30
Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu
35 40 45
Ile Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln
65 70 75 80
Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Tyr Trp Pro
85 90 95
Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105 110
<210> 65
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 65
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 66
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 66
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 67
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 67
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
His Tyr Trp Asn Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Gly Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 68
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 68
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 69
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 69
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
His Tyr Trp Thr Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ala Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 70
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 70
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Gly Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Gln Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 71
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 71
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Ile Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 72
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 72
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 73
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 73
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Gly Ile Ser Gly Ala Gly Asp Ser Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 74
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 74
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Arg Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 75
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 75
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Arg Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Thr Val Val Gly Asp Trp Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 76
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 76
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 77
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 77
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Val Val Ala Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 78
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 78
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Ser Ser Val
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Gln Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 79
<211> 119
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 79
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
Tyr His Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser Leu
50 55 60
Lys Ser Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Pro Tyr Tyr Tyr Gly Val Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 80
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 80
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Arg Val Gly Ser Val
20 25 30
Tyr Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
35 40 45
Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly Ser
50 55 60
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu
65 70 75 80
Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Thr His Asp Pro Val Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 81
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 81
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Ala
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Gly
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 82
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 82
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Thr Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 83
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 83
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
Tyr His Trp Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Tyr Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 84
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 84
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Arg Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 85
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 85
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
His His Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Val Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 86
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 86
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 87
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 87
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Gly Asp Lys Ser Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Ala Val Val Gly Asp Trp Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 88
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 88
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Arg Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 89
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 89
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Ala Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Gly Gly Ser Thr Ala Val Thr Gly Asp Trp Phe Asp
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 90
<211> 107
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 90
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Pro Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 91
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 91
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Ser Gly Asp Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Val Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 92
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 92
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 93
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 93
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Ala Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 94
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 94
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 95
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 95
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 96
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 96
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 97
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 97
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Ala Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 98
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 98
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 99
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 99
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Ala Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 100
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 100
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 101
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 101
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Thr Ala Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 102
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 102
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 103
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 103
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Thr Ala Val Val Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 104
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 104
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 105
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 105
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Thr Ala Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 106
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 106
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 107
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 107
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Met Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Val Val Ala Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 108
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 108
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 109
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 109
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
His His Trp Asp Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Tyr Ile Ser Gly Ala Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 110
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 110
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 111
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 111
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 112
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 112
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 113
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 113
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Ala Gly Ser Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 114
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 114
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 115
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 115
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Ser Gly Asp Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 116
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 116
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 117
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 117
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Thr Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 118
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 118
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 119
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 119
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Asp Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 120
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 120
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 121
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 121
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Tyr Ile Ser Gly Ala Gly Asp Ser Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 122
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 122
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 123
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 123
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Arg
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 124
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 124
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 125
<211> 124
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 125
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 126
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 126
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 127
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 127
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly Asp Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 128
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 128
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 129
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 129
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Thr Trp Ile Arg Gln Ala Pro Gly Lys Ser Leu Glu
35 40 45
Trp Ile Gly Asp Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Ala Val Ala Gly Asp Trp Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 130
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 130
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 131
<211> 123
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 131
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly Asp Ile Tyr His Ser Gly Asn Thr Tyr Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Val Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 132
<211> 108
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 132
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 133
<211> 351
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 133
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt caccttcacc agctacggta ttcactgggt gcgtcaggcc 120
ccgggtaagg gcctcgagtg ggtgtctggt atctctggtg ccggtgatac tacctactac 180
gccgactctg tcaagggccg tttcactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc cagagaacgt 300
gattacgact tcgattactg gggtcaagga acactagtca ccgtctcctc g 351
<210> 134
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 134
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtctgtgtct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tcttactcta cctctcacac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 135
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 135
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtgag ctggattcgt 120
caggccccgg gtaagggcct cgagtggatc ggtatcatca acccaaactt cggtgatact 180
aactacgccc agaagttcca gggtcgtgtg actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgccaga 300
gacgaatact acggtggctc ttactacttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 136
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 136
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca ggacgtgcgc accgccgtgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag tcctacgact ggcctccgac cttcggacag 300
ggtaccaagg tggagatcaa acga 324
<210> 137
<211> 363
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 137
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtgag ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttccgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgccaga 300
gacgacctat actcctggta cttcgacgtg tggggtcaag gaacactagt caccgtctcc 360
tcg 363
<210> 138
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 138
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattggc tcttccctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgcc gcctcttctt tgcagtctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactaca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 139
<211> 360
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 139
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggttacc actggggctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct gctatctctg gtgccggtgg ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgccagagac 300
ggctacggtg gttcctactt cgactactgg ggtcaaggaa cactagtcac cgtctcctcg 360
<210> 140
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 140
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatcagc acgttcctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag gcctactcaa tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 141
<211> 360
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 141
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt caccttcacc ggctactgga ttcactgggt gcgtcaggcc 120
ccgggtaagg gcctcgagtg ggtgggtcgt atcagatcca agaccgacgg ttacactacc 180
gaatacgccg cccctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgccaga 300
ttgggtggtc actggtactt cgacgtctgg ggtcaaggaa cactagtcac cgtctcctcg 360
<210> 142
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 142
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtccatcggc cgctacctga actggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgcgagcaa cccctggaac tcccacgaac cttcggacag 300
ggtaccaagg tggagatcaa acga 324
<210> 143
<211> 366
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 143
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggtcacc actggggctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct ggtatctctg gttacggtga tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgccagagac 300
ccatactcca gcggttccgg ttactttgac tactggggtc aaggaacact agtcaccgtc 360
tcctcg 366
<210> 144
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 144
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattagc tctgccctgg gttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgcc gcctcttctt tgcagtctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag agctactaca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 145
<211> 351
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 145
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggttact actggggctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct ggtatctctg gttccggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgccagaggt 300
acttactcct tcgacgtctg gggtcaagga acactagtca ccgtctcctc g 351
<210> 146
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 146
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattagc tctgacctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgcc gcctctacct tgcagtctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag tactactctt acatcacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 147
<211> 351
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 147
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata caccttcacc ggctacgcta ttcactgggt gcgtcaggcc 120
ccgggtaagg gcctcgagtg ggtgtctgct atctctggtg acggtggttc tacctactac 180
gccgactctg tcaagggccg tttcactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc cagaggctat 300
aggggttact tcgactactg gggtcaagga acactagtca ccgtctcctc g 351
<210> 148
<211> 327
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 148
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctga gtctgttacc tctacctacc tggcctggta tcaacagaaa 120
ccaggaaaag ctccgaagct tctgatctac gacgcctcta acctggaaac cggtgtgcca 180
tctcgcttct ctggatccgg ttccgggacg gatttcactc tgaccatcag cagtctgcag 240
ccggaagact tcgcaactta ttactgccag cagtactccg actggcctcc gaccttcgga 300
cagggtacca aggtggagat caaacga 327
<210> 149
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 149
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggttacc actggaactg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gttccggtgg ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgccagagac 300
cctaattact acagctccgg ctcctacttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 150
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 150
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattggc tctttcctgg gttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag agctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 151
<211> 363
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 151
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggttact actgggactg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gtgacggtga tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgccagagag 300
tactacggat acggttacgc cttggactac tggggtcaag gaacactagt caccgtctcc 360
tcg 363
<210> 152
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 152
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 153
<211> 357
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 153
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggtcact actggggctg gattcgtcag 120
gccccgggta agggcctcga gtggctggcc ctgatcgact ggtacggtga caagtactac 180
tctacctctc tgaagtctcg tctgactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgttccgac 300
tactacggtt ctcacttcga ctactggggt caaggaacac tagtcaccgt ctcctcg 357
<210> 154
<211> 336
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 154
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctga gtctgtggac ttcgacggtt tctctttcct ggcctggtat 120
caacagaaac caggaaaagc tccgaagctt ctgatctacg acgcctctaa cctggaaacc 180
ggtgtgccat ctcgcttctc tggatccggt tccgggacgg atttcactct gaccatcagc 240
agtctgcagc cggaagactt cgcaacttat tactgccagc agtacgatac tttgcctcgg 300
accttcggac agggtaccaa ggtggagatc aaacga 336
<210> 155
<211> 366
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 155
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata caccttctcc aactactgga ttcactgggt gcgtcaggcc 120
ccgggtaagg gcctcgagtg ggtgtcttac atctctggtg acggtgatac tacctactac 180
gccgactctg tcaagggccg tttcactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgtgagggt 300
tctaccaccg tggccggcga ctggttcgcc tactggggtc aaggaacact agtcaccgtc 360
tcctcg 366
<210> 156
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 156
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattggc tctttcctgg gttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag tactactctt tggtcacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 157
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 157
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttacgg ttctactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acgccgtgct cggcgactgg ttcggctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 158
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 158
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatcacc acgtacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactacc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 159
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 159
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 160
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 160
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gggcctctca ggacatcagc acgttcctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag gcctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 161
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 161
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 162
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 162
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gagcgtcagc ccttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 163
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 163
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccgg tgacaagtcc 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 164
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 164
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcgtcagc ccttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 165
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 165
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggttacc actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gtgacggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgaa 300
ggttcagacg ctgtgaccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 166
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 166
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcgtcggc acttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcac tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 167
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 167
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacga tgacaagtac 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctaccg ccgtggccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 168
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 168
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatccgc acgttcctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 169
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 169
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggatc ggtgaaatct accactctgg ttctacctac 180
tactctccat ctctgaagtc tcgtgtgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aaaagctgag gacactgccg tctattattg cgcgcgtgaa 300
ggttcagacg ttgtgaccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 170
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 170
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattagc tctgtcctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 171
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 171
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggtcacc actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct gctatctctg gtgacggttc tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctaccg ccgtgaccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 172
<211> 318
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 172
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgct ctgcctcttc tcgcgtgggc tacgtgcact ggtatcaaca gaaaccagga 120
aaagctccga agcttctgat ctacgacgcc tcttctctgg aatctggtgt gccatctcgc 180
ttctctggat ccggttccgg gacggatttc actctgacca tcagcagtct gcagccggaa 240
gacttcgcaa cttattactg ccagcagggc tactacacct ggaccttcgg acagggtacc 300
aaggtggaga tcaaacga 318
<210> 173
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 173
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccgg tgacaagtcc 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgaa 300
ggtgaagacg ctgtgaccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 174
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 174
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatccgc acgtacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 175
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 175
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tctggtatct ctggttacgg ttctactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gaaggttcag acgctgtggc cggcgactgg ttcgactact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 176
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 176
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca ggatattcgc tcttacctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 177
<211> 357
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 177
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tctggtatct ctggtgacgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcacccgt 300
gaagactacg gtccgcacgc ctactggggt caaggaacac tagtcaccgt ctcctcg 357
<210> 178
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 178
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtccatcacc acgtacctga actggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag tcctactctt actcgacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 179
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 179
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggtcact actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct gctatctctg gttccggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 180
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 180
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattagc tcttccctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 181
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 181
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggtcact actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gttacggttc tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagttt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 182
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 182
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattggc tctttcctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactacc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 183
<211> 360
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 183
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt caccttctcc agctactgga ttcactgggt gcgtcaggcc 120
ccgggtaagg gcctcgagtg ggtgtctgtt atctctggtg acggtgatac tacctactac 180
gccgactctg tcaagggccg tttcactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgttcccgt 300
ggtcttgtgc tagacgcctt cgactactgg ggtcaaggaa cactagtcac cgtctcctcg 360
<210> 184
<211> 330
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 184
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtctgtgagc ggccgtttcc tggcctggta tcaacagaaa 120
ccaggaaaag ctccgaagct tctgatctac gacgcctctt ctctggaatc tggtgtgcca 180
tctcgcttct ctggatccgg ttccgggacg gatttcactc tgaccatcag cagtctgcag 240
ccggaagact tcgcaactta ttactgccag cagtacgact actggccacc ttacaccttc 300
ggacagggta ccaaggtgga gatcaaacga 330
<210> 185
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 185
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 186
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 186
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcggc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 187
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 187
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggtcact actggaactg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct ggtatctctg gtgacggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 188
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 188
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gagcatcagc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcaa cctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 189
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 189
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggtcact actggacctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct gctatctctg gttccggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 190
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 190
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcgtcggc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctaccaac tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 191
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 191
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtgatcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 192
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 192
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gagcatcggc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactacc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 193
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 193
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tctggtatct ctggtgccgg tgattctacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 194
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 194
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca ggatattcgc tcttacctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 195
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 195
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacga tgacaagcgt 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctacca ccgtggtcgg cgactggttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 196
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 196
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcggc acttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 197
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 197
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgacgg tggttctacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gaaggttcag acgttgtggc cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 198
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 198
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca ggatattagc tctgtcctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctaccaaa tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 199
<211> 357
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 199
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggttacc actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtggatcggt gaaatctacc actctggttc tacctactac 180
tctccatctc tgaagtctcg tgtgactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgttcccca 300
tactactacg gtgtgttcga ctactggggt caaggaacac tagtcaccgt ctcctcg 357
<210> 200
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 200
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgct ctgcctcttc tcgcgtgggc agcgtgtact ggtatcaaca gaaaccagga 120
aaagctccga agcttctgat ctacgacgcc tctaacctgg aaaccggtgt gccatctcgc 180
ttctctggat ccggttccgg gacggatttc actctgacca tcagcagtct gcagccggaa 240
gacttcgcaa cttattactg ccagcagtac acccacgacc cagtcacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 201
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 201
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc caggggcctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttacgg ttctactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acgccgtgct cggcgactgg ttcggctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 202
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 202
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatcacc acgtacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactacc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 203
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 203
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggttacc actggagctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gttacggtga tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 204
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 204
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatccgc acgtacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 205
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 205
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggtcacc actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct gttatctctg gttccggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 206
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 206
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcagc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 207
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 207
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacgg tgacaagtcc 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctaccg ccgtggtcgg cgactggttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 208
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 208
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcagc cgttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcac tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 209
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 209
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggtgccgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gggggttcta ccgccgtgac cggcgactgg ttcgactact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 210
<211> 321
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 210
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcagc ccttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg a 321
<210> 211
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 211
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggtggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggttccgg tgatactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtggt cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 212
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 212
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 213
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 213
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgacgg tgatactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtggc cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 214
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 214
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 215
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 215
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttacgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 216
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 216
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 217
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 217
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgccgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 218
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 218
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 219
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 219
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgccgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acgccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 220
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 220
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 221
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 221
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgacgg tgatactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttcta ccgccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 222
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 222
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 223
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 223
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgacgg tggttctacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttcta ccgccgtggt cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 224
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 224
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 225
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 225
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggttacgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttcta ccgccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 226
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 226
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 227
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 227
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggta tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggttacgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gaaggttcag acgttgtggc cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 228
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 228
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 229
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 229
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggtcacc actgggactg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tacatctctg gtgccggtga tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 230
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 230
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 231
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 231
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgacgg tggttctacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 232
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 232
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 233
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 233
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgccgg ttctactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 234
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 234
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 235
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 235
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtgag ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggttccgg tgatactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acgccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 236
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 236
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 237
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 237
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgacgg tgatactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttcta ccaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 238
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 238
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 239
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 239
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgacgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 240
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 240
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tcttactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 241
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 241
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttacatct ctggtgccgg tgattctacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 242
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 242
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtgtgtct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 243
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 243
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttacgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaga 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 244
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 244
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtgtgtct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 245
<211> 372
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 245
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttccgg tggttctacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cg 372
<210> 246
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 246
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtgtgtct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactacacca ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 247
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 247
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggatt ggtgacatct accactctgg tagcacctac 180
tacaacccat ctctgaagtc tcgtgtgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctaccg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 248
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 248
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtctatctct tcttacctga actggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgcc gcctctacct tgcagtctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 249
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 249
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtgac ctggattcgt 120
caggccccgg gtaagagcct cgagtggatc ggtgacatct accactctgg ttctacctac 180
tactctccat ctctgaagtc tcgtgtgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgaa 300
ggttcagacg ctgtggccgg cgactggttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 250
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 250
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtctatctct tcttacctga actggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgcc gcctctacct tgcagtctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 251
<211> 369
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 251
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtggatc ggtgacatct accactctgg taacacctac 180
tacaacccat ctctgaagtc tcgtgtgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtggtcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcg 369
<210> 252
<211> 324
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 252
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtctatctct tcttacctga actggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgcc gcctctacct tgcagtctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acga 324
<210> 253
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 253
Phe Thr Phe Thr Ser Tyr Gly Ile His Trp Val
1 5 10
<210> 254
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 254
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Ser Trp Ile
1 5 10
<210> 255
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 255
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ser Trp Ile
1 5 10
<210> 256
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 256
Tyr Ser Ile Thr Ser Gly Tyr His Trp Gly Trp Ile
1 5 10
<210> 257
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 257
Phe Thr Phe Thr Gly Tyr Trp Ile His Trp Val
1 5 10
<210> 258
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 258
Tyr Ser Ile Ser Ser Gly His His Trp Gly Trp Ile
1 5 10
<210> 259
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 259
Tyr Ser Ile Thr Ser Gly Tyr Tyr Trp Gly Trp Ile
1 5 10
<210> 260
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 260
Tyr Thr Phe Thr Gly Tyr Ala Ile His Trp Val
1 5 10
<210> 261
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 261
Tyr Ser Ile Ser Ser Gly Tyr His Trp Asn Trp Ile
1 5 10
<210> 262
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 262
Tyr Ser Ile Ser Ser Gly Tyr Tyr Trp Asp Trp Ile
1 5 10
<210> 263
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 263
Tyr Ser Ile Ser Ser Gly His Tyr Trp Gly Trp Ile
1 5 10
<210> 264
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 264
Tyr Thr Phe Ser Asn Tyr Trp Ile His Trp Val
1 5 10
<210> 265
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 265
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 266
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 266
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 267
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 267
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 268
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 268
Phe Ser Leu Ser Thr Gly Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 269
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 269
Tyr Ser Ile Ser Ser Gly Tyr His Trp Ala Trp Ile
1 5 10
<210> 270
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 270
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 271
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 271
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 272
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 272
Tyr Ser Ile Thr Ser Gly His His Trp Ala Trp Ile
1 5 10
<210> 273
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 273
Phe Ser Leu Ser Thr Gly Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 274
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 274
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 275
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 275
Phe Ser Leu Ser Thr Gly Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 276
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 276
Tyr Ser Ile Thr Ser Gly His Tyr Trp Ala Trp Ile
1 5 10
<210> 277
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 277
Tyr Ser Ile Thr Ser Gly His Tyr Trp Ala Trp Ile
1 5 10
<210> 278
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 278
Phe Thr Phe Ser Ser Tyr Trp Ile His Trp Val
1 5 10
<210> 279
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 279
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 280
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 280
Tyr Ser Ile Thr Ser Gly His Tyr Trp Asn Trp Ile
1 5 10
<210> 281
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 281
Tyr Ser Ile Ser Ser Gly His Tyr Trp Thr Trp Ile
1 5 10
<210> 282
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 282
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 283
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 283
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 284
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 284
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Ala Trp Ile
1 5 10
<210> 285
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 285
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 286
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 286
Tyr Ser Ile Ser Ser Gly Tyr His Trp Ala Trp Ile
1 5 10
<210> 287
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 287
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 288
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 288
Tyr Ser Ile Thr Ser Gly Tyr His Trp Ser Trp Ile
1 5 10
<210> 289
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 289
Tyr Ser Ile Ser Ser Gly His His Trp Ala Trp Ile
1 5 10
<210> 290
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 290
Phe Ser Leu Ser Thr Gly Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 291
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 291
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 292
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 292
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 293
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 293
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 294
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 294
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 295
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 295
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 296
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 296
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 297
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 297
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 298
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 298
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 299
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 299
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 300
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 300
Phe Ser Leu Ser Thr Ser Gly Met Gly Val Gly Trp Ile
1 5 10
<210> 301
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 301
Tyr Ser Ile Ser Ser Gly His His Trp Asp Trp Ile
1 5 10
<210> 302
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 302
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 303
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 303
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 304
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 304
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Ser Trp Ile
1 5 10
<210> 305
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 305
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 306
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 306
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 307
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 307
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 308
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 308
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 309
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 309
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 310
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 310
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 311
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 311
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Thr Trp Ile
1 5 10
<210> 312
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 312
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Ala Trp Ile
1 5 10
<210> 313
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 313
Val Ser Gly Ile Ser Gly Ala Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 314
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 314
Ile Gly Ile Ile Asn Pro Asn Phe Gly Asp Thr Asn Tyr Ala Gln Lys
1 5 10 15
Phe Gln Gly Arg Val
20
<210> 315
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 315
Val Ser Ser Ile Ser Gly Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 316
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 316
Val Ser Ala Ile Ser Gly Ala Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 317
<211> 23
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 317
Val Gly Arg Ile Arg Ser Lys Thr Asp Gly Tyr Thr Thr Glu Tyr Ala
1 5 10 15
Ala Pro Val Lys Gly Arg Phe
20
<210> 318
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 318
Val Ser Gly Ile Ser Gly Tyr Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 319
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 319
Val Ser Gly Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 320
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 320
Val Ser Ala Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 321
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 321
Val Ser Ser Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 322
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 322
Val Ser Ser Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 323
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 323
Leu Ala Leu Ile Asp Trp Tyr Gly Asp Lys Tyr Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 324
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 324
Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 325
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 325
Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 326
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 326
Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 327
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 327
Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 328
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 328
Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 329
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 329
Val Ser Ser Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 330
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 330
Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 331
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 331
Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 332
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 332
Val Ser Ala Ile Ser Gly Asp Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 333
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 333
Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 334
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 334
Val Ser Gly Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 335
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 335
Val Ser Gly Ile Ser Gly Asp Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 336
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 336
Val Ser Ala Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 337
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 337
Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 338
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 338
Val Ser Val Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 339
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 339
Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 340
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 340
Val Ser Gly Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 341
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 341
Val Ser Ala Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 342
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 342
Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 343
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 343
Val Ser Gly Ile Ser Gly Ala Gly Asp Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 344
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 344
Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Arg Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 345
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 345
Val Ser Tyr Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 346
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 346
Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 347
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 347
Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 348
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 348
Val Ser Ser Ile Ser Gly Tyr Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 349
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 349
Val Ser Val Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 350
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 350
Leu Ala Leu Ile Asp Trp Asp Gly Asp Lys Ser Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 351
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 351
Val Ser Ser Ile Ser Gly Ala Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 352
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 352
Val Ser Tyr Ile Ser Gly Ser Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 353
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 353
Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 354
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 354
Val Ser Ser Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 355
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 355
Val Ser Tyr Ile Ser Gly Ala Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 356
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 356
Val Ser Tyr Ile Ser Gly Ala Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 357
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 357
Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 358
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 358
Val Ser Tyr Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 359
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 359
Val Ser Tyr Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 360
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 360
Val Ser Tyr Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 361
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 361
Val Ser Tyr Ile Ser Gly Ala Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 362
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 362
Val Ser Tyr Ile Ser Gly Asp Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 363
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 363
Val Ser Tyr Ile Ser Gly Ala Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 364
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 364
Val Ser Tyr Ile Ser Gly Ser Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 365
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 365
Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 366
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 366
Val Ser Tyr Ile Ser Gly Asp Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 367
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 367
Val Ser Tyr Ile Ser Gly Ala Gly Asp Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 368
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 368
Val Ser Ser Ile Ser Gly Tyr Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 369
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 369
Val Ser Ser Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 370
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 370
Ile Gly Asp Ile Tyr His Ser Gly Ser Thr Tyr Tyr Asn Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 371
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 371
Ile Gly Asp Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 372
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 372
Ile Gly Asp Ile Tyr His Ser Gly Asn Thr Tyr Tyr Asn Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 373
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 373
Ala Arg Glu Arg Asp Tyr Asp Phe Asp Tyr
1 5 10
<210> 374
<211> 14
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 374
Ala Arg Asp Glu Tyr Tyr Gly Gly Ser Tyr Tyr Phe Asp Tyr
1 5 10
<210> 375
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 375
Ala Arg Asp Asp Leu Tyr Ser Trp Tyr Phe Asp Val
1 5 10
<210> 376
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 376
Ala Arg Asp Gly Tyr Gly Gly Ser Tyr Phe Asp Tyr
1 5 10
<210> 377
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 377
Ala Arg Leu Gly Gly His Trp Tyr Phe Asp Val
1 5 10
<210> 378
<211> 14
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 378
Ala Arg Asp Pro Tyr Ser Ser Gly Ser Gly Tyr Phe Asp Tyr
1 5 10
<210> 379
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 379
Ala Arg Gly Thr Tyr Ser Phe Asp Val
1 5
<210> 380
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 380
Ala Arg Gly Tyr Arg Gly Tyr Phe Asp Tyr
1 5 10
<210> 381
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 381
Ala Arg Asp Pro Asn Tyr Tyr Ser Ser Gly Ser Tyr Phe Asp Tyr
1 5 10 15
<210> 382
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 382
Ala Arg Glu Tyr Tyr Gly Tyr Gly Tyr Ala Leu Asp Tyr
1 5 10
<210> 383
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 383
Ala Arg Ser Asp Tyr Tyr Gly Ser His Phe Asp Tyr
1 5 10
<210> 384
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 384
Ala Arg Glu Gly Ser Thr Thr Val Ala Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 385
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 385
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Gly Tyr
1 5 10 15
<210> 386
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 386
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 387
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 387
Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 388
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 388
Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 389
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 389
Ala Arg Glu Gly Ser Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 390
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 390
Ala Arg Glu Gly Ser Thr Ala Val Ala Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 391
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 391
Ala Arg Glu Gly Ser Asp Val Val Thr Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 392
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 392
Ala Arg Glu Gly Ser Thr Ala Val Thr Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 393
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 393
Ala Arg Glu Gly Glu Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 394
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 394
Ala Arg Glu Gly Ser Asp Ala Val Ala Gly Asp Trp Phe Asp Tyr
1 5 10 15
<210> 395
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 395
Thr Arg Glu Asp Tyr Gly Pro His Ala Tyr
1 5 10
<210> 396
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 396
Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 397
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 397
Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 398
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 398
Ala Arg Ser Arg Gly Leu Val Leu Asp Ala Phe Asp Tyr
1 5 10
<210> 399
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 399
Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 400
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 400
Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 401
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 401
Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 402
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 402
Ala Arg Gly Gly Ser Asp Thr Val Ile Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 403
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 403
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 404
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 404
Ala Arg Glu Gly Ser Thr Thr Val Val Gly Asp Trp Phe Asp Tyr
1 5 10 15
<210> 405
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 405
Ala Arg Glu Gly Ser Asp Val Val Ala Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 406
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 406
Ala Arg Ser Pro Tyr Tyr Tyr Gly Val Phe Asp Tyr
1 5 10
<210> 407
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 407
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Gly Tyr
1 5 10 15
<210> 408
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 408
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 409
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 409
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 410
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 410
Ala Arg Glu Gly Ser Thr Ala Val Val Gly Asp Trp Phe Asp Tyr
1 5 10 15
<210> 411
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 411
Ala Arg Gly Gly Ser Thr Ala Val Thr Gly Asp Trp Phe Asp Tyr
1 5 10 15
<210> 412
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 412
Ala Arg Glu Gly Ser Asp Thr Val Val Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 413
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 413
Ala Arg Glu Gly Ser Asp Thr Val Ala Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 414
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 414
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 415
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 415
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 416
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 416
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 417
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 417
Ala Arg Glu Gly Ser Thr Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 418
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 418
Ala Arg Glu Gly Ser Thr Ala Val Val Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 419
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 419
Ala Arg Glu Gly Ser Thr Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 420
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 420
Ala Arg Glu Gly Ser Asp Val Val Ala Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 421
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 421
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 422
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 422
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 423
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 423
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 424
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 424
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 425
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 425
Ala Arg Glu Gly Ser Thr Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 426
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 426
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 427
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 427
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 428
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 428
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 429
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 429
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 430
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 430
Ala Arg Glu Gly Ser Thr Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 431
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 431
Ala Arg Glu Gly Ser Asp Ala Val Ala Gly Asp Trp Phe Asp Tyr
1 5 10 15
<210> 432
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 432
Ala Arg Gly Gly Ser Asp Thr Val Val Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 433
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 433
Arg Ala Ser Gln Ser Val Ser Ser Tyr Leu Ala
1 5 10
<210> 434
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 434
Arg Ala Ser Gln Asp Val Arg Thr Ala Val Ala
1 5 10
<210> 435
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 435
Arg Ala Ser Gln Gly Ile Gly Ser Ser Leu Ala
1 5 10
<210> 436
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 436
Gln Ala Ser Gln Asp Ile Ser Thr Phe Leu Ala
1 5 10
<210> 437
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 437
Arg Ala Ser Gln Ser Ile Gly Arg Tyr Leu Asn
1 5 10
<210> 438
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 438
Arg Ala Ser Gln Gly Ile Ser Ser Ala Leu Gly
1 5 10
<210> 439
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 439
Arg Ala Ser Gln Gly Ile Ser Ser Asp Leu Ala
1 5 10
<210> 440
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 440
Arg Ala Ser Glu Ser Val Thr Ser Thr Tyr Leu Ala
1 5 10
<210> 441
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 441
Arg Ala Ser Gln Gly Ile Gly Ser Phe Leu Gly
1 5 10
<210> 442
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 442
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 443
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 443
Arg Ala Ser Glu Ser Val Asp Phe Asp Gly Phe Ser Phe Leu Ala
1 5 10 15
<210> 444
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 444
Arg Ala Ser Gln Gly Ile Gly Ser Phe Leu Gly
1 5 10
<210> 445
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 445
Gln Ala Ser Gln Asp Ile Thr Thr Tyr Leu Ala
1 5 10
<210> 446
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 446
Arg Ala Ser Gln Asp Ile Ser Thr Phe Leu Ala
1 5 10
<210> 447
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 447
Arg Ala Ser Gln Ser Val Ser Pro Tyr Leu Ala
1 5 10
<210> 448
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 448
Arg Ala Ser Gln Gly Val Ser Pro Tyr Leu Ala
1 5 10
<210> 449
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 449
Arg Ala Ser Gln Gly Val Gly Thr Tyr Leu Ala
1 5 10
<210> 450
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 450
Gln Ala Ser Gln Asp Ile Arg Thr Phe Leu Ala
1 5 10
<210> 451
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 451
Arg Ala Ser Gln Gly Ile Ser Ser Val Leu Ala
1 5 10
<210> 452
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 452
Ser Ala Ser Ser Arg Val Gly Tyr Val His
1 5 10
<210> 453
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 453
Gln Ala Ser Gln Asp Ile Arg Thr Tyr Leu Ala
1 5 10
<210> 454
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 454
Arg Ala Ser Gln Asp Ile Arg Ser Tyr Leu Ala
1 5 10
<210> 455
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 455
Arg Ala Ser Gln Ser Ile Thr Thr Tyr Leu Asn
1 5 10
<210> 456
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 456
Arg Ala Ser Gln Gly Ile Ser Ser Ser Leu Ala
1 5 10
<210> 457
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 457
Arg Ala Ser Gln Gly Ile Gly Ser Phe Leu Ala
1 5 10
<210> 458
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 458
Arg Ala Ser Gln Ser Val Ser Gly Arg Phe Leu Ala
1 5 10
<210> 459
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 459
Arg Ala Ser Gln Gly Ile Gly Ser Tyr Leu Ala
1 5 10
<210> 460
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 460
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 461
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 461
Arg Ala Ser Gln Gly Val Gly Ser Tyr Leu Ala
1 5 10
<210> 462
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 462
Arg Ala Ser Gln Ser Ile Gly Ser Tyr Leu Ala
1 5 10
<210> 463
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 463
Arg Ala Ser Gln Asp Ile Arg Ser Tyr Leu Ala
1 5 10
<210> 464
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 464
Arg Ala Ser Gln Gly Ile Gly Thr Tyr Leu Ala
1 5 10
<210> 465
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 465
Arg Ala Ser Gln Asp Ile Ser Ser Val Leu Ala
1 5 10
<210> 466
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 466
Ser Ala Ser Ser Arg Val Gly Ser Val Tyr
1 5 10
<210> 467
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 467
Gln Ala Ser Gln Asp Ile Thr Thr Tyr Leu Ala
1 5 10
<210> 468
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 468
Gln Ala Ser Gln Asp Ile Arg Thr Tyr Leu Ala
1 5 10
<210> 469
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 469
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 470
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 470
Arg Ala Ser Gln Gly Ile Ser Arg Tyr Leu Ala
1 5 10
<210> 471
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 471
Arg Ala Ser Gln Gly Ile Ser Pro Tyr Leu Ala
1 5 10
<210> 472
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 472
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 473
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 473
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 474
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 474
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 475
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 475
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 476
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 476
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 477
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 477
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 478
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 478
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 479
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 479
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 480
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 480
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 481
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 481
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 482
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 482
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 483
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 483
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 484
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 484
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 485
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 485
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 486
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 486
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 487
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 487
Arg Ala Ser Gln Gly Val Ser Ser Tyr Leu Ala
1 5 10
<210> 488
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 488
Arg Ala Ser Gln Gly Val Ser Ser Tyr Leu Ala
1 5 10
<210> 489
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 489
Arg Ala Ser Gln Gly Val Ser Ser Tyr Leu Ala
1 5 10
<210> 490
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 490
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn
1 5 10
<210> 491
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 491
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn
1 5 10
<210> 492
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 492
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn
1 5 10
<210> 493
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 493
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 494
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 494
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 495
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 495
Ala Ala Ser Ser Leu Gln Ser Gly Val
1 5
<210> 496
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 496
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 497
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 497
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 498
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 498
Ala Ala Ser Ser Leu Gln Ser Gly Val
1 5
<210> 499
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 499
Ala Ala Ser Thr Leu Gln Ser Gly Val
1 5
<210> 500
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 500
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 501
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 501
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 502
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 502
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 503
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 503
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 504
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 504
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 505
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 505
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 506
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 506
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 507
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 507
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 508
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 508
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 509
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 509
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 510
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 510
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 511
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 511
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 512
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 512
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 513
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 513
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 514
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 514
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 515
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 515
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 516
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 516
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 517
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 517
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 518
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 518
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 519
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 519
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 520
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 520
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 521
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 521
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 522
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 522
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 523
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 523
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 524
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 524
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 525
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 525
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 526
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 526
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 527
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 527
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 528
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 528
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 529
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 529
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 530
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 530
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 531
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 531
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 532
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 532
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 533
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 533
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 534
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 534
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 535
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 535
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 536
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 536
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 537
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 537
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 538
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 538
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 539
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 539
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 540
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 540
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 541
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 541
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 542
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 542
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 543
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 543
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 544
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 544
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 545
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 545
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 546
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 546
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 547
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 547
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 548
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 548
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 549
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 549
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 550
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 550
Ala Ala Ser Thr Leu Gln Ser Gly Val
1 5
<210> 551
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 551
Ala Ala Ser Thr Leu Gln Ser Gly Val
1 5
<210> 552
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 552
Ala Ala Ser Thr Leu Gln Ser Gly Val
1 5
<210> 553
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 553
Tyr Cys Gln Gln Ser Tyr Ser Thr Ser His Thr
1 5 10
<210> 554
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 554
Tyr Cys Gln Gln Ser Tyr Asp Trp Pro Pro Thr
1 5 10
<210> 555
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 555
Tyr Cys Gln Gln Gly Tyr Tyr Thr Trp Thr
1 5 10
<210> 556
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 556
Tyr Cys Gln Gln Ala Tyr Ser Ile Trp Thr
1 5 10
<210> 557
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 557
Tyr Cys Glu Gln Pro Leu Glu Leu Pro Arg Thr
1 5 10
<210> 558
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 558
Tyr Cys Gln Gln Ser Tyr Tyr Thr Trp Thr
1 5 10
<210> 559
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 559
Tyr Cys Gln Gln Tyr Tyr Ser Tyr Ile Thr
1 5 10
<210> 560
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 560
Tyr Cys Gln Gln Tyr Ser Asp Trp Pro Pro Thr
1 5 10
<210> 561
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 561
Tyr Cys Gln Gln Ser Tyr Ser Leu Trp Thr
1 5 10
<210> 562
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 562
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 563
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 563
Tyr Cys Gln Gln Tyr Asp Thr Leu Pro Arg Thr
1 5 10
<210> 564
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 564
Tyr Cys Gln Gln Tyr Tyr Ser Leu Val Thr
1 5 10
<210> 565
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 565
Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
1 5 10
<210> 566
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 566
Tyr Cys Gln Gln Ala Tyr Ser Ile Trp Thr
1 5 10
<210> 567
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 567
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 568
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 568
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 569
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 569
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 570
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 570
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 571
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 571
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 572
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 572
Tyr Cys Gln Gln Gly Tyr Tyr Thr Trp Thr
1 5 10
<210> 573
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 573
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 574
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 574
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 575
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 575
Tyr Cys Gln Gln Ser Tyr Ser Tyr Ser Thr
1 5 10
<210> 576
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 576
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 577
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 577
Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
1 5 10
<210> 578
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 578
Tyr Cys Gln Gln Tyr Asp Tyr Trp Pro Pro Tyr Thr
1 5 10
<210> 579
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 579
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 580
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 580
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 581
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 581
Tyr Cys Gln Gln Gly Tyr Gln Leu Trp Thr
1 5 10
<210> 582
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 582
Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
1 5 10
<210> 583
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 583
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 584
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 584
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 585
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 585
Tyr Cys Gln Gln Gly Tyr Gln Ile Trp Thr
1 5 10
<210> 586
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 586
Tyr Cys Gln Gln Tyr Thr His Asp Pro Val Thr
1 5 10
<210> 587
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 587
Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
1 5 10
<210> 588
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 588
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 589
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 589
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 590
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 590
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 591
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 591
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 592
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 592
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 593
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 593
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 594
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 594
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 595
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 595
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 596
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 596
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 597
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 597
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 598
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 598
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 599
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 599
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 600
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 600
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 601
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 601
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 602
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 602
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 603
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 603
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 604
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 604
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 605
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 605
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 606
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 606
Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 607
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 607
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 608
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 608
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 609
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 609
Tyr Cys Gln Gln Tyr Tyr Thr Thr Pro Leu Thr
1 5 10
<210> 610
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 610
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 611
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 611
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 612
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 612
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 613
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 613
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly Ile Ile Asn Pro Asn Phe Gly Asp Thr Asn Tyr Ala Gln
50 55 60
Lys Phe Gln Gly Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Asp Glu Tyr Tyr Gly Gly Ser Tyr Tyr Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 614
<211> 214
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 614
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Arg Thr Ala
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Asp Trp Pro Pro
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 615
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 615
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 616
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 616
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Ser Thr Phe
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 617
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 617
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 618
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 618
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Pro Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 619
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 619
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
His Tyr Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 620
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 620
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Phe
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 621
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 621
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 622
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 622
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 623
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 623
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Arg Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Thr Val Val Gly Asp Trp Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 624
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 624
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 625
<211> 446
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 625
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
Tyr His Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser Leu
50 55 60
Lys Ser Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Pro Tyr Tyr Tyr Gly Val Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr Gly Pro Pro
210 215 220
Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro Ser Val Phe
225 230 235 240
Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro
245 250 255
Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp Pro Glu Val
260 265 270
Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr
275 280 285
Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val
290 295 300
Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys
305 310 315 320
Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr Ile Ser
325 330 335
Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro
340 345 350
Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val
355 360 365
Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly
370 375 380
Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp
385 390 395 400
Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser Arg Trp
405 410 415
Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His
420 425 430
Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys
435 440 445
<210> 626
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 626
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Arg Val Gly Ser Val
20 25 30
Tyr Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
35 40 45
Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly Ser
50 55 60
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu
65 70 75 80
Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Thr His Asp Pro Val Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 627
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 627
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Gly Asp Lys Ser Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Ala Val Val Gly Asp Trp Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 628
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 628
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Arg Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 629
<211> 448
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 629
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Ser Gly Gly Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Asp Asp Leu Tyr Ser Trp Tyr Phe Asp Val Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr Gly
210 215 220
Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro Ser
225 230 235 240
Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg
245 250 255
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp Pro
260 265 270
Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala
275 280 285
Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val
290 295 300
Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr
305 310 315 320
Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr
325 330 335
Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu
340 345 350
Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys
355 360 365
Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser
370 375 380
Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp
385 390 395 400
Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser
405 410 415
Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala
420 425 430
Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys
435 440 445
<210> 630
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 630
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Ser
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 631
<211> 448
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 631
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
Tyr Tyr Trp Asp Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Tyr Tyr Gly Tyr Gly Tyr Ala Leu Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr Gly
210 215 220
Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro Ser
225 230 235 240
Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg
245 250 255
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp Pro
260 265 270
Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala
275 280 285
Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val
290 295 300
Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr
305 310 315 320
Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr
325 330 335
Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu
340 345 350
Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys
355 360 365
Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser
370 375 380
Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp
385 390 395 400
Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser
405 410 415
Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala
420 425 430
Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys
435 440 445
<210> 632
<211> 214
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 632
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 633
<211> 446
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 633
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
His Tyr Trp Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Leu Ala Leu Ile Asp Trp Tyr Gly Asp Lys Tyr Tyr Ser Thr Ser Leu
50 55 60
Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Asp Tyr Tyr Gly Ser His Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr Gly Pro Pro
210 215 220
Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro Ser Val Phe
225 230 235 240
Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro
245 250 255
Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp Pro Glu Val
260 265 270
Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr
275 280 285
Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser Val
290 295 300
Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys
305 310 315 320
Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr Ile Ser
325 330 335
Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro
340 345 350
Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val
355 360 365
Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly
370 375 380
Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp
385 390 395 400
Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser Arg Trp
405 410 415
Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His
420 425 430
Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys
435 440 445
<210> 634
<211> 218
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 634
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Glu Ser Val Asp Phe Asp
20 25 30
Gly Phe Ser Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro
35 40 45
Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser
50 55 60
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser
65 70 75 80
Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp
85 90 95
Thr Leu Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105 110
Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 635
<211> 449
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 635
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Thr Phe Ser Asn Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Gly Ser Thr Thr Val Ala Gly Asp Trp Phe Ala Tyr Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro
115 120 125
Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr
130 135 140
Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr
145 150 155 160
Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro
165 170 175
Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr
180 185 190
Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp
195 200 205
His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr
210 215 220
Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp
260 265 270
Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly
435 440 445
Lys
<210> 636
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 636
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Gly Ser Phe
20 25 30
Leu Gly Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Tyr Ser Leu Val Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 637
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 637
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Val Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Val Val Thr Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 638
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 638
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Val
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 639
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 639
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
His Tyr Trp Asn Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Gly Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 640
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 640
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 641
<211> 451
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 641
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Gly Ile Ser Gly Ala Gly Asp Ser Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys
115 120 125
Gly Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu
130 135 140
Ser Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro
145 150 155 160
Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr
165 170 175
Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val
180 185 190
Val Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn
195 200 205
Val Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser
210 215 220
Lys Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln
260 265 270
Glu Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Leu Gly Lys
450
<210> 642
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 642
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Arg Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 643
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 643
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
His His Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Val Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 644
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 644
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 645
<211> 451
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 645
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp
50 55 60
Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr
65 70 75 80
Leu Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
85 90 95
Tyr Cys Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Gly
100 105 110
Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys
115 120 125
Gly Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu
130 135 140
Ser Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro
145 150 155 160
Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr
165 170 175
Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val
180 185 190
Val Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn
195 200 205
Val Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser
210 215 220
Lys Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln
260 265 270
Glu Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Leu Gly Lys
450
<210> 646
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 646
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Thr Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 647
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 647
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 648
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 648
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Ser Pro Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 649
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 649
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Ser Ser Gly
20 25 30
Tyr His Trp Ala Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 650
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 650
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Val Gly Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 651
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 651
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Ser
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Thr Ala Val Ala Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 652
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 652
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Arg Thr Phe
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 653
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 653
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Ala Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Glu Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 654
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 654
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Arg Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 655
<211> 447
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 655
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Val Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Arg Gly Leu Val Leu Asp Ala Phe Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr Gly Pro
210 215 220
Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro Ser Val
225 230 235 240
Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
245 250 255
Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp Pro Glu
260 265 270
Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
275 280 285
Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
290 295 300
Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
305 310 315 320
Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr Ile
325 330 335
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro
340 345 350
Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu
355 360 365
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
370 375 380
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
385 390 395 400
Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser Arg
405 410 415
Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu
420 425 430
His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys
435 440 445
<210> 656
<211> 216
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 656
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Gly Arg
20 25 30
Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu
35 40 45
Ile Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln
65 70 75 80
Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Tyr Trp Pro
85 90 95
Pro Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val
100 105 110
Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys
115 120 125
Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg
130 135 140
Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn
145 150 155 160
Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser
165 170 175
Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys
180 185 190
Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr
195 200 205
Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 657
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 657
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Leu Ser Thr Gly
20 25 30
Gly Val Gly Val Gly Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu
35 40 45
Trp Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Gly Gly Ser Asp Thr Val Ile Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 658
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 658
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 659
<211> 450
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 659
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser Ile Thr Ser Gly
20 25 30
Tyr His Trp Ser Trp Ile Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Ser Ser Ile Ser Gly Tyr Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
50 55 60
Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
65 70 75 80
Tyr Leu Gln Leu Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
85 90 95
Cys Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val
195 200 205
Asp His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys
210 215 220
Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu
260 265 270
Asp Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu
435 440 445
Gly Lys
450
<210> 660
<211> 213
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 660
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Arg Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
85 90 95
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210> 661
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 661
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtgag ctggattcgt 120
caggccccgg gtaagggcct cgagtggatc ggtatcatca acccaaactt cggtgatact 180
aactacgccc agaagttcca gggtcgtgtg actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgccaga 300
gacgaatact acggtggctc ttactacttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 662
<211> 642
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 662
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca ggacgtgcgc accgccgtgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag tcctacgact ggcctccgac cttcggacag 300
ggtaccaagg tggagatcaa acgaaccgtg gccgctccct ccgtcttcat ttttccccct 360
tctgacgaac agctgaagag tgggacagcc agcgtggtct gtctgctgaa caatttctac 420
cctagagagg caaaagtgca gtggaaggtc gataacgccc tgcagagcgg caattcccag 480
gagtctgtga ctgaacagga cagtaaagat tcaacctata gcctgtcctc tacactgact 540
ctgtccaagg ctgattacga aaagcataaa gtctatgcat gtgaggtcac ccatcagggg 600
ctgtccagtc cagtcacaaa gtcattcaat aggggggagt gt 642
<210> 663
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 663
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 664
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 664
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gggcctctca ggacatcagc acgttcctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag gcctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 665
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 665
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 666
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 666
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gagcgtcagc ccttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 667
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 667
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggtcact actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gttacggttc tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagttt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 668
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 668
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattggc tctttcctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactacc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 669
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 669
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 670
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 670
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcggc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 671
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 671
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacga tgacaagcgt 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctacca ccgtggtcgg cgactggttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 672
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 672
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcggc acttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 673
<211> 1338
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 673
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggttacc actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtggatcggt gaaatctacc actctggttc tacctactac 180
tctccatctc tgaagtctcg tgtgactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgttcccca 300
tactactacg gtgtgttcga ctactggggt caaggaacac tagtcaccgt ctcctcggct 360
tccaccaagg gcccatcggt cttccccctg gcgccctgct ccaggagcac ctccgagagc 420
acagccgccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac gaagacctac 600
acctgcaacg tagatcacaa gcccagcaac accaaggtgg acaagagagt tgagtccaaa 660
tatggtcccc catgcccacc atgcccagca cctgagttcc tggggggacc atcagtcttc 720
ctgttccccc caaaacccaa ggacactctc atgatctccc ggacccctga ggtcacgtgc 780
gtggtggtgg acgtgagcca ggaagacccc gaggtccagt tcaactggta cgtggatggc 840
gtggaggtgc ataatgccaa gacaaagccg cgggaggagc agttcaacag cacgtaccgt 900
gtggtcagcg tcctcaccgt cctgcaccag gactggctga acggcaagga gtacaagtgc 960
aaggtctcca acaaaggcct cccgtcctcc atcgagaaaa ccatctccaa agccaaaggg 1020
cagccccgag agccacaggt gtacaccctg cccccatccc aggaggagat gaccaagaac 1080
caggtcagcc tgacctgcct ggtcaaaggc ttctacccca gcgacatcgc cgtggagtgg 1140
gagagcaatg ggcagccgga gaacaactac aagaccacgc ctcccgtgct ggactccgac 1200
ggctccttct tcctctacag caggctaacc gtggacaaga gcaggtggca ggaggggaat 1260
gtcttctcat gctccgtgat gcatgaggct ctgcacaacc actacacaca gaagagcctc 1320
tccctgtctc tgggtaaa 1338
<210> 674
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 674
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgct ctgcctcttc tcgcgtgggc agcgtgtact ggtatcaaca gaaaccagga 120
aaagctccga agcttctgat ctacgacgcc tctaacctgg aaaccggtgt gccatctcgc 180
ttctctggat ccggttccgg gacggatttc actctgacca tcagcagtct gcagccggaa 240
gacttcgcaa cttattactg ccagcagtac acccacgacc cagtcacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 675
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 675
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacgg tgacaagtcc 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctaccg ccgtggtcgg cgactggttc gactactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 676
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 676
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcagc cgttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcac tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 677
<211> 1344
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 677
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtgag ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttccgg tggtactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgccaga 300
gacgacctat actcctggta cttcgacgtg tggggtcaag gaacactagt caccgtctcc 360
tcggcttcca ccaagggccc atcggtcttc cccctggcgc cctgctccag gagcacctcc 420
gagagcacag ccgccctggg ctgcctggtc aaggactact tccccgaacc ggtgacggtg 480
tcgtggaact caggcgccct gaccagcggc gtgcacacct tcccggctgt cctacagtcc 540
tcaggactct actccctcag cagcgtggtg accgtgccct ccagcagctt gggcacgaag 600
acctacacct gcaacgtaga tcacaagccc agcaacacca aggtggacaa gagagttgag 660
tccaaatatg gtcccccatg cccaccatgc ccagcacctg agttcctggg gggaccatca 720
gtcttcctgt tccccccaaa acccaaggac actctcatga tctcccggac ccctgaggtc 780
acgtgcgtgg tggtggacgt gagccaggaa gaccccgagg tccagttcaa ctggtacgtg 840
gatggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagtt caacagcacg 900
taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaacgg caaggagtac 960
aagtgcaagg tctccaacaa aggcctcccg tcctccatcg agaaaaccat ctccaaagcc 1020
aaagggcagc cccgagagcc acaggtgtac accctgcccc catcccagga ggagatgacc 1080
aagaaccagg tcagcctgac ctgcctggtc aaaggcttct accccagcga catcgccgtg 1140
gagtgggaga gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac 1200
tccgacggct ccttcttcct ctacagcagg ctaaccgtgg acaagagcag gtggcaggag 1260
gggaatgtct tctcatgctc cgtgatgcat gaggctctgc acaaccacta cacacagaag 1320
agcctctccc tgtctctggg taaa 1344
<210> 678
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 678
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattggc tcttccctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgcc gcctcttctt tgcagtctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactaca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 679
<211> 1344
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 679
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggttact actgggactg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gtgacggtga tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgccagagag 300
tactacggat acggttacgc cttggactac tggggtcaag gaacactagt caccgtctcc 360
tcggcttcca ccaagggccc atcggtcttc cccctggcgc cctgctccag gagcacctcc 420
gagagcacag ccgccctggg ctgcctggtc aaggactact tccccgaacc ggtgacggtg 480
tcgtggaact caggcgccct gaccagcggc gtgcacacct tcccggctgt cctacagtcc 540
tcaggactct actccctcag cagcgtggtg accgtgccct ccagcagctt gggcacgaag 600
acctacacct gcaacgtaga tcacaagccc agcaacacca aggtggacaa gagagttgag 660
tccaaatatg gtcccccatg cccaccatgc ccagcacctg agttcctggg gggaccatca 720
gtcttcctgt tccccccaaa acccaaggac actctcatga tctcccggac ccctgaggtc 780
acgtgcgtgg tggtggacgt gagccaggaa gaccccgagg tccagttcaa ctggtacgtg 840
gatggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagtt caacagcacg 900
taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaacgg caaggagtac 960
aagtgcaagg tctccaacaa aggcctcccg tcctccatcg agaaaaccat ctccaaagcc 1020
aaagggcagc cccgagagcc acaggtgtac accctgcccc catcccagga ggagatgacc 1080
aagaaccagg tcagcctgac ctgcctggtc aaaggcttct accccagcga catcgccgtg 1140
gagtgggaga gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac 1200
tccgacggct ccttcttcct ctacagcagg ctaaccgtgg acaagagcag gtggcaggag 1260
gggaatgtct tctcatgctc cgtgatgcat gaggctctgc acaaccacta cacacagaag 1320
agcctctccc tgtctctggg taaa 1344
<210> 680
<211> 642
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 680
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtatctct tcttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttacta ctgccagcag tactactcta ccccactgac cttcggtcag 300
ggtaccaagg tggagatcaa acgaaccgtg gccgctccct ccgtcttcat ttttccccct 360
tctgacgaac agctgaagag tgggacagcc agcgtggtct gtctgctgaa caatttctac 420
cctagagagg caaaagtgca gtggaaggtc gataacgccc tgcagagcgg caattcccag 480
gagtctgtga ctgaacagga cagtaaagat tcaacctata gcctgtcctc tacactgact 540
ctgtccaagg ctgattacga aaagcataaa gtctatgcat gtgaggtcac ccatcagggg 600
ctgtccagtc cagtcacaaa gtcattcaat aggggggagt gt 642
<210> 681
<211> 1338
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 681
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggtcact actggggctg gattcgtcag 120
gccccgggta agggcctcga gtggctggcc ctgatcgact ggtacggtga caagtactac 180
tctacctctc tgaagtctcg tctgactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgttccgac 300
tactacggtt ctcacttcga ctactggggt caaggaacac tagtcaccgt ctcctcggct 360
tccaccaagg gcccatcggt cttccccctg gcgccctgct ccaggagcac ctccgagagc 420
acagccgccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac gaagacctac 600
acctgcaacg tagatcacaa gcccagcaac accaaggtgg acaagagagt tgagtccaaa 660
tatggtcccc catgcccacc atgcccagca cctgagttcc tggggggacc atcagtcttc 720
ctgttccccc caaaacccaa ggacactctc atgatctccc ggacccctga ggtcacgtgc 780
gtggtggtgg acgtgagcca ggaagacccc gaggtccagt tcaactggta cgtggatggc 840
gtggaggtgc ataatgccaa gacaaagccg cgggaggagc agttcaacag cacgtaccgt 900
gtggtcagcg tcctcaccgt cctgcaccag gactggctga acggcaagga gtacaagtgc 960
aaggtctcca acaaaggcct cccgtcctcc atcgagaaaa ccatctccaa agccaaaggg 1020
cagccccgag agccacaggt gtacaccctg cccccatccc aggaggagat gaccaagaac 1080
caggtcagcc tgacctgcct ggtcaaaggc ttctacccca gcgacatcgc cgtggagtgg 1140
gagagcaatg ggcagccgga gaacaactac aagaccacgc ctcccgtgct ggactccgac 1200
ggctccttct tcctctacag caggctaacc gtggacaaga gcaggtggca ggaggggaat 1260
gtcttctcat gctccgtgat gcatgaggct ctgcacaacc actacacaca gaagagcctc 1320
tccctgtctc tgggtaaa 1338
<210> 682
<211> 654
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 682
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctga gtctgtggac ttcgacggtt tctctttcct ggcctggtat 120
caacagaaac caggaaaagc tccgaagctt ctgatctacg acgcctctaa cctggaaacc 180
ggtgtgccat ctcgcttctc tggatccggt tccgggacgg atttcactct gaccatcagc 240
agtctgcagc cggaagactt cgcaacttat tactgccagc agtacgatac tttgcctcgg 300
accttcggac agggtaccaa ggtggagatc aaacgaaccg tggccgctcc ctccgtcttc 360
atttttcccc cttctgacga acagctgaag agtgggacag ccagcgtggt ctgtctgctg 420
aacaatttct accctagaga ggcaaaagtg cagtggaagg tcgataacgc cctgcagagc 480
ggcaattccc aggagtctgt gactgaacag gacagtaaag attcaaccta tagcctgtcc 540
tctacactga ctctgtccaa ggctgattac gaaaagcata aagtctatgc atgtgaggtc 600
acccatcagg ggctgtccag tccagtcaca aagtcattca atagggggga gtgt 654
<210> 683
<211> 1347
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 683
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata caccttctcc aactactgga ttcactgggt gcgtcaggcc 120
ccgggtaagg gcctcgagtg ggtgtcttac atctctggtg acggtgatac tacctactac 180
gccgactctg tcaagggccg tttcactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgtgagggt 300
tctaccaccg tggccggcga ctggttcgcc tactggggtc aaggaacact agtcaccgtc 360
tcctcggctt ccaccaaggg cccatcggtc ttccccctgg cgccctgctc caggagcacc 420
tccgagagca cagccgccct gggctgcctg gtcaaggact acttccccga accggtgacg 480
gtgtcgtgga actcaggcgc cctgaccagc ggcgtgcaca ccttcccggc tgtcctacag 540
tcctcaggac tctactccct cagcagcgtg gtgaccgtgc cctccagcag cttgggcacg 600
aagacctaca cctgcaacgt agatcacaag cccagcaaca ccaaggtgga caagagagtt 660
gagtccaaat atggtccccc atgcccacca tgcccagcac ctgagttcct ggggggacca 720
tcagtcttcc tgttcccccc aaaacccaag gacactctca tgatctcccg gacccctgag 780
gtcacgtgcg tggtggtgga cgtgagccag gaagaccccg aggtccagtt caactggtac 840
gtggatggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gttcaacagc 900
acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa cggcaaggag 960
tacaagtgca aggtctccaa caaaggcctc ccgtcctcca tcgagaaaac catctccaaa 1020
gccaaagggc agccccgaga gccacaggtg tacaccctgc ccccatccca ggaggagatg 1080
accaagaacc aggtcagcct gacctgcctg gtcaaaggct tctaccccag cgacatcgcc 1140
gtggagtggg agagcaatgg gcagccggag aacaactaca agaccacgcc tcccgtgctg 1200
gactccgacg gctccttctt cctctacagc aggctaaccg tggacaagag caggtggcag 1260
gaggggaatg tcttctcatg ctccgtgatg catgaggctc tgcacaacca ctacacacag 1320
aagagcctct ccctgtctct gggtaaa 1347
<210> 684
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 684
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattggc tctttcctgg gttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag tactactctt tggtcacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 685
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 685
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggatc ggtgaaatct accactctgg ttctacctac 180
tactctccat ctctgaagtc tcgtgtgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aaaagctgag gacactgccg tctattattg cgcgcgtgaa 300
ggttcagacg ttgtgaccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 686
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 686
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggtattagc tctgtcctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactccc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 687
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 687
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggtcact actggaactg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct ggtatctctg gtgacggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgacg ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 688
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 688
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gagcatcagc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcaa cctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 689
<211> 1353
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 689
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tctggtatct ctggtgccgg tgattctacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acaccgtgct cggcgactgg ttcgcctact ggggtcaagg aacactagtc 360
accgtctcct cggcttccac caagggccca tcggtcttcc ccctggcgcc ctgctccagg 420
agcacctccg agagcacagc cgccctgggc tgcctggtca aggactactt ccccgaaccg 480
gtgacggtgt cgtggaactc aggcgccctg accagcggcg tgcacacctt cccggctgtc 540
ctacagtcct caggactcta ctccctcagc agcgtggtga ccgtgccctc cagcagcttg 600
ggcacgaaga cctacacctg caacgtagat cacaagccca gcaacaccaa ggtggacaag 660
agagttgagt ccaaatatgg tcccccatgc ccaccatgcc cagcacctga gttcctgggg 720
ggaccatcag tcttcctgtt ccccccaaaa cccaaggaca ctctcatgat ctcccggacc 780
cctgaggtca cgtgcgtggt ggtggacgtg agccaggaag accccgaggt ccagttcaac 840
tggtacgtgg atggcgtgga ggtgcataat gccaagacaa agccgcggga ggagcagttc 900
aacagcacgt accgtgtggt cagcgtcctc accgtcctgc accaggactg gctgaacggc 960
aaggagtaca agtgcaaggt ctccaacaaa ggcctcccgt cctccatcga gaaaaccatc 1020
tccaaagcca aagggcagcc ccgagagcca caggtgtaca ccctgccccc atcccaggag 1080
gagatgacca agaaccaggt cagcctgacc tgcctggtca aaggcttcta ccccagcgac 1140
atcgccgtgg agtgggagag caatgggcag ccggagaaca actacaagac cacgcctccc 1200
gtgctggact ccgacggctc cttcttcctc tacagcaggc taaccgtgga caagagcagg 1260
tggcaggagg ggaatgtctt ctcatgctcc gtgatgcatg aggctctgca caaccactac 1320
acacagaaga gcctctccct gtctctgggt aaa 1353
<210> 690
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 690
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca ggatattcgc tcttacctgg cttggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 691
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 691
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggtcacc actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct gttatctctg gttccggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 692
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 692
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcatcagc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 693
<211> 1353
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 693
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggc ctggattcgt 120
caggccccgg gtaagggcct cgagtgggtg tcttccatct ctggttacgg ttctactacc 180
tactacgccg actctgtcaa gggccgtttc actataagtc gcgacaattc gaaaaacaca 240
ctgtacctac aactgaacag cttaagagct gaggacactg ccgtctatta ttgcgcgcgt 300
gagggttctg acgccgtgct cggcgactgg ttcggctact ggggtcaagg aacactagtc 360
accgtctcct cggcttccac caagggccca tcggtcttcc ccctggcgcc ctgctccagg 420
agcacctccg agagcacagc cgccctgggc tgcctggtca aggactactt ccccgaaccg 480
gtgacggtgt cgtggaactc aggcgccctg accagcggcg tgcacacctt cccggctgtc 540
ctacagtcct caggactcta ctccctcagc agcgtggtga ccgtgccctc cagcagcttg 600
ggcacgaaga cctacacctg caacgtagat cacaagccca gcaacaccaa ggtggacaag 660
agagttgagt ccaaatatgg tcccccatgc ccaccatgcc cagcacctga gttcctgggg 720
ggaccatcag tcttcctgtt ccccccaaaa cccaaggaca ctctcatgat ctcccggacc 780
cctgaggtca cgtgcgtggt ggtggacgtg agccaggaag accccgaggt ccagttcaac 840
tggtacgtgg atggcgtgga ggtgcataat gccaagacaa agccgcggga ggagcagttc 900
aacagcacgt accgtgtggt cagcgtcctc accgtcctgc accaggactg gctgaacggc 960
aaggagtaca agtgcaaggt ctccaacaaa ggcctcccgt cctccatcga gaaaaccatc 1020
tccaaagcca aagggcagcc ccgagagcca caggtgtaca ccctgccccc atcccaggag 1080
gagatgacca agaaccaggt cagcctgacc tgcctggtca aaggcttcta ccccagcgac 1140
atcgccgtgg agtgggagag caatgggcag ccggagaaca actacaagac cacgcctccc 1200
gtgctggact ccgacggctc cttcttcctc tacagcaggc taaccgtgga caagagcagg 1260
tggcaggagg ggaatgtctt ctcatgctcc gtgatgcatg aggctctgca caaccactac 1320
acacagaaga gcctctccct gtctctgggt aaa 1353
<210> 694
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 694
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatcacc acgtacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactacc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 695
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 695
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccgg tgacaagtcc 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 696
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 696
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcgtcagc ccttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 697
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 697
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatctcc tctggttacc actgggcctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gtgacggttc ttctacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgaa 300
ggttcagacg ctgtgaccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 698
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 698
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gggcgtcggc acttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctcttctc tggaatctgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcac tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 699
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 699
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accagcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggacga tgacaagtac 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctaccg ccgtggccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 700
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 700
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatccgc acgttcctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca cctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 701
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 701
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tggctgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccgg tgacaagtcc 180
tactctacct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgaa 300
ggtgaagacg ctgtgaccgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 702
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 702
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatccgc acgtacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc gtgccaccgg tatcccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 703
<211> 1341
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 703
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt caccttctcc agctactgga ttcactgggt gcgtcaggcc 120
ccgggtaagg gcctcgagtg ggtgtctgtt atctctggtg acggtgatac tacctactac 180
gccgactctg tcaagggccg tttcactata agtcgcgaca attcgaaaaa cacactgtac 240
ctacaactga acagcttaag agctgaggac actgccgtct attattgcgc gcgttcccgt 300
ggtcttgtgc tagacgcctt cgactactgg ggtcaaggaa cactagtcac cgtctcctcg 360
gcttccacca agggcccatc ggtcttcccc ctggcgccct gctccaggag cacctccgag 420
agcacagccg ccctgggctg cctggtcaag gactacttcc ccgaaccggt gacggtgtcg 480
tggaactcag gcgccctgac cagcggcgtg cacaccttcc cggctgtcct acagtcctca 540
ggactctact ccctcagcag cgtggtgacc gtgccctcca gcagcttggg cacgaagacc 600
tacacctgca acgtagatca caagcccagc aacaccaagg tggacaagag agttgagtcc 660
aaatatggtc ccccatgccc accatgccca gcacctgagt tcctgggggg accatcagtc 720
ttcctgttcc ccccaaaacc caaggacact ctcatgatct cccggacccc tgaggtcacg 780
tgcgtggtgg tggacgtgag ccaggaagac cccgaggtcc agttcaactg gtacgtggat 840
ggcgtggagg tgcataatgc caagacaaag ccgcgggagg agcagttcaa cagcacgtac 900
cgtgtggtca gcgtcctcac cgtcctgcac caggactggc tgaacggcaa ggagtacaag 960
tgcaaggtct ccaacaaagg cctcccgtcc tccatcgaga aaaccatctc caaagccaaa 1020
gggcagcccc gagagccaca ggtgtacacc ctgcccccat cccaggagga gatgaccaag 1080
aaccaggtca gcctgacctg cctggtcaaa ggcttctacc ccagcgacat cgccgtggag 1140
tgggagagca atgggcagcc ggagaacaac tacaagacca cgcctcccgt gctggactcc 1200
gacggctcct tcttcctcta cagcaggcta accgtggaca agagcaggtg gcaggagggg 1260
aatgtcttct catgctccgt gatgcatgag gctctgcaca accactacac acagaagagc 1320
ctctccctgt ctctgggtaa a 1341
<210> 704
<211> 648
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 704
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gtctgtgagc ggccgtttcc tggcctggta tcaacagaaa 120
ccaggaaaag ctccgaagct tctgatctac gacgcctctt ctctggaatc tggtgtgcca 180
tctcgcttct ctggatccgg ttccgggacg gatttcactc tgaccatcag cagtctgcag 240
ccggaagact tcgcaactta ttactgccag cagtacgact actggccacc ttacaccttc 300
ggacagggta ccaaggtgga gatcaaacga accgtggccg ctccctccgt cttcattttt 360
cccccttctg acgaacagct gaagagtggg acagccagcg tggtctgtct gctgaacaat 420
ttctacccta gagaggcaaa agtgcagtgg aaggtcgata acgccctgca gagcggcaat 480
tcccaggagt ctgtgactga acaggacagt aaagattcaa cctatagcct gtcctctaca 540
ctgactctgt ccaaggctga ttacgaaaag cataaagtct atgcatgtga ggtcacccat 600
caggggctgt ccagtccagt cacaaagtca ttcaataggg gggagtgt 648
<210> 705
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 705
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggatt ctctctgtct accggcggtg tgggtgtggg ctggattcgt 120
caggccccgg gtaagggcct cgagtggctg gccctgatcg actgggccga tgacaagtac 180
tactctccct ctctgaagtc tcgtctgact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtggg 300
ggttctgaca ccgtgatcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 706
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 706
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc gtgcctctca gagcatcggc agttacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactacc tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 707
<211> 1350
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 707
gaggttcagc tggtggagtc tggcggtggc ctggtgcagc cagggggctc actccgtttg 60
tcctgtgcag cttccggata ctctatcacc tctggttacc actggagctg gattcgtcag 120
gccccgggta agggcctcga gtgggtgtct tccatctctg gttacggtga tactacctac 180
tacgccgact ctgtcaaggg ccgtttcact ataagtcgcg acaattcgaa aaacacactg 240
tacctacaac tgaacagctt aagagctgag gacactgccg tctattattg cgcgcgtgag 300
ggttctgaca ccgtgctcgg cgactggttc gcctactggg gtcaaggaac actagtcacc 360
gtctcctcgg cttccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc 420
acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagtcca aatatggtcc cccatgccca ccatgcccag cacctgagtt cctgggggga 720
ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct 780
gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg 840
tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac 900
agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag 960
gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc 1020
aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag 1080
atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc 1140
gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg 1200
ctggactccg acggctcctt cttcctctac agcaggctaa ccgtggacaa gagcaggtgg 1260
caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca 1320
cagaagagcc tctccctgtc tctgggtaaa 1350
<210> 708
<211> 639
<212> DNA
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 708
gatatccagt tgacccagtc cccgagttcc ctgtccgcct ctgtgggcga tcgggtcacc 60
atcacctgcc aggcctctca ggacatccgc acgtacctgg cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatctacgac gcctctaacc tggaaaccgg tgtgccatct 180
cgcttctctg gatccggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgccagcag ggctactcca tctggacctt cggacagggt 300
accaaggtgg agatcaaacg aaccgtggcc gctccctccg tcttcatttt tcccccttct 360
gacgaacagc tgaagagtgg gacagccagc gtggtctgtc tgctgaacaa tttctaccct 420
agagaggcaa aagtgcagtg gaaggtcgat aacgccctgc agagcggcaa ttcccaggag 480
tctgtgactg aacaggacag taaagattca acctatagcc tgtcctctac actgactctg 540
tccaaggctg attacgaaaa gcataaagtc tatgcatgtg aggtcaccca tcaggggctg 600
tccagtccag tcacaaagtc attcaatagg ggggagtgt 639
<210> 709
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 709
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Ser Trp Ile
1 5 10
<210> 710
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 710
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 711
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 711
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 712
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 712
Tyr Ser Ile Thr Ser Gly His Tyr Trp Ala Trp Ile
1 5 10
<210> 713
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 713
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 714
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 714
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Ala Trp Ile
1 5 10
<210> 715
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 715
Tyr Ser Ile Ser Ser Gly Tyr His Trp Ala Trp Ile
1 5 10
<210> 716
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 716
Phe Ser Leu Ser Thr Gly Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 717
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 717
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ser Trp Ile
1 5 10
<210> 718
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 718
Tyr Ser Ile Ser Ser Gly Tyr Tyr Trp Asp Trp Ile
1 5 10
<210> 719
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 719
Tyr Ser Ile Ser Ser Gly His Tyr Trp Gly Trp Ile
1 5 10
<210> 720
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 720
Tyr Thr Phe Ser Asn Tyr Trp Ile His Trp Val
1 5 10
<210> 721
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 721
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 722
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 722
Tyr Ser Ile Thr Ser Gly His Tyr Trp Asn Trp Ile
1 5 10
<210> 723
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 723
Phe Ser Leu Ser Thr Ser Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 724
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 724
Tyr Ser Ile Ser Ser Gly His His Trp Ala Trp Ile
1 5 10
<210> 725
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 725
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Ala Trp Ile
1 5 10
<210> 726
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 726
Phe Ser Leu Ser Thr Gly Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 727
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 727
Tyr Ser Ile Ser Ser Gly Tyr His Trp Ala Trp Ile
1 5 10
<210> 728
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 728
Phe Ser Leu Ser Thr Ser Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 729
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 729
Phe Ser Leu Ser Thr Gly Gly Val Ala Val Gly Trp Ile
1 5 10
<210> 730
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 730
Phe Thr Phe Ser Ser Tyr Trp Ile His Trp Val
1 5 10
<210> 731
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 731
Phe Ser Leu Ser Thr Gly Gly Val Gly Val Gly Trp Ile
1 5 10
<210> 732
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 732
Tyr Ser Ile Thr Ser Gly Tyr His Trp Ser Trp Ile
1 5 10
<210> 733
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 733
Ile Gly Ile Ile Asn Pro Asn Phe Gly Asp Thr Asn Tyr Ala Gln Lys
1 5 10 15
Phe Gln Gly Arg Val
20
<210> 734
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 734
Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 735
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 735
Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 736
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 736
Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 737
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 737
Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 738
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 738
Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Arg Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 739
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 739
Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 740
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 740
Leu Ala Leu Ile Asp Trp Asp Gly Asp Lys Ser Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 741
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 741
Val Ser Ser Ile Ser Gly Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 742
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 742
Val Ser Ser Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 743
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 743
Leu Ala Leu Ile Asp Trp Tyr Gly Asp Lys Tyr Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 744
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 744
Val Ser Tyr Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 745
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 745
Ile Gly Glu Ile Tyr His Ser Gly Ser Thr Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Val
20
<210> 746
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 746
Val Ser Gly Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 747
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 747
Val Ser Gly Ile Ser Gly Ala Gly Asp Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 748
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 748
Val Ser Val Ile Ser Gly Ser Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 749
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 749
Val Ser Ser Ile Ser Gly Tyr Gly Ser Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 750
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 750
Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 751
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 751
Val Ser Ser Ile Ser Gly Asp Gly Ser Ser Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 752
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 752
Leu Ala Leu Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 753
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 753
Leu Ala Leu Ile Asp Trp Ala Gly Asp Lys Ser Tyr Ser Thr Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 754
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 754
Val Ser Val Ile Ser Gly Asp Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 755
<211> 20
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 755
Leu Ala Leu Ile Asp Trp Ala Asp Asp Lys Tyr Tyr Ser Pro Ser Leu
1 5 10 15
Lys Ser Arg Leu
20
<210> 756
<211> 21
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 756
Val Ser Ser Ile Ser Gly Tyr Gly Asp Thr Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 757
<211> 14
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 757
Ala Arg Asp Glu Tyr Tyr Gly Gly Ser Tyr Tyr Phe Asp Tyr
1 5 10
<210> 758
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 758
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 759
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 759
Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 760
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 760
Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 761
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 761
Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 762
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 762
Ala Arg Glu Gly Ser Thr Thr Val Val Gly Asp Trp Phe Asp Tyr
1 5 10 15
<210> 763
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 763
Ala Arg Ser Pro Tyr Tyr Tyr Gly Val Phe Asp Tyr
1 5 10
<210> 764
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 764
Ala Arg Glu Gly Ser Thr Ala Val Val Gly Asp Trp Phe Asp Tyr
1 5 10 15
<210> 765
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 765
Ala Arg Asp Asp Leu Tyr Ser Trp Tyr Phe Asp Val
1 5 10
<210> 766
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 766
Ala Arg Glu Tyr Tyr Gly Tyr Gly Tyr Ala Leu Asp Tyr
1 5 10
<210> 767
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 767
Ala Arg Ser Asp Tyr Tyr Gly Ser His Phe Asp Tyr
1 5 10
<210> 768
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 768
Ala Arg Glu Gly Ser Thr Thr Val Ala Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 769
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 769
Ala Arg Glu Gly Ser Asp Val Val Thr Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 770
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 770
Ala Arg Gly Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 771
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 771
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 772
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 772
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 773
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 773
Ala Arg Glu Gly Ser Asp Ala Val Leu Gly Asp Trp Phe Gly Tyr
1 5 10 15
<210> 774
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 774
Ala Arg Gly Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 775
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 775
Ala Arg Glu Gly Ser Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 776
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 776
Ala Arg Glu Gly Ser Thr Ala Val Ala Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 777
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 777
Ala Arg Glu Gly Glu Asp Ala Val Thr Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 778
<211> 13
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 778
Ala Arg Ser Arg Gly Leu Val Leu Asp Ala Phe Asp Tyr
1 5 10
<210> 779
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 779
Ala Arg Gly Gly Ser Asp Thr Val Ile Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 780
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 780
Ala Arg Glu Gly Ser Asp Thr Val Leu Gly Asp Trp Phe Ala Tyr
1 5 10 15
<210> 781
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 781
Arg Ala Ser Gln Asp Val Arg Thr Ala Val Ala
1 5 10
<210> 782
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 782
Arg Ala Ser Gln Asp Ile Ser Thr Phe Leu Ala
1 5 10
<210> 783
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 783
Arg Ala Ser Gln Ser Val Ser Pro Tyr Leu Ala
1 5 10
<210> 784
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 784
Arg Ala Ser Gln Gly Ile Gly Ser Phe Leu Ala
1 5 10
<210> 785
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 785
Arg Ala Ser Gln Gly Ile Gly Ser Tyr Leu Ala
1 5 10
<210> 786
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 786
Arg Ala Ser Gln Gly Ile Gly Thr Tyr Leu Ala
1 5 10
<210> 787
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 787
Ser Ala Ser Ser Arg Val Gly Ser Val Tyr
1 5 10
<210> 788
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 788
Arg Ala Ser Gln Gly Ile Ser Arg Tyr Leu Ala
1 5 10
<210> 789
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 789
Arg Ala Ser Gln Gly Ile Gly Ser Ser Leu Ala
1 5 10
<210> 790
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 790
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 791
<211> 15
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 791
Arg Ala Ser Glu Ser Val Asp Phe Asp Gly Phe Ser Phe Leu Ala
1 5 10 15
<210> 792
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 792
Arg Ala Ser Gln Gly Ile Gly Ser Phe Leu Gly
1 5 10
<210> 793
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 793
Arg Ala Ser Gln Gly Ile Ser Ser Val Leu Ala
1 5 10
<210> 794
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 794
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 795
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 795
Arg Ala Ser Gln Asp Ile Arg Ser Tyr Leu Ala
1 5 10
<210> 796
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 796
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210> 797
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 797
Gln Ala Ser Gln Asp Ile Thr Thr Tyr Leu Ala
1 5 10
<210> 798
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 798
Arg Ala Ser Gln Gly Val Ser Pro Tyr Leu Ala
1 5 10
<210> 799
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 799
Arg Ala Ser Gln Gly Val Gly Thr Tyr Leu Ala
1 5 10
<210> 800
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 800
Gln Ala Ser Gln Asp Ile Arg Thr Phe Leu Ala
1 5 10
<210> 801
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 801
Gln Ala Ser Gln Asp Ile Arg Thr Tyr Leu Ala
1 5 10
<210> 802
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 802
Arg Ala Ser Gln Ser Val Ser Gly Arg Phe Leu Ala
1 5 10
<210> 803
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 803
Arg Ala Ser Gln Ser Ile Gly Ser Tyr Leu Ala
1 5 10
<210> 804
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 804
Gln Ala Ser Gln Asp Ile Arg Thr Tyr Leu Ala
1 5 10
<210> 805
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 805
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 806
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 806
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 807
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 807
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 808
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 808
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 809
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 809
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 810
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 810
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 811
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 811
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 812
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 812
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 813
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 813
Ala Ala Ser Ser Leu Gln Ser Gly Val
1 5
<210> 814
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 814
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 815
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 815
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 816
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 816
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 817
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 817
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 818
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 818
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 819
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 819
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 820
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 820
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 821
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 821
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 822
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 822
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 823
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 823
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 824
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 824
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 825
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 825
Asp Ala Ser Asn Arg Ala Thr Gly Ile
1 5
<210> 826
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 826
Asp Ala Ser Ser Leu Glu Ser Gly Val
1 5
<210> 827
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 827
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 828
<211> 9
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 828
Asp Ala Ser Asn Leu Glu Thr Gly Val
1 5
<210> 829
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 829
Tyr Cys Gln Gln Ser Tyr Asp Trp Pro Pro Thr
1 5 10
<210> 830
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 830
Tyr Cys Gln Gln Ala Tyr Ser Ile Trp Thr
1 5 10
<210> 831
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 831
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 832
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 832
Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
1 5 10
<210> 833
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 833
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 834
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 834
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 835
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 835
Tyr Cys Gln Gln Tyr Thr His Asp Pro Val Thr
1 5 10
<210> 836
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 836
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 837
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 837
Tyr Cys Gln Gln Gly Tyr Tyr Thr Trp Thr
1 5 10
<210> 838
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 838
Tyr Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5 10
<210> 839
<211> 11
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 839
Tyr Cys Gln Gln Tyr Asp Thr Leu Pro Arg Thr
1 5 10
<210> 840
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 840
Tyr Cys Gln Gln Tyr Tyr Ser Leu Val Thr
1 5 10
<210> 841
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 841
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 842
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 842
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 843
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 843
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 844
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 844
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 845
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 845
Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
1 5 10
<210> 846
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 846
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 847
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 847
Tyr Cys Gln Gln Gly Tyr Ser Leu Trp Thr
1 5 10
<210> 848
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 848
Tyr Cys Gln Gln Gly Tyr Ser Thr Trp Thr
1 5 10
<210> 849
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 849
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 850
<211> 12
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 850
Tyr Cys Gln Gln Tyr Asp Tyr Trp Pro Pro Tyr Thr
1 5 10
<210> 851
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 851
Tyr Cys Gln Gln Gly Tyr Tyr Leu Trp Thr
1 5 10
<210> 852
<211> 10
<212> PRT
<213> 人工生物体(Artificial organism)
<220>
<223> 合成序列
<400> 852
Tyr Cys Gln Gln Gly Tyr Ser Ile Trp Thr
1 5 10
<210> 853
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<220>
<221> 变体
<222> 1
<223> Xaa = F或Y
<220>
<221> 变体
<222> 5
<223> Xaa = G、N或S
<400> 853
Xaa Thr Phe Ser Xaa Tyr Trp Ile His Trp Val
1 5 10
<210> 854
<211> 12
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<220>
<221> 变体
<222> 4
<223> Xaa = S或T
<220>
<221> 变体
<222> 7
<223> Xaa = H或Y
<220>
<221> 变体
<222> 8
<223> Xaa = H或Y
<220>
<221> 变体
<222> 10
<223> Xaa = A、D、G、N或S
<400> 854
Tyr Ser Ile Xaa Ser Gly Xaa Xaa Trp Xaa Trp Ile
1 5 10
<210> 855
<211> 13
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<220>
<221> 变体
<222> 6
<223> Xaa = G或S
<220>
<221> 变体
<222> 9
<223> Xaa = A或G
<220>
<221> 变体
<222> 11
<223> Xaa = A、G或S
<400> 855
Phe Ser Leu Ser Thr Xaa Gly Val Xaa Val Xaa Trp Ile
1 5 10
<210> 856
<211> 21
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<220>
<221> 变体
<222> 3
<223> Xaa = G、S、V或Y
<220>
<221> 变体
<222> 7
<223> Xaa = A、D、S或Y
<220>
<221> 变体
<222> 9
<223> Xaa = D、G或S
<220>
<221> 变体
<222> 10
<223> Xaa = S或T
<400> 856
Val Ser Xaa Ile Ser Gly Xaa Gly Xaa Xaa Thr Tyr Tyr Ala Asp Ser
1 5 10 15
Val Lys Gly Arg Phe
20
<210> 857
<211> 11
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<220>
<221> 变体
<222> 1
<223> Xaa = Q或R
<220>
<221> 变体
<222> 5
<223> Xaa = D、G或S
<220>
<221> 变体
<222> 6
<223> Xaa = I或V
<220>
<221> 变体
<222> 7
<223> Xaa = G、R、S或T
<220>
<221> 变体
<222> 8
<223> Xaa = P、R、S或T
<220>
<221> 变体
<222> 9
<223> Xaa = A、F、S、V或Y
<220>
<221> 变体
<222> 10
<223> Xaa = L或V
<220>
<221> 变体
<222> 11
<223> Xaa = A或G
<400> 857
Xaa Ala Ser Gln Xaa Xaa Xaa Xaa Xaa Xaa Xaa
1 5 10
<210> 858
<211> 9
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<220>
<221> 变体
<222> 1
<223> Xaa = A或D
<220>
<221> 变体
<222> 4
<223> Xaa = N或S
<220>
<221> 变体
<222> 5
<223> Xaa = L或R
<220>
<221> 变体
<222> 6
<223> Xaa = A、E或Q
<220>
<221> 变体
<222> 7
<223> Xaa = S或T
<220>
<221> 变体
<222> 9
<223> Xaa = I或V
<400> 858
Xaa Ala Ser Xaa Xaa Xaa Xaa Gly Xaa
1 5
<210> 859
<211> 10
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<220>
<221> 变体
<222> 5
<223> Xaa = A或G
<220>
<221> 变体
<222> 7
<223> Xaa = S或Y
<220>
<221> 变体
<222> 8
<223> Xaa = I、L或T
<400> 859
Tyr Cys Gln Gln Xaa Tyr Xaa Xaa Trp Thr
1 5 10
<210> 860
<211> 156
<212> PRT
<213> 食蟹猴(Macaca fascicularis)
<400> 860
Leu Gln Asp Leu Cys Ser Asn Cys Pro Ala Gly Thr Phe Cys Asp Asn
1 5 10 15
Asn Arg Ser Gln Ile Cys Ser Pro Cys Pro Pro Asn Ser Phe Ser Ser
20 25 30
Ala Gly Gly Gln Arg Thr Cys Asp Ile Cys Arg Gln Cys Lys Gly Val
35 40 45
Phe Lys Thr Arg Lys Glu Cys Ser Ser Thr Ser Asn Ala Glu Cys Asp
50 55 60
Cys Ile Ser Gly Tyr His Cys Leu Gly Ala Glu Cys Ser Met Cys Glu
65 70 75 80
Gln Asp Cys Lys Gln Gly Gln Glu Leu Thr Lys Lys Gly Cys Lys Asp
85 90 95
Cys Cys Phe Gly Thr Phe Asn Asp Gln Lys Arg Gly Ile Cys Arg Pro
100 105 110
Trp Thr Asn Cys Ser Leu Asp Gly Lys Ser Val Leu Val Asn Gly Thr
115 120 125
Lys Glu Arg Asp Val Val Cys Gly Pro Ser Pro Ala Asp Leu Ser Pro
130 135 140
Gly Ala Ser Ser Ala Thr Pro Pro Ala Pro Ala Arg
145 150 155
<210> 861
<211> 178
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 861
Met Gly Asn Asn Cys Tyr Asn Val Val Val Ile Val Leu Leu Leu Val
1 5 10 15
Gly Cys Glu Lys Val Gly Ala Val Gln Asn Ser Cys Asp Asn Cys Gln
20 25 30
Pro Gly Thr Phe Cys Arg Lys Tyr Asn Pro Val Cys Lys Ser Cys Pro
35 40 45
Pro Ser Thr Phe Ser Ser Ile Gly Gly Gln Pro Asn Cys Asn Ile Cys
50 55 60
Arg Val Cys Ala Gly Tyr Phe Arg Phe Lys Lys Phe Cys Ser Ser Thr
65 70 75 80
His Asn Ala Glu Cys Glu Cys Ile Glu Gly Phe His Cys Leu Gly Pro
85 90 95
Gln Cys Thr Arg Cys Glu Lys Asp Cys Arg Pro Gly Gln Glu Leu Thr
100 105 110
Lys Gln Gly Cys Lys Thr Cys Ser Leu Gly Thr Phe Asn Asp Gln Asn
115 120 125
Gly Thr Gly Val Cys Arg Pro Trp Thr Asn Cys Ser Leu Asp Gly Arg
130 135 140
Ser Val Leu Lys Thr Gly Thr Thr Glu Lys Asp Val Val Cys Gly Pro
145 150 155 160
Pro Val Val Ser Phe Ser Pro Ser Thr Thr Ile Ser Val Thr Pro Glu
165 170 175
Gly Gly
<210> 862
<211> 116
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<400> 862
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu
1 5 10 15
Ser Leu Arg Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Ser Thr Tyr
20 25 30
Trp Ile Ser Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met
35 40 45
Gly Lys Ile Tyr Pro Gly Asp Ser Tyr Thr Asn Tyr Ser Pro Ser Phe
50 55 60
Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr
65 70 75 80
Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Tyr Gly Ile Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val
100 105 110
Thr Val Ser Ser
115
<210> 863
<211> 108
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<400> 863
Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln
1 5 10 15
Thr Ala Ser Ile Thr Cys Ser Gly Asp Asn Ile Gly Asp Gln Tyr Ala
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr
35 40 45
Gln Asp Lys Asn Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Tyr Thr Gly Phe Gly Ser Leu
85 90 95
Ala Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
100 105
<210> 864
<211> 121
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<400> 864
Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr
20 25 30
Tyr Trp Ser Trp Ile Arg Gln Ser Pro Glu Lys Gly Leu Glu Trp Ile
35 40 45
Gly Glu Ile Asn His Gly Gly Tyr Val Thr Tyr Asn Pro Ser Leu Glu
50 55 60
Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu
65 70 75 80
Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
85 90 95
Arg Asp Tyr Gly Pro Gly Asn Tyr Asp Trp Tyr Phe Asp Leu Trp Gly
100 105 110
Arg Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 865
<211> 109
<212> PRT
<213> 人工序列(Artificial Sequence)
<220>
<223> 合成序列
<400> 865
Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro
65 70 75 80
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro
85 90 95
Ala Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105
Claims (56)
1.一种与人CD137的细胞外结构域结合的分离抗体,或其抗原结合片段,其中所述抗体或所述其抗原结合片段与SEQ ID NO:1的氨基酸残基34-108内的一个或多个氨基酸残基结合。
2.如权利要求1所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段与SEQ IDNO:1的氨基酸残基34-93内的一个或多个氨基酸残基结合。
3.如权利要求1或权利要求2所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段与选自由SEQ ID NO:1的氨基酸残基34-36、53-55和92-93组成的组的一个或多个氨基酸残基结合。
4.如权利要求3所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段与SEQ IDNO:1的氨基酸残基34-36中的一个或多个、氨基酸残基53-55中的一个或多个,以及氨基酸残基92-93中的一个或多个结合。
5.如权利要求1-4中任一项所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段不与选自由SEQ ID NO:1的氨基酸残基109-112、125、126、135-138、150和151组成的组的一个或多个氨基酸残基结合。
6.如权利要求5所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段不与SEQID NO:1的氨基酸残基109-112、125、126、135-138、150和151结合。
7.如权利要求1-6中任一项所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段与来自选自由食蟹猴、小鼠、大鼠和/或狗组成的组的至少一种非人物种的CD137多肽交叉反应。
8.如权利要求7所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段与食蟹猴CD137结合。
9.如权利要求1-8中任一项所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段包含重链可变区和轻链可变区,
其中所述重链可变区包含有包含氨基酸序列SEQ ID NO:711的HVR-H1、包含氨基酸序列SEQ ID NO:735的HVR-H2,以及包含氨基酸序列SEQ ID NO:759的HVR-H3;并且/或者
其中所述轻链可变区包含有包含氨基酸序列SEQ ID NO:783的HVR-L1、包含氨基酸序列SEQ ID NO:807的HVR-L2,以及包含氨基酸序列SEQ ID NO:831的HVR-L3。
10.如权利要求9所述的抗体或抗原结合片段,其中所述重链可变区包含氨基酸序列SEQ ID NO:41,并且/或者所述轻链可变区包含氨基酸序列SEQ ID NO:42。
11.如权利要求10所述的抗体或抗原结合片段,其中所述抗体包含重链和轻链,并且其中所述重链包含氨基酸序列SEQ ID NO:617,并且/或者所述轻链包含氨基酸序列SEQ IDNO:618。
12.如权利要求1-8中任一项所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段包含重链可变区和轻链可变区,
其中所述重链可变区包含有包含氨基酸序列SEQ ID NO:712的HVR-H1、包含氨基酸序列SEQ ID NO:736的HVR-H2,以及包含氨基酸序列SEQ ID NO:760的HVR-H3;并且/或者
其中所述轻链可变区包含有包含氨基酸序列SEQ ID NO:784的HVR-L1、包含氨基酸序列SEQ ID NO:808的HVR-L2,以及包含氨基酸序列SEQ ID NO:832的HVR-L3。
13.如权利要求12所述的抗体或抗原结合片段,其中所述重链可变区包含氨基酸序列SEQ ID NO:61,并且/或者所述轻链可变区包含氨基酸序列SEQ ID NO:62。
14.如权利要求13所述的抗体或抗原结合片段,其中所述抗体包含重链和轻链,其中所述重链包含氨基酸序列SEQ ID NO:619,并且/或者所述轻链包含氨基酸序列SEQ ID NO:620。
15.如权利要求1-8中任一项所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段包含重链可变区和轻链可变区,
其中所述重链可变区包含有包含氨基酸序列SEQ ID NO:731的HVR-H1、包含氨基酸序列SEQ ID NO:755的HVR-H2,以及包含氨基酸序列SEQ ID NO:779的HVR-H3;并且/或者
其中所述轻链可变区包含有包含氨基酸序列SEQ ID NO:803的HVR-L1、包含氨基酸序列SEQ ID NO:827的HVR-L2,以及包含氨基酸序列SEQ ID NO:851的HVR-L3。
16.如权利要求15所述的抗体或抗原结合片段,其中所述重链可变区包含氨基酸序列SEQ ID NO:71,并且/或者所述轻链可变区包含氨基酸序列SEQ ID NO:72。
17.如权利要求16所述的抗体或抗原结合片段,其中所述抗体包含重链和轻链,其中所述重链包含氨基酸序列SEQ ID NO:657,并且/或者所述轻链包含氨基酸序列SEQ ID NO:658。
18.一种与人CD137的细胞外结构域结合的分离抗体,或其抗原结合片段,所述抗体或其抗原结合片段包含重链可变区和轻链可变区,
a)其中所述重链可变区包含HVR-H1、HVR-H2和HVR-H3,
其中所述HVR-H1包含根据选自由以下组成的组的式的氨基酸序列:
式(I):X1TFX2X3YX4IHWV(SEQ ID NO:2),其中X1为F或Y,X2为S或T,X3为G、N或S,并且X4为A、G或W;
式(II):YSIX1SGX2X3WX4WI(SEQ ID NO:3),其中X1为S或T,X2为H或Y,X3为H或Y,并且X4为A、D、G、N、S或T;以及
式(III):FSLSTX1GVX2VX3WI(SEQ ID NO:4),其中X1为G或S,X2为A或G,并且X3为A、G、S或T;
其中所述HVR-H2包含根据选自由以下组成的组的式的氨基酸序列:
式(IV):LALIDWX1X2DKX3YSX4SLKSRL(SEQ ID NO:5),其中X1为A、D或Y,X2为D或G,X3为R、S或Y,并且X4为P或T;
式(V):IGX1IYHSGX2TYYX3PSLKSRV(SEQ ID NO:6),其中X1为D或E,X2为N或S,并且X3为N或S;以及
式(VI):VSX1ISGX2GX3X4TYYADSVKGRF(SEQ ID NO:7),其中X1为A、G、S、V或Y,X2为A、D、S或Y,X3为D、G或S,并且X4为S或T;并且
其中所述HVR-H3包含根据下式的氨基酸序列:式(VII):ARX1GX2X3X4VX5GDWFX6Y(SEQ IDNO:8),其中X1为E或G,X2为E或S,X3为D或T,X4为A、T或V,X5为A、I、L、T或V,并且X6为A、D或G;并且/或者
b)其中所述轻链可变区包含HVR-L1、HVR-L2和HVR-L3,
其中所述HVR-L1包含根据下式的氨基酸序列:式(VIII):X1ASQX2X3X4X5X6X7X8(SEQ IDNO:9),其中X1为Q或R,X2为D、G或S,X3为I或V,X4为G、R、S或T,X5为P、R、S或T,X6为A、D、F、S、V或Y,X7为L或V,并且X8为A、G或N;
其中所述HVR-L2包含根据下式的氨基酸序列:式(IX):X1ASX2X3X4X5GX6(SEQ ID NO:10),其中X1为A或D,X2为N、S或T,X3为L或R,X4为A、E或Q,X5为S或T,并且X6为I或V;并且
其中所述HVR-L3包含根据选自由以下组成的组的式的氨基酸序列:
式(X):YCQQX1YX2X3X4T(SEQ ID NO:11),其中X1为A、G、S或Y,X2为Q、S或Y,X3为I、L、T或Y,并且X4为I、S、V或W;以及
式(XI):YCX1QX2X3X4X5PX6T(SEQ ID NO:12),其中X1为E或Q,X2为P、S或Y,X3为D、L、S、T或Y,X4为D、E、H、S或T,X5为D、L T或W,并且X6为L、P、R或V。
19.如权利要求18所述的抗体或抗原结合片段,其中所述HVR-H1包含选自由SEQ IDNO:253-312组成的组的氨基酸序列,所述HVR-H2包含选自由SEQ ID NO:313-372组成的组的氨基酸序列,所述HVR-H3包含选自由SEQ ID NO:373-432组成的组的氨基酸序列,所述HVR-L1包含选自由SEQ ID NO:433-492组成的组的氨基酸序列,所述HVR-L2包含选自由SEQID NO:493-552组成的组的氨基酸序列,并且/或者所述HVR-L3包含选自由SEQ ID NO:553-612组成的组的氨基酸序列。
20.如权利要求18或权利要求19所述的抗体或抗原结合片段,其中所述重链可变区包含选自由SEQ ID NO:13、15、17、19、21、23、25、27、29、31、33、35、37、39、41、43、45、47、49、51、53、55、57、59、61、63、65、67、69、71、73、75、77、79、81、83、85、87、89、91、93、95、97、99、101、103、105、107、109、111、113、115、117、119、121、123、125、127、129和131组成的组的氨基酸序列,并且/或者所述轻链可变区包含选自由SEQ ID NO:14、16、18、20、22、24、26、28、30、32、34、36、38、40、42、44、46、48、50、52、54、56、58、60、62、64、66、68、70、72、74、76、78、80、82、84、86、88、90、92、94、96、98、100、102、104、106、108、110、112、114、116、118、120、122、124、126、128、130和132组成的组的氨基酸序列。
21.如权利要求18所述的抗体或抗原结合片段,其中所述HVR-H1包含根据选自由以下组成的组的式的氨基酸序列:
式(XII):X1TFSX2YWIHWV(SEQ ID NO:853),其中X1为F或Y,并且X2为N或S;
式(XIII):YSIX1SGX2X3WX4WI(SEQ ID NO:854),其中X1为S或T,X2为H或Y,X3为H或Y,并且X4为A、D、G、N或S;以及
式(XIV):FSLSTX1GVX2VX3WI(SEQ ID NO:855),其中X1为G或S,X2为A或G,并且X3为A、G或S;
其中所述HVR-H2包含根据选自由以下组成的组的式的氨基酸序列:
式(IV):LALIDWX1X2DKX3YSX4SLKSRL(SEQ ID NO:5),其中X1为A、D或Y,X2为D或G,X3为R、S或Y,并且X4为P或T;以及
式(XV):VSX1ISGX2GX3X4TYYADSVKGRF(SEQ ID NO:856),其中X1为G、S、V或Y,X2为A、D、S或Y,X3为D、G或S,并且X4为S或T;并且
其中所述HVR-H3包含根据下式的氨基酸序列:式(VII):ARX1GX2X3X4VX5GDWFX6Y(SEQ IDNO:8),其中X1为E或G,X2为E或S,X3为D或T,X4为A、T或V,X5为A、I、L、T或V,并且X6为A、D或G;并且/或者
其中所述HVR-L1包含根据下式的氨基酸序列:式(XVI):X1ASQX2X3X4X5X6X7X8(SEQ IDNO:857),其中X1为Q或R,X2为D、G或S,X3为I或V,X4为G、R、S或T,X5为P、R、S或T,X6为A、F、S、V或Y,X7为L或V,并且X8为A或G;
其中所述HVR-L2包含根据下式的氨基酸序列:式(XVII):X1ASX2X3X4X5GX6(SEQ ID NO:858),其中X1为A或D,X2为N或S,X3为L或R,X4为A、E或Q,X5为S或T,并且X6为I或V;并且
其中所述HVR-L3包含根据下式的氨基酸序列:式(XVIII):YCQQX1YX2X3WT(SEQ ID NO:859),其中X1为A或G,X2为S或Y,并且X3为I、L或T。
22.如权利要求21所述的抗体或抗原结合片段,其中所述HVR-H1包含选自由SEQ IDNO:709-732组成的组的氨基酸序列,所述HVR-H2包含选自由SEQ ID NO:733-756组成的组的氨基酸序列,所述HVR-H3包含选自由SEQ ID NO:757-780组成的组的氨基酸序列,所述HVR-L1包含选自由SEQ ID NO:781-804组成的组的氨基酸序列,所述HVR-L2包含选自由SEQID NO:805-828组成的组的氨基酸序列,并且所述HVR-L3包含选自由SEQ ID NO:829-852组成的组的氨基酸序列。
23.如权利要求21或权利要求22所述的抗体或抗原结合片段,其中所述重链可变区包含选自由SEQ ID NO:15、17、31、33、35、3/、39、41、43、45、4/、49、53、61、63、65、67、71、73、75、79、83、85和87组成的组的氨基酸序列,并且/或者所述轻链可变区包含选自由SEQ IDNO:16、18、32、34、36、38、40、42、44、46、48、50、54、62、64、66、68、72、74、76、80、84、86和88组成的组的氨基酸序列。
24.如权利要求21-23中任一项所述的抗体或抗原结合片段,其中所述抗体包含重链和轻链,其中所述重链包含选自由SEQ ID NO:613、615、617、619、621、623、625、627、629、631、633、635、637、639、641、643、645、647、649、651、653、655、657和659组成的组的氨基酸序列,并且/或者所述轻链包含选自由SEQ ID NO:614、616、618、620、622、624、626、628、630、632、634、636、638、640、642、644、646、648、650、652、654、656、658和660组成的组的氨基酸序列。
25.如权利要求21所述的抗体或抗原结合片段,其中所述HVR-H1包含氨基酸序列SEQID NO:711或731;所述HVR-H2包含氨基酸序列SEQ ID NO:735或755;所述HVR-H3包含氨基酸序列SEQ ID NO:759或779;所述HVR-L1包含氨基酸序列SEQ ID NO:783或803;所述HVR-L2包含氨基酸序列SEQ ID NO:807或827;并且所述HVR-L3包含氨基酸序列SEQ ID NO:831或851。
26.如权利要求25所述的抗体或抗原结合片段,其中所述重链可变区包含氨基酸序列SEQ ID NO:41或71,并且所述轻链可变区包含氨基酸序列SEQ ID NO:42或72。
27.如权利要求26所述的抗体或抗原结合片段,其中所述抗体包含重链和轻链,其中所述重链包含氨基酸序列SEQ ID NO:617或657,并且所述轻链包含氨基酸序列SEQ ID NO:618或658。
28.如权利要求21所述的抗体或抗原结合片段,其中所述HVR-H1包含氨基酸序列SEQID NO:712;所述HVR-H2包含氨基酸序列SEQ ID NO:736;所述HVR-H3包含氨基酸序列SEQID NO:760;所述HVR-L1包含氨基酸序列SEQ ID NO:784;所述HVR-L2包含氨基酸序列SEQID NO:808;并且所述HVR-L3包含氨基酸序列SEQ ID NO:832。
29.如权利要求28所述的抗体或抗原结合片段,其中所述重链可变区包含氨基酸序列SEQ ID NO:61,并且所述轻链可变区包含氨基酸序列SEQ ID NO:62。
30.如权利要求29所述的抗体或抗原结合片段,其中所述抗体包含重链和轻链,其中所述重链包含氨基酸序列SEQ ID NO:619,并且所述轻链包含氨基酸序列SEQ ID NO:620。
31.如权利要求1-30中任一项所述的抗体或抗原结合片段,其中如通过表面等离子体共振所测量,所述抗体或抗原结合片段以100nM或更小的KD结合人CD137。
32.如权利要求31所述的抗体或抗原结合片段,其中如通过表面等离子体共振所测量,所述抗体或抗原结合片段以50nM或更小的KD结合人CD137。
33.如权利要求18-32中任一项所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段与来自选自由食蟹猴、小鼠、大鼠和/或狗组成的组的至少一种非人物种的CD137多肽交叉反应。
34.如权利要求33所述的抗体或抗原结合片段,其中所述抗体或抗原结合片段与食蟹猴CD 137结合。
35.如权利要求1-34中任一项所述的抗体或抗原结合片段,其中当与所述抗体或抗原结合片段接触时,人细胞上表达的人CD137的活性降低。
36.如权利要求1-34中任一项所述的抗体或抗原结合片段,其中对于阻断人CD137与人CD137L的体外结合,所述抗体或抗原结合片段具有约100nM或更小的半最大抑制浓度(IC50)。
37.如权利要求1-34中任一项所述的抗体或抗原结合片段,其中当所述抗体或抗原结合片段以约1μM或更大的浓度提供时,所述抗体或抗原结合片段完全阻断人CD137与人CD137L的体外结合。
38.如权利要求1-34中任一项所述的抗体或抗原结合片段,其中当与所述抗体或抗原结合片段接触时,人细胞上表达的人CD 137的活性增加。
39.如权利要求38所述的抗体或抗原结合片段,其中使表达CD137的人细胞与所述抗体或抗原结合片段接触导致增加的NF-κB依赖性转录。
40.如权利要求1-39中任一项所述的抗体或抗原结合片段,其中所述抗体包含人IgG2Fc区。
41.如权利要求1-40中任一项所述的抗体或抗原结合片段,其中所述抗体包含人IgG4Fc区。
42.如权利要求41所述的抗体或抗原结合片段,其中所述人IgG4Fc区包含S241P突变,其中编号是根据Kabat进行的。
43.如权利要求18-20中任一项所述的抗体或抗原结合片段,其中所述重链可变区由包含选自由SEQ ID NO:133、135、137、139、141、143、145、147、149、151、153、155、157、159、161、163、165、167、169、171、173、175、177、179、181、183、185、187、189、191、193、195、197、199、201、203、205、207、209、211、213、215、217、219、221、223、225、227、229、231、233、235、237、239、241、243、245、247、249和251组成的组的序列的多核苷酸编码,并且/或者所述轻链可变区由包含选自由SEQ ID NO:134、136、138、140、142、144、146、148、150、152、154、156、158、160、162、164、166、168、170、172、174、176、178、180、182、184、186、188、190、192、194、196、198、200、202、204、206、208、210、212、214、216、218、220、222、224、226、228、230、232、234、236、238、240、242、244、246、248、250和252组成的组的序列的多核苷酸编码。
44.如权利要求24所述的抗体或抗原结合片段,其中所述重链由包含选自由SEQ IDNO:661、663、665、667、669、671、673、675、677、679、681、683、685、687、689、691、693、695、697、699、701、703、705和707组成的组的序列的多核苷酸编码,并且/或者所述轻链由包含选自由SEQ ID NO:662、664、666、668、670、672、674、676、678、680、682、684、686、688、690、692、694、696、698、700、702、704、706和708组成的组的序列的多核苷酸编码。
45.一种多核苷酸,其编码如权利要求1-44中任一项所述的抗体或抗原结合片段。
46.一种多核苷酸,其包含选自由SEQ ID NO:133-252组成的组的序列。
47.一种载体,其包含如权利要求45-46中任一项所述的多核苷酸。
48.如权利要求47所述的载体,其中所述载体是表达载体。
49.一种宿主细胞,其包含如权利要求47或权利要求48所述的载体。
50.一种制备抗体或抗原结合片段的方法,其包括在适于产生所述抗体或抗原结合片段的条件下培养如权利要求49所述的宿主细胞。
51.如权利要求50所述的方法,其还包括回收由所述细胞产生的所述抗体或抗原结合片段。
52.一种药物组合物,其包含如权利要求1-42中任一项所述的抗体或抗原结合片段,以及药学上可接受的载剂。
53.一种用于治疗有需要的受试者中的癌症的方法,其包括向所述受试者施用治疗有效量的如权利要求1-42中任一项所述的抗体或抗原结合片段。
54.如权利要求53所述的方法,其还包括向所述受试者施用治疗有效量的至少一种另外的治疗剂。
55.如权利要求54所述的方法,其中所述至少一种另外的治疗剂选自由以下组成的组:病毒基因疗法、免疫检查点抑制剂、靶疗法、放射疗法以及化学疗法。
56.如权利要求54或权利要求55所述的方法,其中所述至少一种另外的治疗剂选自由以下组成的组:泊马度胺、来那度胺、雷利度胺、泊马度胺、沙利度胺、DNA-烷基化含铂衍生物、顺铂、5-氟尿嘧啶、环磷酰胺、抗CTLA4抗体、抗PD-1抗体、抗PD-L1抗体、抗CD20抗体、抗CD40抗体、抗DR5抗体、抗CD1d抗体、抗TIM3抗体、抗SLAMF7抗体、抗KIR受体抗体、抗OX40抗体、抗HER2抗体、抗ErbB-2抗体、抗EGFR抗体、西妥昔单抗、利妥昔单抗、曲妥珠单抗、派姆单抗、放射疗法、单剂量放射、分割放射、病灶放射、全器官放射、IL-12、IFNα、GM-CSF、嵌合抗原受体、过继转移的T细胞、抗癌疫苗以及溶瘤病毒。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2017/098332 WO2019036855A1 (en) | 2017-08-21 | 2017-08-21 | ANTI-CD137 MOLECULES AND THEIR USE |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111511762A true CN111511762A (zh) | 2020-08-07 |
Family
ID=65360267
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780095721.7A Pending CN111511762A (zh) | 2017-08-21 | 2017-08-21 | 抗cd137分子及其用途 |
CN201880063358.5A Pending CN111465615A (zh) | 2017-08-21 | 2018-08-21 | 抗cd137分子及其用途 |
CN202010923848.7A Pending CN112175081A (zh) | 2017-08-21 | 2018-08-21 | 抗cd137分子及其用途 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880063358.5A Pending CN111465615A (zh) | 2017-08-21 | 2018-08-21 | 抗cd137分子及其用途 |
CN202010923848.7A Pending CN112175081A (zh) | 2017-08-21 | 2018-08-21 | 抗cd137分子及其用途 |
Country Status (13)
Country | Link |
---|---|
US (3) | US11242395B2 (zh) |
EP (1) | EP3672991A4 (zh) |
JP (2) | JP7369688B2 (zh) |
KR (1) | KR20200038997A (zh) |
CN (3) | CN111511762A (zh) |
AU (1) | AU2018320257A1 (zh) |
BR (1) | BR112020003601B1 (zh) |
CA (1) | CA3072384A1 (zh) |
IL (1) | IL272700A (zh) |
MX (1) | MX2020001996A (zh) |
SG (1) | SG11202001562YA (zh) |
WO (2) | WO2019036855A1 (zh) |
ZA (1) | ZA202001113B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112175081A (zh) * | 2017-08-21 | 2021-01-05 | 天演药业公司 | 抗cd137分子及其用途 |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201805186VA (en) * | 2016-01-20 | 2018-07-30 | Fate Therapeutics Inc | Compositions and methods for immune cell modulation in adoptive immunotherapies |
SG10201913147WA (en) | 2017-07-11 | 2020-02-27 | Compass Therapeutics Llc | Agonist antibodies that bind human cd137 and uses thereof |
AU2018316166A1 (en) | 2017-08-07 | 2020-02-06 | The Regents Of The University Of California | Platform for generating safe cell therapeutics |
US11718679B2 (en) | 2017-10-31 | 2023-08-08 | Compass Therapeutics Llc | CD137 antibodies and PD-1 antagonists and uses thereof |
WO2019100052A2 (en) | 2017-11-20 | 2019-05-23 | Compass Therapeutics Llc | Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof |
WO2019148444A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Anti-ctla4 antibodies and methods of making and using the same |
WO2019148445A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
RU2020132924A (ru) | 2018-03-08 | 2022-04-11 | Рубиус Терапьютикс, Инк. | Терапевтические клеточные системы и способы лечения рака и инфекционных заболеваний |
EP3894422A4 (en) * | 2018-11-27 | 2022-08-24 | Khona Scientific Holdings, Inc. | BI-DIRECTIONAL MULTIENZYME SCAFFOLDS FOR CANNABINOID BIOSYNTHESIS |
AU2020263959A1 (en) | 2019-04-24 | 2021-11-25 | Heidelberg Pharma Research Gmbh | Amatoxin antibody-drug conjugates and uses thereof |
EP3980461A1 (en) * | 2019-06-05 | 2022-04-13 | Adagene Pte. Ltd. | Anti-cd137l antibodies and methods of using same |
KR20220087479A (ko) * | 2019-11-13 | 2022-06-24 | 허페이 한커맵 바이오테크놀로지 컴퍼니 리미티드 | 인간 4-1bb와 결합할 수 있는 분자 및 이의 응용 |
CN112898426A (zh) * | 2019-11-19 | 2021-06-04 | 非同(成都)生物科技有限公司 | 人源化4-1bb单克隆抗体及其药物组合物 |
TW202144395A (zh) * | 2020-02-12 | 2021-12-01 | 日商中外製藥股份有限公司 | 用於癌症之治療的抗cd137抗原結合分子 |
KR20220148209A (ko) * | 2020-02-28 | 2022-11-04 | 상하이 헨리우스 바이오테크, 인크. | 항cd137 작제물 및 그 용도 |
CA3177717A1 (en) * | 2020-05-13 | 2021-11-18 | Adagene Ag | Compositions and methods for treating cancer |
WO2021226883A1 (en) * | 2020-05-13 | 2021-11-18 | Adagene Ag | Compositions and methods for treating cancer submission of sequence listing on ascii text file |
EP4168048A4 (en) * | 2020-06-23 | 2024-10-16 | Adagene Pte Ltd | COMBINATION THERAPY INCLUDING ANTI-CD137 ANTIBODIES |
WO2022036495A1 (en) | 2020-08-17 | 2022-02-24 | Utc Therapeutics Inc. | Lymphocytes-antigen presenting cells co-stimulators and uses thereof |
JP2024517381A (ja) * | 2021-04-11 | 2024-04-22 | アダジーン インコーポレイテッド | がんを治療するための併用療法 |
EP4416183A1 (en) * | 2021-10-12 | 2024-08-21 | Concept to Medicine Biotech Co., Ltd. | Single-domain 4-1bb antibodies |
WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005035584A1 (en) * | 2003-10-10 | 2005-04-21 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1bb (cd137) |
CN1867585A (zh) * | 2003-10-10 | 2006-11-22 | 布里斯托尔-迈尔斯·斯奎布公司 | 抗人4-1bb(cd137)的完全人抗体 |
AU2015201981A1 (en) * | 2005-10-21 | 2015-05-07 | Genzyme Corporation | Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
Family Cites Families (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
JP2919890B2 (ja) | 1988-11-11 | 1999-07-19 | メディカル リサーチ カウンスル | 単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用 |
US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
EP0861893A3 (en) | 1991-09-19 | 1999-11-10 | Genentech, Inc. | High level expression of immunoglobulin polypeptides |
ES2227512T3 (es) | 1991-12-02 | 2005-04-01 | Medical Research Council | Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago. |
DK0616640T3 (da) | 1991-12-02 | 2004-12-20 | Medical Res Council | Fremstilling af anti-selv antistoffer fra repertoirer af antistofsegmenter og fremvist på fag |
US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
US6765087B1 (en) | 1992-08-21 | 2004-07-20 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
DE69427974T2 (de) | 1993-04-29 | 2001-12-06 | Unilever N.V., Rotterdam | Herstellung von antikörpern oder funktionstüchtig gemachten teilen davon, abgeleitet von schweren ketten von immunglobulinen von camelidae |
US7138500B1 (en) | 1993-05-07 | 2006-11-21 | Immunex Corporation | Antibodies to human 4-1BB |
US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
ATE226641T1 (de) * | 1995-04-08 | 2002-11-15 | Lg Chemical Ltd | Humaner 4-1bb spezifischer humaner antikörper und diesen produzierende zellinie |
US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
WO1998042752A1 (en) | 1997-03-21 | 1998-10-01 | Brigham And Women's Hospital Inc. | Immunotherapeutic ctla-4 binding peptides |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
KR20000034847A (ko) * | 1998-11-17 | 2000-06-26 | 성재갑 | 인간 4-1비비 분자에 대한 인간화 항체 및 이를 포함하는 약학조성물 |
CN1328571B (zh) | 1998-12-23 | 2016-08-31 | 辉瑞大药厂 | 抗ctla-4的人单克隆抗体 |
US20030118588A1 (en) | 1999-05-22 | 2003-06-26 | Linda Diehl | Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
US7605238B2 (en) | 1999-08-24 | 2009-10-20 | Medarex, Inc. | Human CTLA-4 antibodies and their uses |
AU784012B2 (en) | 1999-08-24 | 2006-01-12 | E. R. Squibb & Sons, L.L.C. | Human CTLA-4 antibodies and their uses |
US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
CN100427603C (zh) | 1999-10-04 | 2008-10-22 | 麦迪卡格公司 | 调控外源基因转录的方法 |
JP4200627B2 (ja) | 2000-03-01 | 2008-12-24 | 味の素株式会社 | 変異型チロシンリプレッサー遺伝子とその利用 |
AU2002231368C1 (en) | 2001-01-05 | 2018-08-16 | Amgen Fremont Inc. | Antibodies to insulin-like growth factor I receptor |
CN100335132C (zh) | 2001-01-09 | 2007-09-05 | 默克专利有限公司 | 含有受体酪氨酸激酶抑制剂和血管生成抑制剂的药物组合物及试剂盒 |
WO2004081026A2 (en) | 2003-06-30 | 2004-09-23 | Domantis Limited | Polypeptides |
WO2003002609A2 (en) | 2001-06-28 | 2003-01-09 | Domantis Limited | Dual-specific ligand and its use |
AU2002331643B2 (en) | 2001-08-17 | 2007-10-11 | Coley Pharmaceutical Gmbh | Combination motif immune stimulatory oligonucleotides with improved activity |
AR039067A1 (es) | 2001-11-09 | 2005-02-09 | Pfizer Prod Inc | Anticuerpos para cd40 |
US7771951B2 (en) | 2001-12-03 | 2010-08-10 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
EP1523574A4 (en) | 2002-03-01 | 2005-11-30 | Dyax Corp | MODULAR RECOMBINATORY DISPLAY BANKS |
EP2135879A3 (en) | 2002-06-28 | 2010-06-23 | Domantis Limited | Ligand |
US6887673B2 (en) | 2002-07-30 | 2005-05-03 | Bristol-Myers Squibb Company | Humanized antibodies against human 4-1BB |
AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
DK3284753T3 (da) | 2002-10-17 | 2021-07-05 | Genmab As | Humane monoklonale antistoffer mod cd20 til anvendelse i behandlingen af multipel sclerose |
BRPI0316779B1 (pt) | 2002-12-16 | 2020-04-28 | Genentech Inc | anticorpo humanizado que liga cd20 humano, composição, artigo manufaturado, método de indução da apoptose, método de tratamento de câncer cd20 positivo, métodos de tratamento de doenças autoimunes, ácidos nucléicos isolados, vetores de expressão, células hospedeiras, método para a produção de um anticorpo 2h7 humanizado, polipeptídeo isolado, formulação líquida, método de tratamento de artrite reumatóide (ra) e anticorpos de ligação de cd20 humanizados |
EP1578801A2 (en) | 2002-12-27 | 2005-09-28 | Domantis Limited | Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
EP2357237A1 (en) | 2003-05-14 | 2011-08-17 | Domantis Limited | A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
CN102373214B (zh) | 2003-11-05 | 2014-07-09 | 罗氏格黎卡特股份公司 | 具有增加的Fc受体结合亲和性和效应子功能的CD20抗体 |
WO2005103081A2 (en) | 2004-04-20 | 2005-11-03 | Genmab A/S | Human monoclonal antibodies against cd20 |
US20070253961A1 (en) | 2004-06-09 | 2007-11-01 | Ulsan Industrial Education Foundation | Pharmaceutical Composition Comprising the Anti-4-1Bb Antibody for Treating or Preventing Rheumatoid Arthritis |
US20080152655A1 (en) | 2004-09-08 | 2008-06-26 | The Ohio State University Research Foundation | Combination Therapy With Anti-Ctla4 and Anti-4-1BB Antibodies |
WO2006055697A2 (en) | 2004-11-17 | 2006-05-26 | Board Of Regents, The University Of Texas System | Cancer immunotherapy incorporating p53 |
DE102004063494A1 (de) | 2004-12-23 | 2006-07-13 | Tegenero Ag | Antikörper |
AU2005325801A1 (en) | 2005-01-31 | 2006-08-03 | Ablynx N.V. | Method for generating variable domain sequences of heavy chain antibodies |
WO2006088447A1 (en) | 2005-02-15 | 2006-08-24 | Gtc Biotherapeutics, Inc. | An anti-cd137 antibody as an agent in the treatement of cancer and glycosylation variants thereof |
JP4361545B2 (ja) | 2005-05-09 | 2009-11-11 | 小野薬品工業株式会社 | ProgrammedDeath1(PD−1)に対するヒトモノクローナル抗体および抗PD−1抗体単独または他の免疫療法と併用した癌治療方法 |
CA2610661A1 (en) | 2005-06-03 | 2006-12-07 | Pfizer Products Inc. | Combinations of erbb2 inhibitors with other therapeutic agents in the treatment of cancer |
AR055137A1 (es) | 2005-08-26 | 2007-08-08 | Glycart Biotechnology Ag | Moleculas de union al antigeno modificadas con actividad de senalizacion celular alterada |
CN1294146C (zh) | 2005-10-17 | 2007-01-10 | 山东大学 | 与t细胞表面共刺激分子cd137结合的多肽及其应用 |
WO2007062093A2 (en) | 2005-11-22 | 2007-05-31 | Incyte Corporation | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor |
KR20080090406A (ko) | 2005-11-28 | 2008-10-08 | 젠맵 에이/에스 | 재조합 1가 항체 및 그의 제조 방법 |
US8247537B2 (en) * | 2006-11-15 | 2012-08-21 | Medarex, Inc. | Human monoclonal antibodies to BTLA and methods of use |
KR20080107050A (ko) | 2007-06-05 | 2008-12-10 | 울산대학교 산학협력단 | 항-cd137 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물 |
MX2010000970A (es) | 2007-07-31 | 2010-03-09 | Regeneron Pharma | Anticuerpos humanos contra cd20 humano y metodo para utilizarlos. |
WO2009022215A1 (en) | 2007-08-13 | 2009-02-19 | Pfizer Inc. | Combination motif immune stimulatory oligonucleotides with improved activity |
CA2697032C (en) | 2007-08-22 | 2021-09-14 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
AU2013202755B2 (en) | 2007-08-22 | 2016-05-12 | Cytomx Therapeutics, Inc. | Activatable binding polypeptides and methods of identification and use thereof |
ES2336873B1 (es) | 2007-11-07 | 2011-01-24 | Proyecto De Biomedicina Cima, S.L. | Composicion farmaceutica para el tratamiento de cancer. |
SG10201604770VA (en) | 2007-12-14 | 2016-08-30 | Bristol Myers Squibb Co | Binding molecules to the human ox40 receptor |
US8119129B2 (en) | 2008-08-01 | 2012-02-21 | Bristol-Myers Squibb Company | Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases |
CN106995495A (zh) | 2009-01-12 | 2017-08-01 | 希托马克斯医疗有限责任公司 | 修饰抗体组合物及其制备和使用方法 |
WO2010132389A2 (en) | 2009-05-14 | 2010-11-18 | University Of Maryland, Baltimore | Methods for treating cancers and diseases associated with 4-1bb (cd137) expression |
US9193791B2 (en) | 2010-08-03 | 2015-11-24 | City Of Hope | Development of masked therapeutic antibodies to limit off-target effects |
PT2614082T (pt) | 2010-09-09 | 2018-12-03 | Pfizer | Moléculas de ligação a 4-1bb |
EP2637694B1 (en) | 2010-11-12 | 2021-04-07 | Nektar Therapeutics | Conjugates of an il-2 moiety and a polymer |
BR112014031689A2 (pt) | 2012-06-22 | 2017-07-25 | Cytomx Therapeutics Inc | anticorpos reativos cruzados anti-jagged 1/jagged 2, anticorpos anti-jagged ativáveis e métodos de uso deles |
EP2970952B1 (en) | 2013-03-14 | 2018-07-11 | Adagene Inc. | An integrated system for library construction, affinity binder screening and expression thereof |
CN104250302B (zh) | 2013-06-26 | 2017-11-14 | 上海君实生物医药科技股份有限公司 | 抗pd‑1抗体及其应用 |
CN118146306A (zh) | 2013-09-25 | 2024-06-07 | 西托姆克斯治疗公司 | 基质金属蛋白酶底物和其它可切割部分及其使用方法 |
BR112016013741A2 (pt) | 2013-12-17 | 2017-10-03 | Genentech Inc | Usos de antagonistas de ligação de eixo de pd-1 e um anticorpo de anti-cd20, e kit compreendendo os mesmos |
WO2015094123A1 (en) | 2013-12-20 | 2015-06-25 | National University Of Singapore | Differentiation therapy with cd137 ligand agonists |
ES2872848T3 (es) | 2014-02-21 | 2021-11-02 | Nektar Therapeutics India Pvt Ltd | Agonistas selectivos de IL-2Rbeta en combinación con un anticuerpo anti-CTLA-4 o un anticuerpo anti-PD-1 |
EP3130606B1 (en) | 2014-04-07 | 2021-10-13 | Chugai Seiyaku Kabushiki Kaisha | Immunoactivating bispecific antibodies |
AU2015292406B2 (en) | 2014-07-25 | 2021-03-11 | Cytomx Therapeutics, Inc | Anti-CD3 antibodies, activatable anti-CD3 antibodies, multispecific anti-CD3 antibodies, multispecific activatable anti-CD3 antibodies, and methods of using the same |
CN105296433B (zh) | 2014-08-01 | 2018-02-09 | 中山康方生物医药有限公司 | 一种ctla4抗体、其药物组合物及其用途 |
EP3244907B1 (en) | 2015-01-13 | 2020-02-19 | City of Hope | Ctla4-binding protein peptide-linker masks |
KR20180006367A (ko) | 2015-02-13 | 2018-01-17 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Ctla4에 결합하는 항체 치료제 |
US10233251B2 (en) | 2015-02-22 | 2019-03-19 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind CD137 |
SG11201707383PA (en) | 2015-03-13 | 2017-10-30 | Cytomx Therapeutics Inc | Anti-pdl1 antibodies, activatable anti-pdl1 antibodies, and methods of use thereof |
WO2016179335A1 (en) | 2015-05-04 | 2016-11-10 | Cytomx Therapeutics, Inc. | Anti-itga3 antibodies, activatable anti-itga3 antibodies, and methods of use thereof |
HUE049866T2 (hu) | 2015-05-04 | 2020-11-30 | Cytomx Therapeutics Inc | Aktiválható anti-CD166 antitestek, illetve azok alkalmazási módszerei |
JP2018520650A (ja) | 2015-05-21 | 2018-08-02 | アリゲーター・バイオサイエンス・アーベー | 新規のポリペプチド |
CN108431018A (zh) | 2015-06-12 | 2018-08-21 | 王天欣 | 药物应用中蛋白质修饰的方法 |
BR112018000768A2 (pt) | 2015-07-13 | 2018-09-25 | Cytomx Therapeutics Inc | anticorpos anti-pd-1, anticorpos anti-pd-1 ativáveis e métodos de uso dos mesmos |
CN108026169B (zh) * | 2015-09-22 | 2021-05-28 | 苏州丁孚靶点生物技术有限公司 | 抗人cd137的完全人抗体及其应用 |
GB201519481D0 (en) | 2015-11-04 | 2015-12-16 | Cancer Rec Tech Ltd | Immunomodulatory antibodies |
US10618960B2 (en) | 2015-12-15 | 2020-04-14 | Oncoimmune, Inc. | Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof |
BR112018012138A2 (pt) | 2015-12-17 | 2018-12-04 | Novartis Ag | moléculas de anticorpo para pd-1 e usos das mesmas |
US20190016812A1 (en) | 2015-12-22 | 2019-01-17 | Abbvie Stemcentrx Llc | Novel anti-tnfsf9 antibodies and methods of use |
EP3417293A1 (en) | 2016-02-18 | 2018-12-26 | Institut Gustave Roussy | Methods and kits for predicting the sensitivity of a subject to immunotherapy |
WO2017151940A2 (en) | 2016-03-03 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
SG10201603721TA (en) | 2016-05-10 | 2017-12-28 | Agency Science Tech & Res | Anti-CTLA-4 Antibodies |
US10875921B2 (en) | 2016-05-27 | 2020-12-29 | Abbvie Biotherapeutics Inc. | Anti-4-1BB antibodies and their uses |
KR102632202B1 (ko) * | 2016-07-14 | 2024-02-02 | 젠맵 에이/에스 | Cd40 및 cd137에 대한 다중특이적 항체 |
CN107840887B (zh) | 2016-09-21 | 2022-03-25 | 基石药业(苏州)有限公司 | 一种新的pd-1单克隆抗体 |
GB201619648D0 (en) | 2016-11-21 | 2017-01-04 | Alligator Bioscience Ab | Novel antibodies and uses thereof |
EP3523332B1 (en) | 2017-01-06 | 2021-12-29 | Eutilex Co., Ltd. | Anti-human 4-1 bb antibodies and use thereof |
TWI842672B (zh) | 2017-04-13 | 2024-05-21 | 美商艾吉納斯公司 | 抗cd137抗體及其使用方法 |
KR20180119135A (ko) | 2017-04-24 | 2018-11-01 | 주식회사 제넥신 | 4-1bbl 변이체 및 이를 포함하는 융합 단백질 |
US20200048358A1 (en) | 2017-05-02 | 2020-02-13 | Alligator Bioscience Ab | Bispecific antibody against ox40 and ctla-4 |
BR112019023992A2 (pt) | 2017-05-19 | 2020-06-16 | Wuxi Biologics (Shanghai) Co., Ltd. | Anticorpo ou fragmento de ligação ao antígeno do mesmo, seu método de produção, seus usos, bem como molécula de ácido nucleico, vetor de clonagem ou expressão, célula hospedeira, hibridoma, composição farmacêutica e imunoconjugado |
SG10201913147WA (en) | 2017-07-11 | 2020-02-27 | Compass Therapeutics Llc | Agonist antibodies that bind human cd137 and uses thereof |
GB201712032D0 (en) | 2017-07-26 | 2017-09-06 | Bioinvent Int Ab | Antibodies and uses thereof |
CN111511762A (zh) * | 2017-08-21 | 2020-08-07 | 天演药业公司 | 抗cd137分子及其用途 |
CA3072143A1 (en) | 2017-08-21 | 2019-02-28 | Adagene Inc. | Dynamic human heavy chain antibody libraries |
SG11202001549UA (en) | 2017-08-21 | 2020-03-30 | Adagene Inc | Dynamic human antibody light chain libraries |
US11718679B2 (en) | 2017-10-31 | 2023-08-08 | Compass Therapeutics Llc | CD137 antibodies and PD-1 antagonists and uses thereof |
WO2019104716A1 (en) | 2017-12-01 | 2019-06-06 | Adagene Inc. | Methods for using cd137 ligand as biomarker for treatment with anti-cd137 antibody |
WO2019148444A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Anti-ctla4 antibodies and methods of making and using the same |
WO2019148445A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
EP3980461A1 (en) | 2019-06-05 | 2022-04-13 | Adagene Pte. Ltd. | Anti-cd137l antibodies and methods of using same |
CA3177717A1 (en) | 2020-05-13 | 2021-11-18 | Adagene Ag | Compositions and methods for treating cancer |
-
2017
- 2017-08-21 CN CN201780095721.7A patent/CN111511762A/zh active Pending
- 2017-08-21 WO PCT/CN2017/098332 patent/WO2019036855A1/en active Application Filing
-
2018
- 2018-08-21 EP EP18847500.8A patent/EP3672991A4/en active Pending
- 2018-08-21 KR KR1020207007877A patent/KR20200038997A/ko not_active Application Discontinuation
- 2018-08-21 JP JP2020510103A patent/JP7369688B2/ja active Active
- 2018-08-21 AU AU2018320257A patent/AU2018320257A1/en active Pending
- 2018-08-21 US US16/108,018 patent/US11242395B2/en active Active
- 2018-08-21 WO PCT/CN2018/101501 patent/WO2019037711A1/en unknown
- 2018-08-21 BR BR112020003601-3A patent/BR112020003601B1/pt active IP Right Grant
- 2018-08-21 CN CN201880063358.5A patent/CN111465615A/zh active Pending
- 2018-08-21 MX MX2020001996A patent/MX2020001996A/es unknown
- 2018-08-21 CA CA3072384A patent/CA3072384A1/en active Pending
- 2018-08-21 SG SG11202001562YA patent/SG11202001562YA/en unknown
- 2018-08-21 CN CN202010923848.7A patent/CN112175081A/zh active Pending
- 2018-08-21 US US16/640,684 patent/US11859003B2/en active Active
-
2020
- 2020-02-16 IL IL272700A patent/IL272700A/en unknown
- 2020-02-21 ZA ZA2020/01113A patent/ZA202001113B/en unknown
-
2021
- 2021-12-28 US US17/564,022 patent/US20220204637A1/en active Pending
-
2022
- 2022-11-28 JP JP2022189388A patent/JP2023036590A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005035584A1 (en) * | 2003-10-10 | 2005-04-21 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1bb (cd137) |
CN1867585A (zh) * | 2003-10-10 | 2006-11-22 | 布里斯托尔-迈尔斯·斯奎布公司 | 抗人4-1bb(cd137)的完全人抗体 |
AU2015201981A1 (en) * | 2005-10-21 | 2015-05-07 | Genzyme Corporation | Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
Non-Patent Citations (2)
Title |
---|
MAKKOUK A等: "Rationale for anti-CD137 cancer immunotherapy", EUR J CANCE, vol. 54, 2 January 2016 (2016-01-02), pages 112 - 119, XP029401784, DOI: 10.1016/j.ejca.2015.09.026 * |
李娜等: "人CD137胞外区噬菌体展示系统的构建及鉴定", 中国免疫学杂志, vol. 04, 20 April 2006 (2006-04-20), pages 294 - 298 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112175081A (zh) * | 2017-08-21 | 2021-01-05 | 天演药业公司 | 抗cd137分子及其用途 |
Also Published As
Publication number | Publication date |
---|---|
MX2020001996A (es) | 2020-09-09 |
EP3672991A1 (en) | 2020-07-01 |
JP2020532965A (ja) | 2020-11-19 |
CN112175081A (zh) | 2021-01-05 |
US11859003B2 (en) | 2024-01-02 |
US20200369776A1 (en) | 2020-11-26 |
CN111465615A (zh) | 2020-07-28 |
IL272700A (en) | 2020-04-30 |
EP3672991A4 (en) | 2021-05-26 |
JP2023036590A (ja) | 2023-03-14 |
US11242395B2 (en) | 2022-02-08 |
CA3072384A1 (en) | 2019-02-28 |
US20190055314A1 (en) | 2019-02-21 |
KR20200038997A (ko) | 2020-04-14 |
WO2019037711A1 (en) | 2019-02-28 |
BR112020003601B1 (pt) | 2023-10-31 |
AU2018320257A1 (en) | 2020-03-05 |
ZA202001113B (en) | 2022-07-27 |
JP7369688B2 (ja) | 2023-10-26 |
SG11202001562YA (en) | 2020-03-30 |
BR112020003601A2 (pt) | 2020-09-01 |
WO2019036855A1 (en) | 2019-02-28 |
US20220204637A1 (en) | 2022-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2023036590A (ja) | 抗cd137分子及びその使用 | |
KR102569813B1 (ko) | Cd73에 대항한 항체 및 그의 용도 | |
KR102493282B1 (ko) | Tim3에 대한 항체 및 그의 용도 | |
KR101923326B1 (ko) | 글루코코르티코이드-유도 종양 괴사 인자 수용체 (gitr)에 대한 항체 및 그의 용도 | |
KR102473028B1 (ko) | 항-tim-3 항체 및 조성물 | |
JP2022046651A (ja) | 4-1bb結合分子 | |
AU2024200534A1 (en) | Anti-TL1A/anti-TNF-alpha bispecific antigen binding proteins and uses thereof | |
KR20230038311A (ko) | 항-cd73 항체와의 조합 요법 | |
KR20180082563A (ko) | 글루코코르티코이드-유도된 종양 괴사 인자 수용체 (gitr)에 대한 항체 및 그의 용도 | |
TW202428604A (zh) | 結合至ilt4的抗體 | |
KR20180048684A (ko) | 암의 치료에 사용하기 위한 5-브로모-2,6-디-(1h-피라졸-1-일)피리미딘-4-아민 | |
TW201008579A (en) | Anti-Fn14 antibodies and uses thereof | |
TW201032823A (en) | Human CGRP receptor binding proteins | |
KR20200044899A (ko) | 암의 치료 및 진단을 위한 tim-3 길항제 | |
KR20180118746A (ko) | Il7 수용체 세포외 도메인의 알파 쇄에 대해 지시된 비-길항성 항체 및 암 치료에 있어서 이의 용도 | |
KR20200006115A (ko) | 항-gitr 효능제 항체에 의한 암의 치료 | |
KR20200108870A (ko) | Tim3에 대한 항체 및 그의 용도 | |
KR20210031722A (ko) | 산성 pH에서 VISTA에 결합하는 항체 | |
KR20240017912A (ko) | 항-ccr8 항체 및 이의 용도 | |
AU2020316498A1 (en) | Humanized anti-VEGF monoclonal antibody | |
KR20220117300A (ko) | 고형 종양의 치료를 위한 메소텔린-표적화 cd40 작용성 다중특이성 항체 작제물 | |
CN117580861A (zh) | 用抗icos抗体治疗pd-l1阴性或低表达癌症 | |
NZ789986A (en) | Antibodies against tim3 and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |